Bioactive 4-phenylcoumarins from Mesua Elegans and Mesua Kunstleri / Chan Gomathi by Chan, Gomathi
 BIOACTIVE 4-PHENYLCOUMARINS FROM 
MESUA ELEGANS AND MESUA KUNSTLERI  
 
 
 
 
 
 
 
 
 
 
 
 
CHAN GOMATHI 
 
 
 
 
 
 
 
 
 
 
 
 
 
FACULTY OF SCIENCE 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
 
2015
i 
 
BIOACTIVE 4-PHENYLCOUMARINS FROM 
MESUA ELEGANS AND MESUA KUNSTLERI  
 
 
 
 
 
 
 
 
 
CHAN GOMATHI 
 
 
 
 
 
 
 
 
 
THESIS SUBMITTED IN FULFILMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
 
 
 
 
FACULTY OF SCIENCE 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
 
2015 
ii 
ABSTRACT 
 
Phytochemical analyses on the bark of two Clusiaceae plants, Mesua elegans and 
Mesua kunstleri, were carried out. Twenty-four compounds were successfully isolated 
using several chromatographic techniques; column chromatography (CC), thin layer 
chromatography (TLC), preparative thin layer chromatography (PTLC), centrifugal 
partition chromatography (CPC) and high performance liquid chromatography (HPLC). 
The structures of the isolated compounds were elucidated using various spectroscopic 
methods; 1D-NMR (1H, 13C and DEPT), 2D-NMR (COSY, HSQC, HMBC and 
NOESY), UV, IR, HRESIMS and by comparison with data from the literature. 
  
A total of twenty-two compounds were isolated from M. elegans, namely mammea 
A/BA 28, 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-
phenyl-2H-chromen-2-one 47, 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one 48, mammea A/BB 55, mammea 
A/BA cyclo D 187, mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, 
ochrocarpin E 192, mammea A/BB cyclo F 193, mammea A/BA cyclo F 194, 
mesuagenin F 195, mesuagenin D 196, isodisparfuran 197, mesuagenin G 198, 
mesuagenin H 199, mesuagenin I 200, mesuagenin J 201, mesuagenin K 202, 
mesuagenin L 203, mesuagenin M 204 and mesuagenin N 205, of which thirteen are 
new; mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, mesuagenin F 195, 
mesuagenin D 196, mesuagenin G 198, mesuagenin H 199, mesuagenin I 200, 
mesuagenin J 201, mesuagenin K 202, mesuagenin L 203, mesuagenin M 204 and 
mesuagenin N 205.  
 
iii 
From M. kunstleri, a total of ten compounds were isolated, which are mammea A/BA 
28, 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-
2H-chromen-2-one 47, 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-
2,6-dienyl]-4-phenyl-2H-chromen-2-one 48, mammea A/BB 55, mammea A/BB cyclo 
D 186, mammea A/BA cyclo D 187, mesuagenin E 188, mesuagenin A 189, 
mesuagenin B 190 and mesuagenin C 191, of which one is new; mesuagenin E 188. 
 
Bioassay-guided study of the bark from M. elegans afforded mesuagenin B 190 from 
the hexane fraction as the active constituent for acetylcholinesterase (AChE) inhibition 
activity with an IC50 value of 0.70 µM. Further isolation work carried out on this hexane 
extract afforded more natural 4-phenylcoumarins Semi-synthetic work was done on the 
major 4-phenylcoumarins from this extract, which afforded seventeen semi-synthetic 
compounds. All of the natural and semi-synthetic 4-phenylcoumarin analogues were 
subjected to a SAR study for AChE activity. Another bioassay-guided study was carried 
out to isolate and evaluate the neuroprotective compounds from the hexane extract of 
the bark of M. kunstleri. Mesuagenin C 191 was isolated as the most active compound; 
cell viability data demonstrated that this compound significantly increased cell viability 
(78.99 ± 3.49%) after NG108-15 cells were exposed to 2 mM H2O2 and 2 hours of 
pretreatment with mesuagenin C 191.  
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ABSTRAK 
 
Kajian fitokimia telah dijalankan dengan menggunakan bahagian batang daripada dua 
pokok Clusiaceae, Mesua elegans dan Mesua kunstleri. Dua puluh empat sebatian telah 
berjaya dipisahkan dengan menggunakan beberapa kaedah spektroskopi; kromatografi 
turus, kromatografi lapisan nipis, kromatografi lapisan nipis persediaan, kromatografi 
partisi empar dan kromatografi cecair prestasi tinggi. Struktur sebatian-sebatian yang 
dipisahkan telah diilusidasi dengan menggunakan pelbagai kaedah spektroskopi; 1D 
NMR (1H, 13C dan DEPT), 2D NMR (COSY, HSQC, HMBC dan NOESY), UV, IR, 
HRESIMS dan perbandingan dengan data-data daripada kesusasteraan. 
 
Sejumlah dua puluh dua sebatian telah dipisahkan daripada M. elegans, iaitu mammea 
A/BA 28, 5,7-dihidroksi-8-(2-metilbutanoil)-6-[(E)-3,7-dimetilokta-2,6-dienil]-4-fenil-
2H-kromen-2-one 47, 5,7-dihidroksi-8-(3-metilbutanoil)-6-[(E)-3,7-dimetilokta-2,6-
dienil]-4-fenil-2H-kromen-2-on 48, mammea A/BB 55, mammea A/BA siklo D 187, 
mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, ochrocarpin E 192, 
mammea A/BB siklo F 193, mammea A/BA siklo F 194, mesuagenin F 195, 
mesuagenin D 196, isodisparfuran 197, mesuagenin G 198, mesuagenin H 199, 
mesuagenin I 200, mesuagenin J 201, mesuagenin K 202, mesuagenin L 203, 
mesuagenin M 204 dan mesuagenin N 205, di mana tiga belas daripadanya ialah 
sebatian baru; mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, mesuagenin F 
195, mesuagenin D 196, mesuagenin G 198, mesuagenin H 199, mesuagenin I 200, 
mesuagenin J 201, mesuagenin K 202, mesuagenin L 203, mesuagenin M 204 dan 
mesuagenin N 205. 
 
v 
Daripada M. kunstleri, sejumlah sepuluh sebatian telah dipisahkan, iaitu mammea A/BA 
28, 5,7-dihidroksi-8-(2-metilbutanoil)-6-[(E)-3,7-dimetilokta-2,6-dienil]-4-fenil-2H-
kromen-2-one 47, 5,7-dihidroksi-8-(3-metilbutanoil)-6-[(E)-3,7-dimetilokta-2,6-dienil]-
4-fenil-2H-kromen-2-on 48, mammea A/BB 55, mammea A/BB siklo D 186, mammea 
A/BA siklo D 187, mesuagenin E 188, mesuagenin A 189, mesuagenin B 190 dan 
mesuagenin C 191, dimana satu sebatian ialah baru; mesuagenin E 188. 
 
Kajian berpandukan bioesei dijalankan dengan menggunakan bahagian batang daripada 
M. elegans memberikan mesuagenin B 190 sebagai sebatian yang aktif daripada ekstrak 
heksana untuk aktiviti penyekatan asetil kolinesterina (AChE) dengan IC50 0.70µM. 
Kerja pengasingan selanjutnya yang dijalankan dengan ekstrak heksana ini memberikan 
lebih banyak 4-fenilkomarin semulajadi dan kerja-kerja separa-sintesis dijalankan ke 
atas sebatian 4-fenilkomarin utama (major) daripada ekstrak ini, dimana tujuh belas 
sebatian separa-sintesis telah diperolehi. Satu kajian SAR telah dijalankan ke atas 
semua analog 4-fenilkomarin semulajadi dan separa-sintesis. Satu lagi kajian 
berpandukan bioesei telah dijalankan untuk mengasing dan menilai sebatian-sebatian 
pelindung neuro dengan menggunakan ekstrak heksana bahagian batang daripada M. 
kunstleri. Mesuagenin C 191 telah diasingkan sebagai sebatian yang paling aktif; data 
daya maju sel menunjukkan sebatian ini telah meningkatkan daya maju sel dengan 
ketara (78.99 ± 3.49%) selepas sel-sel NG108-15 telah didedahkan kepada  2 mM H2O2 
dan 2 jam prarawatan dengan mesuagenin C 191. 
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CHAPTER 1 
INTRODUCTION 
 
Throughout the ages, humans have depended on nature for their basic needs, including 
medicines for the treatment of a wide spectrum of diseases1. Plants have formed the 
basis of sophisticated traditional medicine systems, with the earliest records of natural 
products depicted on clay tablets in cuneiform from Mesopotamia (2600 B.C.). These 
documented oils from Cupressus sempervirens (Cypress) and Commiphora species 
(myrrh), which are still used today to treat coughs, colds and inflammation. The use of 
natural products as medicines has been described throughout history in the form of 
traditional medicines, remedies, potions and oils, with many of these bioactive natural 
products still being unidentified2. A vast majority of people on this planet still rely on 
their traditional material medica (medicinal plants and other materials) for their 
everyday healthcare needs, and their use by different cultures, has been extensively 
documented3. The World Health Organization (WHO) estimated in 1985, that 
approximately 65% of the population of the world predominantly relied on plant-
derived traditional medicines for their primary health care4. Interestingly, more than 
90% of current therapeutic classes derive from a natural product prototype4.  
 
Natural products have been the most successful source of potential drug leads1,2,3,5 
because they possess a vast range of unique structures with unusual functional groups 
that have been an inspiration for creating new entities through synthetic 
chemistry6,7,8,9,10. Their magnificent structural diversity and complexity has urged 
synthetic chemists to produce them in the laboratory, often with beneficial therapeutic 
applications in mind. Natural products have been precious as tools for deciphering the 
logic of biosynthesis, and as platforms for developing front-line drugs, and many drugs 
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used today are natural products or natural-product derivatives5, 11. Indeed, the plant 
kingdom has proven to be among the best source of natural products, with leading 
examples such as morphine 1, vincristine 2, vinblastine 3, artemisinin 4, quinine 5 and 
paclitaxel 8, while etoposide 6 and teniposide 7 are examples of potent natural-product 
derivatives12.  
 
Amongst all types of forest, the tropical rainforest is considered as the most diverse and 
dense. There are only three areas in the world where tropical rainforests are found – 
tropical South America, Central Africa and Southeast Asia. The rainforests of Southeast 
Asia are believed to be the oldest, and among the most biologically diverse, in the 
world13,14,15. The species richness and endemism of Malaysia is of major global 
importance. It ranks 21st among all countries in absolute diversity and 20th when 
adjusted to the country's area. Malaysia has more than 15,000 higher plant species, of 
which 2,700 species are endemic16. Therefore, the Malaysian flora is a potential 
producer of potent bioactive compounds which could serve as leads in drug discovery 
research.  
 
Some examples of unique bioactive compounds from this extremely rich flora are 
rhazinilam 9, calanolide A 10, and kingianin A 11. Rhazinilam 9, a substance first 
isolated from Rhazya stricta (Apocynaceae), has been re-isolated from a Malaysian 
plant, Kopsia singapurensis, and is an antitubulin alkaloid which possesses both the 
effect of the vinblastine and taxol classes of compounds and is widely studied for its’ 
activity and synthesis17,18,19. In another study, calanolide A 10, discovered in the 
extracts from the Malaysian tropical rainforest tree, Calophyllum lanigerum 
(Clusiaceae), is a novel inhibitor of the human immunodeficiency virus (HIV) type 1, 
and various studies have been carried out on this compound since its’ discovery in 
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199220,21,22,23. Kingianin A 11, from a Malaysian Endiandra kingiana (Lauraceae), is a 
new polyketide that has an unprecedented pentacyclic carbon skeleton and constitutes 
the first member of a new chemical series. The (˗)-enantiomer of kingianin A 11 
posseses a binding affinity evaluated on Bcl-xL by competition against the fluorescent-
tagged BH3 domain of the protein Bak24,25. 
 
Due to the vastness and diversity of this rich flora, many of Malaysian plants have never 
been the subject of any chemical or biological studies. Therefore, under the framework 
of French-Malaysian collaboration program, a survey on extracts inhibiting 
acetylcholinesterase (AChE) was conducted on plants from the Malaysian flora, and it 
was found that the ethyl acetate extracts from Mesua elegans (King) Kosterm. and 
Mesua kunstleri (King) Kosterm. exhibited strong AChE inhibitory activity, with 90% 
inhibition at 10 g/mL, for both plants. In addition to the AChE activity, a bioassay-
guided study of neuroprotective inhibition activity was also done, since both the 
activities (AChE inhibition and neuroprotective inhibition activities), are related to 
neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. Henceforth, a 
bioassay-guided study and structure-activity relationship (SAR) study of AChE 
inhibitors from Mesua elegans (King) Kosterm. and a bioassay-guided study of 
neuroprotective inhibition activity from Mesua kunstleri (King) Kosterm. shall be 
reported. Both plants belong to the family Clusiaceae. The plant sample of M. elegans 
was collected from Sintok Forest Reserve, Kedah, while M. kunstleri was collected 
from Rimba Teloi Forest Reserve, Kedah.  
 
The objectives of this research are:  
i. to isolate the chemical constituents from M. elegans and M. kunstleri by using 
different chromatographic techniques; CC, PTLC, HPTLC, CPC and HPLC. 
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ii. to characterize the chemical structures of the isolated compounds by using various 
1D and 2D spectroscopic methods; NMR, UV, IR and LC-MS. 
iii. to evaluate the acetylcholinesterase (AChE) inhibitory activity of the isolated 
compounds from M. elegans through bioassay-guided approach and identify the 
compound/s which is/are responsible as AChE inhibitor/s. 
iv. to perform chemical modifications on the isolated major chemical constituents from 
M. elegans and subject the modified compounds for AChE inhibitory activity 
evaluation. 
v. to conduct a structure-activity relationship (SAR) studies on the constituents and 
chemically modified compounds from M. elegans for AChE inhibitory activity. 
vi. to evaluate the neuroprotective effects of the isolated compounds from M. kunstleri 
through bioassay-guided method and identify the compound/s which is/are 
responsible as neuroprotective agent(s). 
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1.1 Clusiaceae: Distribution and Habitat 
The Clusiaceae in Peninsular Malaysia, which was formerly known as the Guttiferae, 
includes some important and well-known trees. Many plants from this family are known 
for their timber value and there are extensive stands in parts of the hill forests which are 
likely to become important. This family is mainly distributed in the tropical regions, 
comprising 40 genera and more than 1000 species, which are least abundant in Africa. 
Peninsular Malaysia elaborates 4 genera with 121 species. They can be found in all 
kinds of habitat, and are an important component of the Peninsular Malaysian Rain 
Forest. The family includes Calophyllum, Garcinia, Mammea and Mesua26. 
 
Calophyllum, Garcinia and Mesua are all found from the sea level to the top of the 
highest mountains; the latter two genera are found mainly in dry land forests, and only 
Calophyllum is common in swamp forests. The genus Mammea is rare and is restricted 
to the lowlands. Several Mesua characterise poor sites in ridge forests27. Clusiaceae is a 
family of the main canopy of the forest and no species grows to become an emergent 
tree26. 
 
 1.2 General Appearance and Morphology 
This tropical family is often related with the St. John’s Wort-family (Hypericaceae)28. 
Plants from Clusiaceae are usually rather slender, small to medium or big trees, and are 
occasionally shrubs. Inner bark is usually sticky exudate, which is occasionally very 
slowly appearing, clear or opaque, white or yellow. The wood is usually hard, dark and 
dense26. 
 
Twigs are usually square at first. The leaves are opposite, decussate, coriaceous and 
shortly stalked; commonly leathery, with oil glands or passages, which is sometimes 
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visible as translucent dots27. The secondary nerves are usually numerous, more or less 
straight and parallel, frequently with equally prominent, shorter and intermediate nerves 
(intercostals); sometimes with tiny reduced needle-like leaves resembling stipules26. 
 
Flowers are often bright and showy, scented and insect-pollinated; solitary or in short 
cymose to umbellate groups, terminal, axillary, or on the twigs behind the leaves28. It is 
often with bracteoles below the calyx, with sepals free and usually overlapping (fused at 
first in Mammea) and with petals free and overlapping. The stamens are usually 
numerous, often variously united as a ring or into bundles and with ovary superior, 1-3-
5-(12) chambers, each with 1-2 basal or axile ovules. They are with 1 style and often a 
big stigma; unisexual and monoecious, dioecious or hermaphrodite26. 
 
The fruit is a drupe (Calophyllum and Mammea), a nut (Mesua) or a berry with the 
seeds embedded in pulp (Garcinia); sometimes seated on the persistent sepals. The 
seeds are without endosperm, either with big cotyledons (Calophyllum, Mammea and 
Mesua) or apparently without cotyledons and germinating with the root and shoot 
emerging at opposite ends (Garcinia)26. 
 
1.3 Classification of the Clusiaceae29,30  
Classification of the family Clusiaceae is not an easy task. Determination of a genus is 
dependent on a combination of characters, for instance those of the petal and fruit. This 
family is divided into six sub-families: Kielmeyeroideae, Calophylloideae, Clusioideae, 
Moronoboideae, Lorostemonoideae and Hypericoideae (Scheme 1.1). These sub-
families are further divided into a few tribes and each tribe comprises of several genera 
(Scheme 1.2). 
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Phylum    Gymnospermae   Angiospermae 
 
Sub-phylum             Monocotyledones   Dicotyledones 
 
Division        Lignosae                  Herbaceae 
 
Order       Guttiferales 
 
Family                  Clusiaceae               Hypericaceae 
 
Sub-family         Kielmeyeroideae          Moronoboideae          Lorostemonoideae 
 
                                  Calophylloideae            Clusioideae             Hypericoideae 
 
Scheme 1.1: Classification of the Clusiaceae  
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     Sub-family            Kielmeyeroideae         Calophylloideae         Moronoboideae          Clusioideae         Lorostemonoideae     Hypericoideae 
 
     Tribe       Calophylleae               Clusieae                Garcinieae 
 
     Genus      Calophyllum*                   Clusia       Allanblackia 
            Mesua*         Tovomita              Garcinia* 
          Mammea*              Pentaphalangium 
                           Rheedia 
 
Scheme 1.2: Genera of the Clusiaceae 
     * Genus found in Peninsular Malaysia3  
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1.4 The Genus: Mesua 
The genus Mesua is locally known as ‘penaga’, comprising small to medium trees with 
very hard and heavy wood. Mesua ferrea is the commonest wild species in this genus, 
and is also a common ornamental26. Table 1.1 below lists some of the species of Mesua 
and their distributions. 
 
Table 1.1: Species of Mesua and Their Distribution26,27 
Mesua Species  Distribution 
M. ferrea Linn. Malacca, Negeri Sembilan, Pahang, Selangor, Perak, 
Penang, India, Cambodia and Siam 
M. kochummeniana 
Whitmore 
Johor and Pahang (Common in Gunung Lesong Forest 
Reserve) 
M. daphnifolia (Ridley) 
Kosterm. 
Perak and Fraser’s Hill, Pahang 
M. racemosa (Planch. ex 
Triana et Planch) Kosterm. 
Kelantan, Terengganu, Kedah, Perak, Penang, Pahang, 
Selangor and Malacca 
M. kunstleri (King) 
Kosterm. 
Malacca and central Pahang 
M. rosea (Ridley) Kosterm. Johor 
M. elegans (King) Kosterm. Perak, Selangor, Kedah, Pahang, Negeri Sembilan, Johor 
and Singapore 
M. purseglovei Whitmore Pahang 
M. wrayi (King) Kosterm. Gunung Korbu and Cameron Highlands 
M. lepidota T. Anders. Terengganu, Pahang, Perak, Selangor, Negeri Sembilan, 
Malacca, Johor and Sumatra 
M. nuda Kosterm. Ex 
Whitmore 
Kelantan, Terengganu, Kedah, Penang, Perak, Pahang 
(common in Baloh Forest Reserve), Selangor (common 
in Ulu Gombak Forest Reserve), Malacca, Negeri 
Sembilan and Johor 
M. grandis (King) Kosterm. Terengganu, Perak and Pahang 
M. aff. assamica (King et 
Prain) Kosterm. 
Kedah, West Kelantan, Terengganu, Pahang (including 
Pulau Tioman), Negeri Sembilan, Johor and Assam 
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1.5 Mesua: General Morphology and Appearance 
Plants from the genus Mesua are bushes or small to large trees, and their crown is 
monopodial, but becoming sympodial. The branches and foliage sprays are often 
pendulous. The bole is commonly fluted, especially at butt, sometimes of rather poor 
form. The bark is smooth to adherent-scaly, sometimes somewhat dippled. The inner 
bark is firmly fibrous, usually pink to red, with a little, usually clear, sticky exudate 
appearing as a thin, varnish-like film, or as separate drops. The outer bark is sometimes 
with an ochre to buff layer inwards. The wood is exceedingly hard, dark inwards, 
sometimes tangentially banded pale and dark26. 
 
Leaves are opposite and stiffly coriaceous27. They are also glabrous or occasionally 
glaucous (M. ferrea and M. kochummeniana), and often shiny. The secondary nerves are 
usually arising nearly normal to midrib, running parallel nearly to margin then looping; 
frequently with equally prominent intercostals. It has small or tiny reduced interpetiolar 
leaves (hypsophylls), sometimes persistent, with paired needle-like stipules26. 
 
The flowers are bisexual, axillary or terminal, and usually they are stalked with small 
paired bracts; solitary or cymosely in 1-9 flowered open panicles27. They have sepals 
with 2+2 orientation, decussate, and usually they are round. The petals are usually white 
with numerous free stamens. The ovaries are with 1 or 2 chambers, each with 1-2 axile 
ovules26. Fruits are usually thinly woody and often not splitting open, and they are 
usually tipped by the protruding, persistent style base27. The fruits often exude resinous 
droplets, embraced by the persistent sepals (except M. nuda), or enveloped by the 
variously woody to leathery sepals, and often contain 1 to 4 dry seeds28. 
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1.6 Biological Importance of Mesua species 
M. ferrea, known with several common names, such as ‘Ironwood’, ‘Nagkesar’ or 
‘Cobra’s saffron’, is the most widely studied plant in this genus, and is a medium to 
large sized well-known tropical tree31,32. It is traditionally used as antiseptic, 
antiasthmatic and antiallergic activities. It is an ingredient of Ayurvedic formulations 
such as Brahma Rasayana and Chyavanprash which are used to improve immunity32,33. 
It is also used in folk medicine for the treatment of fever, dyspepsis and renal 
diseases34,35,36. The flowers are said to be astringent, and a stomachic and expectorant, 
and useful in bleeding piles and dysentery. 
 
Leaves and flowers are used in the treatment of snake bite and scorpion sting34. The 
seeds of M. ferrea have been recommended for treating painful and inflammatory 
conditions like arthritis, wound healing and skin diseases31. Different aerial parts of M. 
ferrea are traditionally used in the preparation of cosmetics and unguents. The extracts 
of M. ferrea had been studied for their antioxidant and hepatoprotective activity37,38. 
The plant had also been reported to possess antidote to scorpion venom39, CNS 
depressant40, anticancer41 and antibacterial activity41,42,43,44,45,46. 
 
The ethyl acetate extract from the leaves of M. racemosa was selected for 
phytochemical investigation due to its significant cytotoxic activity against P388 
(leukemia cells) and KB cells (epidermal carcinoma of the nasopharynx) by Morel et 
al.47; 100% at a concentration of 10 µg/mL against P388, and 83 and 19% for 
concentrations of 10 and 1 µg/mL, respectively, against KB cells. They have reported 
that preliminary biological evaluation of racemosol 12 and mammea A/AC cyclo F 13 
exhibited a weak cytotoxicity activity against KB cells; 49 and 23% for 12 and 32 and 
17% for 13 at 10 and 1 μg/mL, respectively. 
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Chemical constituents from M. daphnifolia were tested in vitro for their cytotoxic 
activities against four cell lines, MDA-MB-231 (human estrogen receptor negative 
breast cancer), HeLa (cervical carcinoma), CEM-SS (T-lymphoblastic leukemia) and 
CaOV3 (human ovarian cancer) by Ee et al.48. Cudraxanthone G 14 showed a broad 
spectrum of activity against the MDA-MB-231, HeLa and CEM-SS cell lines with the 
IC50 values of 1.3, 4.0 and 6.7 μg/mL, respectively. Besides 14, the MDA-MB-231 cell 
line was also found to be very susceptible towards ananixanthone 15 with an IC50 value 
of 4.6 μg/mL. Meanwhile, inhibitory activities were observed for friedelan-1,3-dione 16 
against the HeLa cell line with an IC50 value of 4.6 μg/mL, and weaker activity was 
observed for lup-20(29)-en-3β-ol 17 with an IC50 value of 8.6 μg/mL. The CEM-SS cell 
line was found to be moderately susceptible towards 17 with the IC50 value of 13.8 
μg/mL. A moderate IC50 value of 9.0 μg/mL was observed for euxanthone 18 towards 
the CaOV3 cell line. 
 
Meanwhile, the same group, Ee et al.49 has performed a study on the hexane extract of 
the stem bark of M. corneri, which was found to be cytotoxic against CEM-SS cell lines 
with an IC50 value of less than 30 μg/mL. Rubraxanthone 19 was isolated from this 
extract with an IC50 value of 5.0 μg/mL. 
 
Congestiflorone 20 from M. congestiflora had been subjected to cytotoxic tests against 
various cancer cell lines by Ee et al.50, including Raji (human B lymphocyte), SNU-1 
(human gastric carcinoma), LS-174T (human colorectal adenocarcinoma), HeLa 
(human cervical cells), SK-MEL-28 (human malignant melanoma cells), NCI-H23 
(human lung adenocarcinoma), IMR-32 (human neuroblastoma), Hep-G2 (human 
hepatocellular liver carcinoma) and K562 (human erythroleukemia cells). Compound 20 
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showed weak cytotoxic activities against the entire cancer cells except for Raji which 
gave cytotoxic activity with an IC50 value of 10.85 ± 1.10 μg/mL. 
 
Teh et al.51 carried out in vitro cytotoxic activities of the isolates from M. beccariana 
against a panel of human cancer cell lines; Raji, SNU-1, K562, LS-174T, HeLa, SK-
MEL-28, NCI-H23, IMR-32 and Hep-G2 using the MTT assay. Mesuadione 21, 
beccamarin 22, betulinic acid 23 and stigmasterol 24 displayed strong inhibition of Raji 
cell proliferation, while the proliferation rate of HeLa and SK-MEL-28 were strongly 
inhibited by 22 and 24, with IC50 values of less than 3.91 and 3.90 μg/mL, respectively. 
 
In a study carried out by the same group52,53, it was found that the methanol extracts of 
M. beccariana and M. ferrea showed high antioxidant activities with EC50 values of 
12.70 and 9.77 μg/mL, respectively, which are comparable to ascorbic acid (EC50 = 5.62 
μg/mL). The methanol extract of M. beccariana showed some activities against Gram-
positive bacteria; Bacillus cereus, methicillin-sensitive Staphylococcus aureus (MSSA), 
and methicillin-resistant Staphylococcus aureus (MRSA), while the hexane extract also 
contributed some activities towards Bacillus cereus. 
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CHAPTER 2 
GENERAL CHEMICAL ASPECTS 
 
Extensive work on the isolation and identification of chemical compounds from Mesua 
species, as well as their biological activities have been reported, as many of the plants 
from this genus are known for their medicinal value. Mesua species are known to 
furnish various types of compounds, including coumarins, xanthones, flavones, 
terpenoids and phenolics. Amongst the species from this genus, Mesua ferrea is the 
most widely studied, mainly due to its availability and biological value8. Table 2.1 
below lists the chemical constituents found in Mesua species and their references. 
 
Table 2.1: Chemical Constituents of Mesua species 
Mesua sp. Plant part Compounds References 
Mesua 
beccariana 
(Baill.) 
Kosterm. 
 
 
 
 
 
 
 
 
 
Stem bark Beccamarin 22 
Betulinic acid 23 
6-Deoxyjacareubin 25 
2,5-Dihydroxy-1,3,4-
trihydroxyanthraquinone 26  
Friedelin 27 
Mammea A/BA 28 
Mesuadione 21 
Mesuarianone 29 
Mesuasinone 30 
4-Methoxy-1,3,5-trihydroxyanthraquinone 
31 
Stigmasterol 24 
 
51,52,53,54,55 
Mesua 
congestiflora 
Roots Congestiflorone 20  
α-Mangostin 32 
 
52,53,50,56 
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Mesua sp. Plant part Compounds References 
Mesua  
Corneri 
Linn. 
Stem bark Friedelan-1,3-dione 16 
Friedelin 27 
Inophyllin B 33 
Rubraxanthone 19 
Stigmasterol 24 
 
49 
Mesua 
daphnifolia 
(Ridley) 
Kosterm. 
Stem bark Ananixanthone 15 
Cudraxanthone G 14 
Daphnifolin 34 
Euxanthone 18 
Friedelan-1,3-dione 16 
Friedelin 27 
Lup-20(29)-en-3β-ol 17 
 
48,57,58 
Mesua  
ferrea Linn. 
 
Bark (-)-Epicatechin 35  
Ferruol A 36 
5-Hydroxy-1-methoxyxanthone 37 
Mammea B/BB 38 
Mammea C/BB 39 
Mesuferrol A 40 
Mesuferrol B 41 
59,60 
 Flower Assamene 42 
8,9-Dihydro-5-hydroxy-6-(2-
methylbutanoyl)-4-phenyl-8-(prop-1-en-2-
yl)-furo[2,3-h]-chromen-2-one 43 
8,9-Dihydro-5-hydroxy-6-(3-
methylbutanoyl)-4-phenyl-8-(prop-1-en-2-
yl)-furo[2,3-h]-chromen-2-one 44 
5,7-Dihydroxy-6-(2-methylbutanoyl)-8-
[(E)-3,7-dimethylocta-2,6-dienyl]-4-
phenyl-2H-chromen-2-one 45 
5,7-Dihydroxy-6-(3-methylbutanoyl)-8-
[(E)-3,7-dimethylocta-2,6-dienyl]-4-
46 
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Mesua sp. Plant part Compounds References 
phenyl-2H-chromen-2-one 46 
5,7-Dihydroxy-8-(2-methylbutanoyl)-6-
[(E)-3,7-dimethylocta-2,6-dienyl]-4-
phenyl-2H-chromen-2-one (DMDP-1) 47 
5,7-Dihydroxy-8-(3-methylbutanoyl)-6-
[(E)-3,7-dimethylocta-2,6-dienyl]-4-
phenyl-2H-chromen-2-one (DMDP-2) 48 
5-Hydroxy-6-isobutyryl-8-methyl-8-(4-
methylpent-3-enyl)-4-phenyl-2H-
pyrano[2,3-h]chromen-2-one 49 
5-Hydroxy-8-methyl-6-(2-
methylbutanoyl)-8-(4-methylpent-3-enyl)-
4-phenyl-2H-pyrano[2,3-h]chromen-2-one 
50 
Mammea A/AA cyclo D 51 
Mammea A/AA cyclo F 52 
Mammea A/AB cyclo F 53 
Mammea A/AD cyclo F 54 
Mammea A/BA 28 
Mammea A/BB or isomammeisin 55 
Surangin C 56 
 Heartwood 1,5-Dihydroxyxanthone 57 
Euxanthone 18 
Euxanthone-7-methyl ether 58 
Ferrxanthone 59 
Mesuaxanthone A 60 
Mesuaxanthone B 61 
β-Sitosterol 62 
61,62,63 
 Leaves Mesuein 63 64 
 Root bark Betulinic acid 23 
Caloxanthone C 64 
1,8-Dihydroxy-3-methoxy-6-
methylanthraquinone 65 
52,65 
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Mesua sp. Plant part Compounds References 
Friedelin 27 
Macluraxanthone 66 
Mesuaferrin A 67 
Mesuaferrin B 68 
Mesuaferrin C 69 
β-Sitosterol 62 
Tovopyrifolin C 70 
 Seeds Mammea A/AA or mammeisin 71 
Mammea A/AB 72 
Mammea A/AB cyclo D or mammeigin 73 
Mammea A/AD cyclo D or mesuagin 74 
Mesuarin 75 
Mesuol 76 
66,67,68,69 
 Stamens β-Amyrin 77 
Mesuaferrol 78 
Mesuaferrone A 79 
Mesuaferrone B 80 
Mesuanic acid 81 
β-Sitosterol 62 
70,71,72,73 
Mesua  
ferrea Linn. 
 
Stem bark 1,6-Dihydroxyxanthone 82 
(-)-Epicatechin 35  
Mesuabixanthone A 83 
Mesuabixanthone B 84 
Pyranojacareubin 85 
 
 
 
 
 
 
 
 
 
 
Bark, 
leaves, buds 
and flowers 
in full 
blossom 
 
 
 
 
Acetic acid 86 
4-Acetyl-1-methylcyclohexene 87 
3-Acetyl-3-methylcyclopentene 88 
α-Acoradiene 89 
Alloaromadendrene 90 
Ar-curcumene 91 
Aromadendrene 92 
Trans-α-bergamotene 93 
β-Bisabolene 94 
74 
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Mesua sp. Plant part Compounds References 
(E)-γ-Bisabolene 95 
(E)-α-Bisabolene 96 
(Z)-γ-Bisabolene 97 
(Z)-α-Bisabolene 98 
β-Bourbonene 99 
α-Cadinol 100 
δ-Cadinene 101 
T-cadinol 102 
β-Calacorene 103 
β-Caryophyllene 104 
Caryophyllene oxide 105 
1,8-Cineole 106 
Cubenol 107 
1-Epi-cubenol 108 
α-Copaene 109 
α-Cubebene 110 
Cyclosativene 111 
Cyperene 112 
2-Decanone 113 
(E)-2-Decenal 114 
1,4-Dimethoxybenzene 115 
Drima-7,9(11)-diene 116 
Elema-1,3,11(15)-trien-12-al 117 
β-Elemene 118 
(E,E)-Farnesol 119 
(E,E)-Farnesyl acetate 120 
Geraniol 121 
Germacrene D 122 
Globulol 123 
Hexanal 124 
Hexanol 125 
(Z)-3-Hexen-2-one 126 
5-Hexen-2-one 127 
Chapter 2                                                                                                               General Chemical Aspects 
22 
Mesua sp. Plant part Compounds References 
(Z)-3-Hexenyl acetate 128 
(Z)-3-Hexenyl benzoate 129 
Hexyl acetate 130 
α-Humulene 131 
Humulene oxide 132 
α-Ionone 133 
Isocaryophyllene 134 
Junenol 135 
Limonene 136 
Linalool 137 
1-Methylcyclohexene 138 
(E)-6-Methyl-3,5-heptadien-2-one 139 
6-Methyl-5-hepten-2-one 140 
3-Methyl-2-pentanone 141 
Methyl-4-methoxybenzoate 142 
4-Methoxybenzaldehyde 143 
T-muurolol 144 
Myrcene 145 
(E)-Nerolidol 146 
Nonanal 147 
Nonanoic acid 148 
Nonanol 149 
(E)-β-Ocimene 150 
Octanal 151 
n-Octane 152 
Octanol 153 
α-Selinene 154 
β-Selinene 155 
β-Sesquiphellandrene 156 
Spathulenol 157 
Styrene 158 
α-Terpineol 159 
Toluene 160 
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Mesua sp. Plant part Compounds References 
α-Ylangene 161 
 
Mesua 
myrtifolia 
(Baill.) 
Kosterm. 
 
 
Bark Betulinic acid 23 
Jacareubin 162 
Myrtifolic acid 163 
Oleanolic acid 164 
Simiarenone 165 
Simiarenol 166 
β-Sitosterol 62 
Taraxerol 167 
 
75 
Mesua 
racemose 
(Planch. ex 
Triana et 
Planch) 
Kosterm. 
 
 
 
 
 
Leaves Furanoracemosone 168 
Isoracemosol 169 
Mammea A/AA or mammeisin 71  
Mammea A/AC 170 
Mammea A/AC cyclo D 171 
Mammea A/AC cyclo F 13 
Mammea A/BB or isomammeisin 55 
Mammea A/BC 172 
Mammea A/AD cyclo D or mesuagin 74 
Racemosol 12 
Racemosone 173 
 
76,47 
Mesua 
thwaitesii 
Planch. & 
Triana 
Bark Mammea A/AA cyclo F 52 
Mammea A/AB cyclo F 53 
Mesuaxanthone B 61 
β-Sitosterol 62 
77 
 Seeds Mammea A/AA or mammeisin 71 
Mammea A/AA cyclo D 51 
Mammea A/AA cyclo F 52 
Mammea A/AB 72 
Mammea A/AB cyclo D or mammeigin 73 
Mammea A/AD cyclo D or mesuagin 74 
77 
 
 
 
 
 
Chapter 2                                                                                                               General Chemical Aspects 
24 
Mesua sp. Plant part Compounds References 
Mammea A/AD cyclo F 54 
Mesuol 76 
 
 Timber 1,3-Dimethoxy-5-hydroxyxanthone 174 
1,5-Dihydroxyxanthone 57 
Euxanthone 18 
 
77 
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2.1 General Chemical Aspects of Coumarins 
Mesua plants are known producers of various compounds, notably coumarins and 
xanthones. In this study, both Mesua species studies yielded prenylated and geranylated 
4-phenylcoumarins. Therefore, the following sub-chapters will discuss briefly the 
biosynthesis and characteristics of the coumarins, particularly the 4-phenylcoumarins 
(neoflavonoids). 
 
2.1.1 Coumarins 
Coumarins possess the nucleus 2H-1-benzopyran-2-one which may be considered, on 
first approximation, as lactone of 2’-hydroxy-Z-cinnamic acid78. Since the discovery by 
Vogel in 1820 of the simplest member of the class, coumarin itself 175, in Dipteryx 
odorata Willd. (Fabaceae) (the tonka bean), this compound and a wide range of its 
structural derivatives have been shown to occur in hundreds of plant species79. More 
than one thousand coumarins have been described, and the simplest among them are 
widely distributed throughout the vegetable kingdom78. 
 
 
 
      Coumarin 175  
 
Except for a few rare cases, all coumarins are substituted by a hydroxyl group in 
position 7. Umbelliferone 176 which is 7-hydroxycoumarin itself, is the precursor of the 
6,7-di- and 6,7,8-trihydroxylated coumarins. The hydroxyl group of these simple 
coumarins are either methylated, or sometimes one of them is engaged in glycosidic 
linkage. Another structural feature which is common to many coumarins is prenylation 
O ORO
176 R = H 
177 R = Me 
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and geranylation; O-prenylation or O-geranylation, or more frequently, prenylation or 
geranylation on the ring in the 6- or 8-position of umbelliferone 176 or herniarin 177, 
which gives rise to aurapten 178, suberosin 179 and osthol 18078. 
 
There may even be a five-carbon residue on the 3-position, although to a much lesser 
extent. The high reactivity of the isoprene chain (C5, C10, or more rarely C15) explains 
the large number of derived structures (epoxidized, mono- and dihydroxylated, and 
cyclised). Prenylation and geranylation are also the origin of the polycyclic coumarins, 
the furano- and pyranocoumarins, and the linear (e.g. imperatorin 181 and xanthyletin 
182), and angular (e.g. angelicin 183 and visnadin 184) coumarins78. 
 
 
 
 
 
 
 
  
 
 
 
 
O OO O OH3CO
O OO
O
O OO
O OO
O OO
OO
O
O
184 
179 178 
180 181 182 
183 
O OMeO
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2.1.2 4-Phenylcoumarins – Neoflavonoids 
The term neoflavonoid refers to a group of C15 naturally-occurring compounds having a 
C6-C3-C6 skeleton, structurally related to flavonoids and isoflavonoids, and constructed 
on a 1,1-diphenylpropane skeleton78. This term was suggested by Swain to describe the 
group of natural products with a 4-phenylchroman skeleton80. 
 
Like the 2- and 3-phenylchromanes, they arise from the condensation of three acetate 
molecules with one cinnamate molecule, but their mechanism of formation is very 
different. It is possible that they arise from the reaction of a phenol such as 
phloroglucinol or resorcinol with the α-carbon of the side chain of a phenylpropane unit. 
The vast majority of known neoflavonoids have been encountered in the Fabaceae and 
Clusiaceae. Some are also present in the Rubiaceae78. Scheme 2.1 shows the naturally 
occurring neoflavonoids that have been arranged conveniently (although arbitrarily) in 
groups according to their structural type, as proposed by Donnelly in 197580. 
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4-Arylcoumarin        Dalbergione          Neoflavene 
 
 
 
 
 
Dalbergiquinol    4-Arylchroman      Coumarinic Acid 
 
Scheme 2.1: Examples of Neoflavonoid Skeletons 
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2.2 Biosynthesis of Coumarins and 4-Phenylcoumarins 
Coumarins in higher plants have been known to derive from the shikimate pathway. The 
shikimate pathway is a major route leading to the formation of aromatic compounds in 
living systems. The structure of shikimic acid 185 is shown below, after which the 
pathway was named. 
 
 
 
 
Shikimic acid 185 
 
The building blocks of shikimic acid are phosphoenolpyruvate (PEP) and D-erythrose-
4-phosphate (E4P). These combine in a reaction catalyzed by the enzyme DAHP 
synthase to give the 7-carbon sugar; 3-deoxy-D-arabino-heptulosonic acid-7-phosphate, 
which is subsequently cyclised to the first carbocyclic compound, 3-dehydroquinate 
(DHQ). Hydrolysis of the latter gives 3-dehydroshikimate (DHS), followed by 
reduction of the carbonyl functional group to give shikimate, which is subsequently 
phosphorylated in the position-3 to form shikimate 3-phosphate (SA3P). Attachment of 
a 3-carbon side chain, provided by another molecule of phosphoenolpyruvate leads to 
the formation of 5-enolpyruvylshikimate-3-phosphate (EPSP), followed by a 1,4-
elimination of the elements of phosphoric acid to form of chorismate81. These processes 
are illustrated in Scheme 2.2. 
 
 
 
COOH
HO
OH
OH
3 
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Scheme 2.2: The Shikimate to Chorismate Biosynthetic Pathway 
E1: 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase(DAHP syntase/synthetase) 
E2: 3-Dehydroquinate synthetase 
E3: 3-Dehydroquinate hydro-lyase (DHQase) 
E4: Shikimate dehydrogenase (SHorase) 
E5: Shikimate kinase 
E6: 5-Enolpyruvylshikimate-3-phosphate synthase (EPS synthase) 
E7: Chorismate synthase 
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Chorismate, the product of the shikimate pathway is the key compound for the 
formation of coumarin through Claisen rearrangement, which leads to the formation of 
phenylalanine and tyrosine (Scheme 2.3). The committed step in the formation of 
coumarin is the ortho-hydroxylation of a trans-cinnamic acid, which is derived from 
phenylalanine by the action of phenylalanine ammonia-lyase (Scheme 2.4)81. 
 
The addition of a prenyl group at the C-6 or C-8 position of coumarin also often 
occurs79. Prenylation of the benzene ring by dimethylallyl pyrophosphate (DMAPP) in 
the 6- or 8-position of a 7-hydroxycoumarin is the origin of the extra ring which 
characterizes these molecules. Prenylation in the 6-position yields the so-called ‘linear’ 
furano- or pyranocoumarins; in the 8-position it affords the ‘angular’ homologs78. 
 
The cyclization of 6- or 8-isoprenylcoumarin is probably due to nucleophilic attack by 
the hydroxyl group in the 7-position on an epoxide formed by oxidation of the double 
bond of the isopentenyl residue. The product of this reaction depends on the orientation 
of the nucleophilic attack. It is either a 2-hydroxyisopropy-ldihydrofuranocoumarin, or, 
in the case of an attack on the tertiary carbon, a hydroxydimethyl-
dihydropyranocoumarin78. 
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Scheme 2.3: Pathways to Phenylalanine and Tyrosine 
E8 : Chorismate mutase  
E9 : Prephenate dehydratase  
E10 : Phenylalanine aminotransferase 
E11 : Prephenate dehydrogenase 
E12 : Tyrosine aminotransferase 
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Scheme 2.4: Biosynthetic Pathway from Phenylalanine to Coumarin 
 
Coumarins with a phenyl substituent at carbon 3 or 4 are formed through an entirely 
different route from those discussed so far. In the case of 4-phenylcoumarins, Kunesh 
and Polonsky in 1967 showed that the benzene ring of the benzopyran nucleus derives 
from acetate, not shikimate, and that the remaining nine carbons are shikimate-derived. 
The coumarin nucleus of calophyllolide, for example, a 4-phenylcoumarin from 
Calophyllum inophyllum L., originates through a condensation involving C-3 of a 
phenylpropanoid and an acetate-derived phenol. The molecule formed then undergoes 
reduction followed by cyclization through the loss of water to give 4-phenylcoumarin. 
The proposed biosynthetic pathway to 4-phenylcoumarins is shown in Scheme 2.579. 
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Scheme 2.5: Biosynthetic Pathway to 4-Phenylcoumarin 
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2.3 The Naming System of Coumarins  
To avoid the proliferation of very similar trivial names, a naming system for the so-
called mammea coumarins were introduced by Crombie et al., when the author was 
working with Mammea americana82. Within each group, as well as a 5,7-dioxygenated 
pattern, the aromatic ring carries an acyl and a prenyl group. The name mammea is 
followed by a first letter designating the 4-substituent, and a stroke separates this from a 
second letter designating whether a 6-acyl or 8-acyl group is present. A third letter 
designates the type of acyl substituent. Where the prenyl substituent has been modified 
by cyclisation, the third letter is followed by the prefix cyclo and a fourth letter indicates 
the type of heterocyclisation. Table 2.2 below shows a summary of the coding system. 
Some examples of coumarin derivatives and their naming system are described in Table 
2.3. 
 
Table 2.2: Summary of the Naming System for the Mammea Type Coumarins 
1st Letter 2nd Letter 3rd Letter 
4th Letter 
(if cyclisation occurs) 
A = phenyl 
B = propyl 
C = pentyl 
D = 1-methylpropyl 
E = 1-acetoxypropyl 
A = 6-acyl 
B = 8-acyl 
A = 3-methylbutyryl 
B = 2-methylbutyryl 
C = butyryl 
D = 2-methylpropionyl 
cyclo D  
= 2,2-dimethylchromene  
cyclo E  
= 3-hydroxy-2,2-
dimethyldihydropyran 
cyclo F  
= 2-(1-hydroxy-1-
methylethyl)dihydrofuran 
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Table 2.3: Examples of Coumarin Derivatives and Their Naming System 
Compound 1st Letter 2nd Letter 3rd Letter 
4th Letter 
(if cyclisation occurs) 
Structure 
Mammea 
A/AA 
71 
 
A = phenyl A = 6-acyl 
 
A =3-methylbutyryl 
 
                    -  
Mammea 
B/BB 
38 
 
B = propyl 
 
B = 8-acyl B =2-methylbutyryl 
 
                    -  
Mammea 
A/AD cyclo D 
74 
 
A = phenyl 
 
A = 6-acyl 
 
D =2-methylpropionyl cyclo D  
= 2,2-dimethylchromene  
 
 
Mammea 
A/AB cyclo F 
53 
 
A = phenyl 
 
A = 6-acyl 
                                                                                                                                                                                                                
B = 2-methylbutyryl cyclo F  
= 2-(1-hydroxy-1-
methylethyl)dihydrofuran 
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2.4 Structural Elucidation: General Methods and Theory 
Various methods are being used by natural product chemists to identify and structurally 
elucidate the isolated chemical constituents. Amongst the methods being applied 
include the ultraviolet (UV), infrared (IR), mass spectrometry (MS), proton nuclear 
magnetic resonance (1H NMR) and carbon nuclear magnetic resonance (13C NMR). 
 
2.4.1 Ultraviolet Spectra of Coumarins  
Coumarins have characteristic UV spectra which are heavily influenced by the nature 
and the position of substituents, and by alkalinisation (KOH, NaOCH3) if a phenolic 
group is present78. A coumarin has UV absorption bands at max 212, 274, 282 and 312 
nm, while a 7-hydroxycoumarin (umbelliferone 176) has characteristic UV absorptions 
at max 210, 240 and 325nm83. 
 
The orientation of the acyl group in substituted coumarins can be assigned based on UV 
absorption data. The UV spectra of the 6-acylcoumarins are consistent, irrespective of 
the acyl group and the C-4 substituent, and the same applies to 8-acylcoumarins. 
Typical spectra in ethanol and with base-shift, for a 6-acyl and 8-acyl isomer are shown 
in Figures 2.1 and 2.2, respectively. The base-shifts are characteristically different, and 
in addition, the presence of a max at 281 ± 1nm in the 6-acyl isomers, and of a max at 
290 ± 1nm in the 8-acyl isomers, is the most useful aid to the rapid differentiation of 
isomers without resorting to a base-shift82.  
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Figure 2.1: Typical UV Spectrum of (i) 6-Acyl-5,7-dihydroxycoumarin and (ii) 8-Acyl-
5,7-dihydroxycoumarin in Ethanol 
 
 
 
Figure 2.2: Typical UV Spectrum of (iii) 6-Acyl-5,7-dihydroxy-8-prenylcoumarin and 
(iv) 8-Acyl-5,7-dihydroxy-6-prenylcoumarin in Ethanol 
 
 
 
(i) (ii) 
(iii) (iv) 
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2.4.2 Mass Spectrometry of Coumarins  
The mass spectra of the 4-phenylcoumarins show the loss of CO from the molecular ion 
resulting in a benzofuran cation. However, the lower mass fragments are not intense. 
The fragmentation pathway is demonstrated for dalbergin (Scheme 2.6). The 
fragmentations of the coumarins are mainly due to the loss of side chains at C-6 and C-
8. The acyl group displays the loss of the group attached to it (Scheme 2.7)80. 
 
 
 
 
 
  
 
 
 
 
 
Scheme 2.6: Mass Spectral Fragmentation Pathway for Dalbergin80 
 
 
 
– [CO] 
 
– [CO] 
 
m/z 268 m/z 240 
m/z 225 m/z 197 
– [Me] 
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– [CH2CH(CH3)2]˙ 
 
– [C(CH3)2OH]˙ 
 
– [CH2CH(CH3)2]˙ 
 
– [C(CH2CH3)OH]˙ 
 
– [OH]˙ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.7: Mass Spectral Fragmentation Pathway of a 4-Phenylcoumarin80 
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2.4.3 1H NMR Spectroscopy of 4-Phenylcoumarins 
The 1H NMR spectrum can yield valuable and important information leading to the 
structural elucidation of coumarins. The chemical shifts are very dependent on the 
position of the protons and the substituents with respect to the coumarin nucleus. 
Several general features have been observed in the proton shifts of these coumarins. 
Figure 2.3 shows the structure of a 4-phenylcoumarin81. 
 
 
 
 
 
Figure 2.3: The Structure of a 4-Phenylcoumarin 
 
There are some characteristic features for the chemical shifts of the 4-phenylcoumarins. 
When position C-4 is substituted by a phenyl group, two sets of multiplets will be 
apparent in the 1H NMR spectrum, at δ 7.30 – 7.40 and δ 7.41 – 7.56 (integrated for two 
and three protons, respectively), along with a characteristic H-3 singlet at δ 5.95 – 
6.0246, 84. For a prenyl substituent at position C-6 or C-8, a broad triplet can be detected 
at δ 5.07 - 5.21, with coupling constant of 6.0 – 7.5 Hz, and a doublet for the methylene 
protons at δ 3.30 – 3.57 (J = 6.5 - 7.5 Hz)46, 76, 84. In addition, for a geranyl substituent at 
position C-6 or C-8, two broad triplets can be detected at δ 4.95 - 5.22, with coupling 
constants of 6.0 – 7.5 Hz, a doublet for the methylene protons at δ 3.30 – 3.57 (J = 6.5 - 
7.5 Hz), multiplets for two more methylene protons at δ 1.98 – 2.20 and three methyl 
singlets at δ 1.52 – 1.7046. 
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Positions C-5 and C-7 are commonly substituted by hydroxyl and methoxyl groups. In 
the case of 6-acyl-5,7-dihydroxycoumarin derivatives, both of the hydroxyl protons will 
be chelated due to the presence of the acyl carbonyl at C-6, and they will appear at 
around δ 10.30 – 12.20 as two singlets. However, in the case of the 8-acyl-5,7-
dihydroxycoumarin derivatives, the hydroxyl proton at C-7 will appear further 
downfield at δ 14.30 – 14.55 than the C-5 hydroxyl proton, which appears at δ 5.58 – 
6.00. A rapid differentiation between 6-acyl-5,7-dihydroxycoumarin and 8-acyl-5,7-
dihydroxycoumarin derivatives is that in 8-acyl-5,7-dihydroxycoumarin, only the C-7 
hydroxyl group is chelated by the C-8 acyl group. However, in 6-acyl-5,7-
dihydroxycoumarin, both the C-5 and C-7 hydroxyl groups are chelated by the C-6 acyl 
group46, 84.  
 
Common substituents of the acyl group are 3-methylbutyryl, 2-methylbutyryl or 2-
methylpropionyl. For a 3-methylbutyryl group, a doublet integrating for six protons will 
appear at δ 0.90 – 1.10, with J = 6.5 – 7.0 Hz, in addition to a methylene doublet at δ 
3.00 – 3.30 (J = 6.5 – 7.0 Hz) and a multiplet at δ 2.10 – 2.25 (integrating for one 
proton). For a 2-methylbutyryl group, two methyl protons will be visible as a doublet 
and a triplet at δ 1.00 – 1.30 (J = 6.5 – 7.0 Hz) and δ 0.80 – 1.10 (J = 7.0 – 7.5 Hz). As 
for the 2-methylpropionyl group, the two methyl groups will appear as a six-proton 
doublet at δ 1.25 – 1.30 (J = 6.5 – 7.0 Hz), together with a multiplet for one proton at δ 
3.98 – 4.10. This multiplet is more downfileld than that of the 2-methylbutyryl due to its 
position nearer to the acyl carbonyl46-47, 84-85. 
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2.4.4 13C NMR Spectroscopy of 4-Phenylcoumarins 
The 13C chemical shifts of coumarin were assigned by comparison with the spectrum of 
cinnamic acid, and from the knowledge that for benzenoid methine carbons introduction 
of an acyloxy function into the benzene ring causes small shifts of the meta carbons, 
and shifts the signals of the para carbons to higher field, while the ortho carbons 
become even more shielded (Figure 2.4)86. 
 
 
 
Figure 2.4: Structures and 13C Chemical Shifts (δ) of Coumarin and a Furanocoumarin, 
Psoralen 
 
Recording the 13C NMR spectra of coumarins in different solvents, such as 
deuterochloroform, dimethyl sulfoxide or methanol, shows that the shifts change only 
by about ± 1 ppm. Using titanium tetrachloride as a complexing reagent causes strong 
downfield shifts for the signals of C=O and C-4, and much less deshielding for C-4a, C-
5, C-6, C-7 and C-8. The resonances of C-3 and C-8a are shifted to higher field. An 
enhanced contribution of a dipolar mesomeric form is thought to be responsible for this 
effect86. 
 
Aromatic carbon (sp2) atoms, as in 4-phenyl coumarins, absorb at δ 128.5 in CDCl3 
(deuterated chloroform) or CCl4 (carbon tetrachloride). Shifts of the aromatic carbon 
atom directly attached to a substituent are correlated with substituent’s electronegativity 
after correcting for magnetic anisotropy effects. For example, an aromatic carbon atom 
attached to an ethylene resonates at δ 137.6, while that attached to a methoxy resonates 
at δ 159.987.  
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CHAPTER 3 
 CHEMICAL CONSTITUENTS FROM M. elegans AND M. kunstleri 
 
An attempt at the bioassay-guided isolation of the acetylcholinesterase (AChE) and 
neuroprotective compounds was performed on the bark material of Mesua elegans and 
Mesua kunstleri. In addition, a thorough phytochemical analysis was carried out on the 
active hexane extracts of these plants. The present chapter deals with phytochemical 
studies of the bark of M. elegans and M. kunstleri.  
 
Various chromatographic techniques, such as column chromatography (CC), preparative 
thin layer chromatography (PTLC), high performance liquid chromatography (HPLC) 
and centrifugal chromatographic technique (CPC) were used in this study to isolate the 
compounds. The structures were determined by using combinations of different 
spectroscopic methods; 1D NMR (1H, 13C, DEPT), 2D NMR (COSY, NOESY, HSQC, 
HMBC and NOESY), UV, IR and HRESIMS. The structures      of the compounds were 
also elucidated by literature comparison with previous studies.  
 
3.1 Chemical Constituents from the Hexane Extracts of M. elegans and M. 
kunstleri 
Isolation from the hexane extracts of the bark of M. elegans and M. kunstleri yielded 
twenty-four 4-phenylcoumarins, and Table 3.1 shows the list of compounds isolated 
from these plants. A total of twenty-two compounds were isolated from M. elegans, of 
which thirteen are new; mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, 
mesuagenin F 195, mesuagenin D 196, mesuagenin G 198, mesuagenin H 199, 
mesuagenin I 200, mesuagenin J 201, mesuagenin K 202, mesuagenin L 203, 
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mesuagenin M 204 and mesuagenin N 205. From M. kunstleri, a total of ten compounds 
were isolated, of which one is new; mesuagenin E 188.  
 
The structures of these 4-phenylcoumarins were identified through the analysis of their 
spectral data, and also by comparison of their spectral data with those described in the 
literature. The following sub-chapters discuss briefly the structural elucidation of the 
isolated compounds. 
 
Table 3.1: Chemical Constituents from M. elegans and M. kunstleri 
Plants Isolates Name of Isolates 
M. elegans Compound B Mammea A/BA cyclo D or isomammeigin 187 
 Compound D Mesuagenin A 189 
 Compound E Mesuagenin B 190 
 Compound F Mammea A/BB or isomammeisin 55 
 Compound G Mammea A/BA 28 
 Compound H Mesuagenin C 191 
 Compound I 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-
one 47 
 Compound J 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-
one 48 
 Compound K Ochrocarpin E 192 
 Compound L Mammea A/BB cyclo F 193 
 Compound M Mammea A/BA cyclo F 194 
 Compound N Mesuagenin F 195 
 Compound O Mesuagenin D 196 
 Compound P Isodisparfuran 197 
 Compound Q Mesuagenin G 198 
 Compound R Mesuagenin H 199 
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Plants Isolates Name of Isolates 
 Compound S Mesuagenin I 200 
 Compound T Mesuagenin J 201 
 Compound U Mesuagenin K 202 
 Compound V Mesuagenin L 203 
 Compound W Mesuagenin M 204 
 Compound X Mesuagenin N 205 
M. kunstleri Compound A Mammea A/BB cyclo D or ponnalide 186 
 Compound B Mammea A/BA cyclo D or isomammeigin 187 
 Compound C Mesuagenin E 188 
 Compound D Mesuagenin A 189 
 Compound E Mesuagenin B 190 
 Compound F Mammea A/BB or isomammeisin 55 
 Compound G Mammea A/BA 28 
 Compound H Mesuagenin C 191 
 Compound I 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-
one 47 
 Compound J 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-
one 48 
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3.1.1 Compound A: Mammea A/BB cyclo D or Ponnalide 186 
 
 
 
 
 
 
Compound A was isolated as a pale yellowish oil, and the HRESIMS spectrum showed 
an [M+Na]+ ion at m/z 427.1510 (calculated 427.1521), which corresponded to the 
molecular formula C25H24O5. The UV spectrum (EtOH) supported an 8-acyl-5,7-
dioxycoumarin type, with absorptions at λmax 237, 284 and 339 nm82. The IR spectrum 
showed absortions at νmax 1740 cm-1 which belongs to an α-pyrone and a broad peak at 
3461 cm-1 due to OH stretching47, 88. 
 
The 1H NMR spectrum of compound A showed signals typical of a 4-phenylcoumarin. 
A typical H-3 singlet was observed at δ 6.01 in the 1H NMR spectrum, characteristic of 
the C-3 proton of a 4-substituted coumarin. The presence of a mono-substituted phenyl 
group at C-4 was corroborated by the presence of two sets of multiplets, centred at δ 
7.39 (H-3'-H-5') and 7.26 (H-2', H-6'), corresponding to three and two aromatic protons, 
respectively. Furthermore, the 1H NMR spectrum of compound A supported the 
presence of a chelated hydroxyl by revealing a proton singlet characteristic of a chelated 
hydroxyl at δ 14.62, and a broad OH absorption depicted from the IR spectrum further 
supported this finding. All these observations from the 1H NMR spectrum, together with 
186 
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the UV and IR data reported earlier, suggested the presence of an 8-acyl-5,7-dioxy-4-
phenylcoumarin type skeleton47. 
 
The 13C NMR spectrum of compound A showed four methyl, one methylene, nine 
methine and eleven quaternary signals. The 1H NMR spectrum also showed two singlets 
at δ 0.95 (H-4'') and 0.96 (H-5''), integrating for three protons each, along with two 
doublets of one proton each at δ 6.62 (J = 10.1 Hz, H-1'') and 5.38 (J = 10.1 Hz, H-2''). 
The olefinic protons H-1'' and H-2'' correlated with the quaternary carbon C-6 (δ 
106.00) in the HMBC spectrum. All these observations indicated the presence of a 
cyclised prenyl group in compound A, substituted at position C-6.  
 
The signals of two methylene protons as two sets of multiplets at δ 1.50 (1H, m, H-4'''α) 
and 1.92 (1H, m, H-4'''β) were apparent in the 1H NMR spectrum. In the HMBC 
spectrum, these protons correlated with a carbonyl (C-1''', δ 210.67), a methine (C-2''', δ 
47.09) and two methyl groups (C-3''', δ 16.72 and C-5''', δ 11.90). Protons of the two 
methyls (C-3'''' and C-5''') were observed as a doublet at δ 1.28 (J = 6.7 Hz, H-3''') and 
as a triplet at δ 1.02 (J = 7.3, H-5'''), respectively. These elements confirmed the 
presence of the 2-methylbutanoyl moiety linked at C-8. 
 
The positions of the substituents were confirmed by spectroscopic analysis and also by 
direct comparison with the literature values. Thus, compound A was identified as the 
known mammea A/BB cyclo D or ponnalide 186, which was first isolated from 
Calophyllum inophyllum89,90, a plant from the same family as M. elegans and M. 
kunstleri. 
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Table 3.2: 1H NMR, 13C NMR and COSY (in CDCl3, 400 MHz) of Compound A 186 
Position δH, J (Hz)  δC COSY 
2  - 159.0   
3 6.01 (1H, s) 112.1   
4  - 157.1   
4a  - 102.3   
5  - 156.4   
6  - 106.0   
7-OH 14.62 (1H, s) 164.0   
8  - 104.3   
8a  - 156.2   
1'  - 140.2   
2' 7.26 (1H, m, Ar) 127.3   
3'  127.8   
4'     7.39 (3H, m, Ar) 127.9   
5'  127.8   
6' 7.26 (1H, m, Ar) 127.3   
1'' 6.62 (1H, d, J = 10.1) 115.5 2'' 
2'' 5.38 (1H, d, J = 10.1) 126.9   
3'' - 79.2   
4'' 0.95 (3H, s) 27.9   
5'' 0.96 (3H, s) 27.9   
1'''  - 210.7   
2''' 3.95 (1H, m) 47.1 3''' 
3''' 1.28 (3H, d, J = 6.7) 16.7  
4'''α 1.50 (1H, m)    4'''β, 5'''  
4'''β 1.92 (1H, m) 4'''α, 5''' 
5''' 1.02  (3H, t, J = 7.3) 11.9  
 
 
 
 
27.3 
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Figure 3.1: 1H NMR Spectrum of Compound A 186 
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3.1.2 Compound B: Mammea A/BA cyclo D or Isomameigin 187 
 
 
 
 
 
 
A pale yellowish oil was obtained as compound B. The HRESIMS revealed an [M+Na]+ 
ion at m/z 427.1535 (calculated 427.1521), which corresponded to the molecular 
formula C25H24O5. The IR spectrum showed absortions at νmax 1382 (geminal dimethyl), 
1740 (α-pyrone) and a broad peak at 3461 cm-1 (OH stretching)47, 88. The UV spectrum 
(EtOH) supported an 8-acyl-5,7-dioxycoumarin type, with absorptions at λmax 237, 284 
and 339 nm82.  
 
The 1H and 13C NMR spectra of compound B are reminiscent of those of compound A, 
which suggested a close structural relationship between these two compounds. Indeed, 
the same substituents for the coumarin could be characterized in both compounds at 
positions C-4, C-5, C-6 and C-7, namely, a typical H-3 signal of a 4-phenylcoumarin (δ 
6.00, s, H-3), a monosubstituted phenyl (δ 7.37 and 7.23, 5H, m, H-2'-H6'), a cyclized 
prenyl group [δ 6.60 (1H, d, J = 10.1 Hz, H-1''), 5.37 (1H, d, J = 10.1 Hz, H-2''), 0.94 
(6H, s, H-4'' and H-5'') and a chelated hydroxyl group (δ 14.63, s, 7-OH)47. 
 
However in the 1H NMR spectrum, compounds A and B exhibited quite different 
patterns for the remaining substituent at C-8. The cross correlation deduced from COSY 
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spectrum revealed the presence of an iso-butyryl spin system with signals at δ 3.17 (2H, 
d, J = 6.7 Hz, H-2'''), 2.31 (1H, m, H-3''') and 1.04 (6H, d, J = 6.7, H-4''' and H-5'''). In 
the HMBC spectrum of compound B, the methylene protons and the methine proton 
produced cross-peaks with a keto function at δ 206.2, which corresponded to C-1'''. 
With this, it was identified that a 3-methylbutanoyl chain was the other substituent of 
the 4-phenylcoumarin, instead of a 2-methylbutanoyl chain as in compound A.  
 
The assignments of all the proton and carbon signals of compound B were confirmed by 
direct comparison with the literature values. Thus, compound B was identified as 
mammea A/BA cyclo D or isomammeigin 187, which was first isolated from Kilmeyera 
pumila Pohl (Clusieaceae)91.  
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0.94 (6H, s) 
 
Table 3.3: 1H NMR, 13C NMR and COSY (in CDCl3, 400 MHz) of Compound B 187 
Position δH, J (Hz)  δC COSY 
2  - 159.0   
3 6.00 (1H, s) 112.1   
4  - 157.1   
4a  - 102.3   
5  - 156.4   
6  - 106.0   
7-OH 14.63 (1H, s) 163.9   
8  - 104.3   
8a  - 156.2   
1'  - 140.2   
2' 7.23 (1H, m, Ar) 127.3   
3'  127.8   
4'     7.37 (3H, m, Ar) 127.9   
5'  127.8   
6' 7.23 (1H, m, Ar) 127.3   
1'' 6.60 (1H, d, J = 10.1) 115.5 2'' 
2'' 5.37 (1H, d, J = 10.1) 126.9   
3'' - 79.2   
4''  
       
27.6   
5'' 27.6   
1'''  - 206.2   
2''' 3.17 (2H, d, J = 6.7) 53.7 3''' 
3''' 2.31 (1H, m) 25.8 4''', 5''' 
4'''  
     1.04 (6H, d, J = 6.7) 
22.9   
5''' 22.9   
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Figure 3.2: 1H NMR Spectrum of Compound B 187 
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3.1.3 Compound C: Mesuagenin E 188 
 
 
 
 
 
 
Separation by using column chromatography, followed by HPLC, afforded compound C 
as a yellowish oil. The molecular formula of C29H30O5 was deduced from the 
HRESIMS measurement of compound C; [M+Na]+ ion at m/z 481.1553 (calculated 
481.1991). The UV spectrum (EtOH) supported an 8-acyl-5,7-dihydroxycoumarin type, 
with absorptions at λmax 237, 285 and 335 nm82. The IR spectrum showed absorptions at 
υmax 1382 cm-1 which belongs to a geminal dimethyl, and at 1612 cm-1 which belongs to 
a chelated acyl group. The IR spectrum also exhibited a strong peak at 1741 cm-1 due to 
the presence of an α-pyrone and a broad peak at 3461 cm-1 due to OH stretching47, 88. 
 
In the 1H NMR spectrum, the typical H-3 singlet of a 4-phenylcoumarin moiety was 
observed at δ 6.03. The presence of a mono-substituted phenyl group at C-4 was 
corroborated by the presence two sets of multiplets, centred at δ 7.41 (H-3'-H-5') and δ 
7.24 (H-2', H-6'), corresponding to three and two aromatic protons, respectively. In 
addition, a proton singlet characteristic of a chelated hydroxyl at δ 14.60 (7-OH) was 
also observed. All these observations supported the presence of an 8-acyl-5,7-dioxy-4-
phenylcoumarin type47. 
 
188 
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13C NMR spectrum of compound C showed the presence twenty-nine signals; five 
methyls, two methylenes, ten methines and twelve quaternaries. Furthermore, the 1H 
NMR spectrum also showed a set of doublets, most probably belonging to the olefinic 
protons H-1'' and H-2'' at δ 6.71 (J = 10.1 Hz, H-1'') and 5.36 (J = 10.1 Hz, H-2''). A 
methyl singlet was also apparent at δ 1.00 (H-4''). All these protons correlated with the 
quaternary carbon C-3'' (δ 81.9) in the HMBC spectrum. In addition, the olefinic 
protons (H-1'' and H-2'') correlated with the quaternary C-6 (δ 105.6). This inferred the 
presence of a cyclised prenyl group attached to C-6. However, the methyl C-5'' signal as 
a singlet was absent, replaced by a methylene multiplet at δ 1.21 (H-5''). In the HMBC 
spectrum, δ 1.67 (2H, m, H-6'') correlated with the methylene carbon (C-5'', δ 40.9), an 
sp3 methine (C-7'', δ 123.5) and an sp2 quaternary carbon (C-8'', δ 131.8). C-8'', in 
return, correlated with two geminal dimethyl protons (δ 1.54, H-9'' and δ 1.67, H-10'') in 
the HMBC spectrum. These resonances implied the presence of another prenyl group 
attached to C-5''. All this information established the nature of the C-5/C-6 substituent 
as the 3-methyl-3-prenyl-Δ3-pyran ring system. 
 
The cross correlations deduced from the COSY spectrum revealed the presence of an 
iso-propyl spin system, with signals at δ 4.14 (1H, m, H-2''') and δ 1.32 (6H, d, J = 6.7 
Hz, H-3''' and H-4'''). In the HMBC spectrum, the methine proton and the methyl 
protons gave cross-peaks with the C-1''' keto function at δ 210.7. With this, it was 
identified that an iso-butanoyl chain was the other substituent on the 4-phenylcoumarin 
nucleus, which was attached at C-8.  
 
In view of the above data, and a thorough search in the SciFinder database, it was 
deduced that compound C was a new compound with the proposed structure of 
mesuagenin E 188.  
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Table 3.4: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound C 188 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.9     
3 6.03 (1H, s) 111.9   2, 4a, 1' 
4  - 156.8     
4a  - 102.0     
5  - 156.6     
6  - 105.6     
7-OH 14.60 (1H, s) 163.9   7,8 
8  - 103.2     
8a  - 156.2     
1'  - 140.1     
2' 7.24 (1H, m, Ar) 127.0   4 
3'  127.7   1', 2' 
4'     7.41 (3H, m, Ar) 127.8     
5'  127.7     
6' 7.24 (1H, m, Ar) 127.1     
1'' 6.71 (1H, d, J = 10.1) 116.0 2'' 6, 7, 3'' 
2'' 5.36 (1H, d, J = 10.1) 125.4 1'' 6, 3'', 5'' 
3'' - 81.9     
4'' 1.00 (3H, s) 26.8   2'', 3'', 5'' 
5'' 1.21 (2H, m) 40.9   6'' 
6'' 1.67 (2H, m) 22.8   3'', 5'', 7'', 8'' 
7'' 4.91 (1H, brt, J = 6.8) 123.5 6'', 9'' 5'', 6'', 9'', 10'' 
8''  - 131.8     
9'' 1.54 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.67 (3H, s) 25.6   7'', 8'', 9'' 
1'''  - 210.7     
2''' 4.14 (1H, m) 40.3 3''', 4''' 1''', 3''', 4''' 
3'''  
     1.32 (6H, d, J = 6.7) 
19.3 2''', 4''' 1''', 2''', 4''' 
4''' 19.3 2''', 3''' 1''', 2''', 3''' 
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Figure 3.3: 1H NMR Spectrum of Compound C 188 
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Figure 3.4: 13C NMR Spectrum of Compound C 188 
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3.1.4 Compound D: Mesuagenin A 189 
 
 
 
 
 
 
The molecular formula of compound D was determined by the HRESIMS measurement 
of its [M+Na]+ ion at m/z 495.2128 (calculated 495.2147), as C30H32O5. Compound D 
was separated as a yellowish oil with []26D +10 (c 0.0002, EtOH). The IR spectrum 
also exhibited strong peaks at 1382 (geminal dimethyl), 1612 (chelated acyl group), 
1741 (α-pyrone) and a broad peak at 3461 cm-1 (OH stretching)47, 88. The UV spectrum 
(EtOH) supported an 8-acyl-5,7-dioxycoumarin type, with absorptions at λmax 272 and 
313 nm82. 
 
The 13C NMR spectrum of compound D displayed a total of thirty carbon signals; five 
methyls, three methylenes, ten methines and twelve quaternary carbons. The 1H NMR 
spectrum of compound D showed striking similarities with the 1H NMR spectrum of 
compound C, with similar substituents observed at positions C-3 (the typical H-3 singlet 
of a 4-substituted coumarin at δ 5.99), C-4 (monosubstituted phenyl; δ 7.38 and 7.22, 
5H, m, H-2'-H6'), C-5/C-6 [3-methyl-3-prenyl-Δ3-pyran ring; δ 6.65 (1H, d, J = 10.4 
Hz, H-1''), 5.32 (1H, d, J = 10.4 Hz, H-2''), 0.96 (3H, s, H-4''), 1.21 (2H, m, H-5''), 1.67 
(2H, m, H-6''), 1.50 (3H, s, H-9'') and 1.63 (3H, s, H-10'')] and C-7 (chelated hydroxyl 
group; δ 14.64, s, 7-OH).  
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Nonetheless, compound D exhibited notably different patterns for the remaining 
substituent at C-8 in the 1H NMR spectrum as compared with compound C; δ 3.16 (2H, 
d, J = 6.7 Hz, H-2'''), 2.31 (1H, m, H-3''') and δ 1.04 (6H, d, J = 6.7 Hz, H-4''' and H-5'''). 
An iso-butyryl spin system could be deduced from the COSY and HMBC correlations 
of compound D. With this, it was identified that a 3-methylbutanoyl chain was the other 
substituent of the 4-phenylcoumarin, which was attached at C-8.  
 
After a thorough search in the SciFinder database, it was found that compound D was a 
new chemical entity, with the IUPAC name 7-hydroxy-6-methyl-6-(4-methylpent-3-
enyl)-8-(3-methylbutanoyl)-4-phenyl-2H-pyrano[2,3-h]chromen-2-one or which has 
been named as mesuagenin A92 189. 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: The HMBC Correlations of Compound D 189 
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Table 3.5: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound D 189 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.8     
3 5.99 (1H, s) 111.9   2, 4a, 1' 
4  - 157.0     
4a  - 102.0     
5  - 156.6     
6  - 105.4     
7-OH 14.64 (1H, s) 163.7   7,8 
8  - 104.0     
8a  - 156.0     
1'  - 140.0     
2' 7.22 (1H, m, Ar) 127.1   4 
3'  127.6   1', 2' 
4'     7.38 (3H, m, Ar) 127.8     
5'  127.6     
6' 7.22 (1H, m, Ar) 127.1     
1'' 6.65 (1H, d, J = 10.4) 115.9 2'' 6, 7, 3'' 
2'' 5.32 (1H, d, J = 10.4) 125.3 1'' 6, 3'', 5'' 
3'' - 81.9     
4'' 0.96 (3H, s) 26.8   2'', 3'', 5'' 
5'' 1.21 (2H, m) 40.9   6'' 
6'' 1.67 (2H, m) 22.8   3'', 5'', 7'', 8'' 
7'' 4.87 (1H, brt, J = 6.7) 123.5 6'', 9'' 5'', 6'', 9'', 10'' 
8''  - 131.8     
9'' 1.50 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.63 (3H, s) 25.7   7'', 8'', 9'' 
1'''  - 206.0     
2''' 3.16 (2H, d, J = 6.7) 53.5 3''' 1''', 3''', 4''', 5''' 
3''' 2.31 (1H, m) 25.6 4''', 5''' 1''', 2''', 4''', 5''' 
4'''  
    1.04 (6H, d, J = 6.7)  
22.7   2''', 3''', 5''' 
5''' 22.7   2''', 3''', 4''' 
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Figure 3.6: 1H NMR Spectrum of Compound D 189 
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Figure 3.7: 13C NMR Spectrum of Compound D 189 
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3.1.5 Compound E: Mesuagenin B 190 
 
 
 
 
 
 
 
Compound E was purified as a yellowish oil with []26D +16 (c 0.0003, EtOH). A 
pseudomolecular [M+Na]+ ion at m/z 495.2120 (calculated 495.2147) was detected in 
its HRESIMS spectrum, which was associated with the molecular formula C30H32O5. 
The UV spectrum showed absorptions at λmax 272 and 313 nm, which supported an 8-
acyl-5,7-dioxycoumarin type82. The IR spectrum showed strong absorptions at υmax 
3475 cm-1 (OH), 1742 cm-1 (α-pyrone) and 1614 cm-1 (chelated acyl group)47, 88. 
 
Similar features were evident in the 1H and 13C NMR spectra of compounds D and E, 
which confirmed a close structural relationship between these two compounds. The 
same substituents for the coumarins were characterized in these compounds through 
COSY, HMQC and HMBC experiments, namely a monosubstituted phenyl at C-4, a 
cyclized geranyl group at C-5/C-6 and a chelated hydroxyl at C-7. 
 
However, there was an obvious difference in the 1H NMR spectrum of compound E, in 
that the gem-dimethyl doublet (six protons) which was apparent in compound D was 
absent in this spectrum. Instead, the signal of the two methyls was replaced by a doublet 
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[Me-3''', δ 1.27 (J = 6.7 Hz)] and a triplet [Me-5''', δ 1.01 (J = 7.3 Hz)]. These 
observations indicate the presence of a 2-methylbutanoyl chain, instead of a 3-
methylbutanoyl chain as in compound D, attached to the C-8 position. Therefore, 
indicating that compound E was indeed an isomer of compound D. 
                                                                                                                                           
In view of the above data, and after a thorough search in the SciFinder database, it is 
deduced that compound E possesses the proposed structure; 7-hydroxy-6-methyl-6-(4-
methylpent-3-enyl)-8-(2-methylbutanoyl)-4-phenyl-2H-pyrano[2,3-h]chromen-2-one, 
which has been synthesized by Verotta et al. (2004)46. However, this compound has 
been isolated as a new natural product from M. elegans and M. kunstleri, and has been 
named as mesuagenin B 190.  
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Table 3.6: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of          
Compound E 190 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.0     
3 5.99 (1H, s) 112.0   2, 4a, 1' 
4  - 156.2     
4a  - 102.1     
5  - 156.6     
6  - 105.7     
7-OH 14.63 (1H, s) 164.0   6, 7 
8  - 103.7     
8a  - 156.9     
1'  - 140.2     
2' 7.23 (1H, m, Ar) 127.2   4, 4' 
3'  127.6   1', 2' 
4'     7.39 (3H, m, Ar) 127.9     
5'  127.6     
6' 7.23 (1H, m, Ar) 127.2     
1'' 6.66 (1H, d, J = 9.7) 116.1 2'' 5, 7, 3'' 
2'' 5.32 (1H, d, J = 9.7) 125.5 1'' 6, 3'' 
3'' - 82.0     
4'' 0.96 (3H, s) 26.9   1'', 2'', 5'' 
5'' 1.20 (2H, m) 41.0   6'' 
6'' 1.67 (2H, m) 22.9   5'', 7'', 8'' 
7'' 4.87 (1H, brt, J = 6.7) 123.6   6'', 9'', 10'' 
8''  - 131.9     
9'' 1.50 (3H, s) 17.8   7'', 8'', 10'' 
10'' 1.63 (3H, s) 25.7   7'', 8'', 9'' 
1'''  - 210.6     
2''' 3.96 (1H, m)  47.0 3''' 1''', 3''', 4''', 5''' 
3''' 1.27 (3H, d, J = 6.7) 16.7   1''', 2''', 4''' 
4'''α 1.94 (1H, m)  
     27.3 
4'''β 1''', 2''', 5''' 
4'''β 1.47 (1H, m) 4'''α, 5''' 1''', 2''', 3''', 5''' 
5''' 1.01 (3H, t, J = 7.3) 11.9   2''', 4''' 
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Figure 3.8: 1H NMR Spectrum of Compound E 190 
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Figure 3.9: 13C NMR Spectrum of Compound E 190 
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3.1.6 Compound F: Mammea A/BB 55 
 
 
 
 
 
 
Compound F was obtained as a colourless oil using column chromatography 
fractionation, followed by HPLC separation. The HRESIMS spectrum showed a 
pseudomolecular ion [M+H]+ at m/z 407.1855 (calculated 407.1858), which  suggested 
a molecular formula of C25H26O5. The UV spectrum supported an 8-acyl-5,7-
dihydroxycoumarin type, with absorptions at λmax 226, 297 and 331 nm82. The IR 
spectrum showed absorptions at υmax 3482 (OH), 1717 (α,β-unsaturated lactone) and 
1602 cm-1 (chelated acyl group)47. 
 
The 13C NMR spectrum showed the signals of four methyls, two methylenes, eight 
methines and eleven quaternary carbons. The presence of a 4-phenylcoumarin type 
skeleton was indicated by the typical singlet of H-3 proton at δ 5.99, which is vicinal to 
the lactone functionality of the coumarin skeleton in the 1H NMR spectrum. In addition, 
two sets of multiplets corresponding to five protons centred at δ 7.55 (H-3' - H-5') and  
7.41 (H-2' and H-6'), respectively, were also observed in the 1H NMR spectrum of 
compound F. The 1H NMR spectrum also exhibited a singlet of a chelated hydroxyl 
proton at δ 14.57 and an unchelated phenolic hydroxyl singlet at δ 5.94, which were 
55 
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exchangeable with D2O. All these observations suggested the presence of an 8-acyl-5,7-
dihydroxy-4-phenylcoumarin type47. 
 
The 1H NMR resonances at δ 3.27 (2H, d, J = 6.7 Hz, H-1''), 5.07 (1H, brt, J = 6.7 Hz, 
H-2''), 1.68 (3H, s, H-4'') and 1.63 (3H, s, H-5''), together with the 13C signals at δ 21.7 
(C-1''), 120.9 (C-2''), 134.2 (C-3''), 18.0 (C-4'') and 25.8 (C-5'') implied the presence of 
an isoprenyl group. Correlations in the HMBC spectrum between H-1'' with C-6 (δ 
112.8) and C-7 (δ 167.0) indicated that the isoprenyl group was attached to C-6. 
 
Signals of non-equivalent geminal protons of C-4''' showed two methylene protons as 
two sets of multiplets at δ 1.51 (1H, m, H-4'''α) and 1.93 (1H, m, H-4'''β) on the 1H 
NMR spectrum. In the HMBC spectrum of compound F, these methylene protons 
correlated with a carbonyl (C-1''', δ 210.6), a methine (C-2''', δ 47.1) and two methyls 
(C-3''', δ 16.7 and C-5''', δ 11.9). Protons of the two methyls (C-3''' and C-5''') were 
observed as a doublet at δ 1.27 (J = 6.7 Hz) and as a triplet at δ 1.01 (J = 7.3 Hz), 
respectively. These signals confirmed the presence of the 2-methylbutanoyl moiety 
linked at C-8. 
  
The observed data of compound F indicated that this compound is mammea A/BB 55, 
as reported in the literature93, which has previously been isolated from Mammea 
americana for the first time in 1966. 
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27.3 
 
Table 3.7: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound F 55 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.8     
3 5.99 (1H, s) 112.2   2, 4a, 1' 
4  - 157.1     
4a  - 100.6     
5-OH 5.94 (1H, s) 154.2  4, 4a, 6, 1' 
6  - 112.8     
7-OH 14.57 (1H, s) 167.0  6, 7, 8 
8  - 104.3     
8a  - 155.9     
1'  - 136.9     
2' 7.41 (1H, m, Ar) 127.6     
3'  129.7   1', 2' 
4'     7.55 (3H, m, Ar) 130.3     
5'  129.7     
6' 7.41 (1H, m, Ar) 127.6   5, 4', 5'  
1'' 3.27 (2H, d, J = 6.7) 21.7 2'', 4'', 5'' 4, 6, 7, 2'', 3'' 
2'' 5.07 (1H, brt, J = 6.7) 120.9 1'' 1'', 4'', 5'' 
3''  - 134.2     
4'' 1.68 (3H, s) 18.0   2'', 3'', 5'' 
5'' 1.63 (3H, s) 25.8   2'', 3'', 4'' 
1'''  - 210.6     
2''' 3.94 (1H, m) 47.1 3''' 1''', 3''', 4''', 5''' 
3''' 1.27 (3H, d, J = 6.7) 16.7 2''' 1''', 2''', 4''' 
4'''α 1.51 (1H, m)      4'''β, 5''' 1''', 2''', 5''' 
4'''β 1.93 (1H, m) 4'''α, 5''' 1''', 2''', 3''', 5''' 
5''' 1.01 (3H, t, J = 7.3) 11.9 4'''α, 4'''β 2''', 4''' 
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 Figure 3.10: 1H NMR Spectrum of Compound F 55 
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3.1.7 Compound G: Mammea A/BA 28 
 
 
 
 
 
 
Compound G was obtained as a colourless oil using column chromatography 
fractionation followed by HPLC separation. The HRESIMS measurement of its [M+H]+ 
ion at m/z 407.1855 (calculated 407.1858) suggested a molecular formula of C25H26O5. 
The UV spectrum supported an 8-acyl-5,7-dihydroxycoumarin type, with absorptions at 
λmax 226, 297 and 331 nm82. The IR spectrum showed absorptions at υmax 3482 cm-1 
(OH), 1717 cm-1 (α,β-unsaturated lactone), 1602 cm-1 (chelated acyl group) and 1385 
cm-1 (geminal dimethyl)47. 
 
The 1H and 13C NMR spectra of compound G were similar to those of compound F, thus 
suggesting a close relationship between these two compounds. Indeed, the same 
substituents for the coumarin skeleton could be characterized in both compounds, 
namely a typical H-3 singlet of a 4-phenylcoumarin (δ 5.98, s, H-3), a monosubstituted 
phenyl (δ 7.52 and 7.45, 5H, m, H-2'-H6'), a prenyl group [δ 3.27 (2H, d, J = 6.7 Hz, H-
1''), 5.07 (1H, brt, J = 6.7 Hz, H-2''), 1.68 (3H, s, H-4'') and 1.63 (3H, s, H-5'')] and a 
chelated hydroxyl (δ 14.59, s, 7-OH).  
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However, close inspection of 1H NMR spectrum of compound G revealed a difference 
in the coupling pattern of the substituent group at position C-8; a methylene at δ 3.16 
(2H, d, J = 6.7, H-2'''), 2.30 (1H, m, H-3''') and 1.03 (6H, d, J = 7.3, H-4''' and H-5'''). 
The observations from the COSY spectrum revealed the presence of an iso-butyryl spin 
system (C-2'''-C-3'''-C-4'''-C-5''') with cross peaks between H-2'''/H-3''' and H-3'''/H-4''', 
H-5'''. In the HMBC spectrum of compound G, the methylene protons produced cross-
peaks with a carbonyl function at δ 206.2 (C-1'''). With this, it was identified that a 3-
methylbutanoyl moiety was the substituent of the 4-phenylcoumarin at position C-8. 
 
Comparison of the spectral data of compound G with literature values showed that this 
compound is mammea A/BA 28 and was first isolated from Mammea americana 
(Clusiaceae) in 1966 by Crombie et al.93. 
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Table 3.8: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound G 28 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.8     
3 5.98 (1H, s) 112.3   2, 4a, 1' 
4  - 157.2     
4a  - 100.6     
5-OH 5.95 (1H, s) 154.2  4, 4a, 6, 1' 
6  - 112.7     
7-OH 14.59 (1H, s) 166.9  6, 7, 8 
8  - 104.7     
8a  - 156.0     
1'  - 136.9     
2' 7.45 (1H, m, Ar) 127.6     
3'     129.7   1', 2' 
4'    7.52 (3H, m, Ar) 130.3     
5'   129.7     
6'  7.45 (1H, m, Ar) 127.6   5, 4', 5'  
1'' 3.27 (2H, d, J = 6.7) 21.7 2'', 4'', 5'' 4, 6, 7, 2'', 3'' 
2'' 5.07 (1H, brt, J = 6.7) 120.9 1'', 4'', 5'' 1'', 4'', 5'' 
3''  - 134.2     
4'' 1.68 (3H, s) 18.0   2'', 3'', 5'' 
5'' 1.63 (3H, s) 25.9   2'', 3'', 4'' 
1'''  - 206.2     
2''' 3.16 (2H, d, J = 6.7) 53.7 3''' 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 2''', 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.03 (6H, d, J = 7.3) 
22.8   2''', 3''', 5''' 
5''' 22.8   2''', 3''', 4''' 
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Figure 3.11: 1H NMR Spectrum of Compound G 28 
7-OH 
3'-5' 
2', 6' 
3 
5-OH 
2'' 
2''' 
1'' 
3''' 
4'' 
5'' 
4''', 5''' 
O O
OH
HO
O
1
2
3
4
1'
2'
3'
4'
5'
6'
4a
5
6
7
8
8a
1'''
2'''
3'''
4''' 5'''
1''
2''
3''
4''
5''
Chapter 3                                                               Chemical Constituents from M. elegans and M. kunstleri 
91 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: 13C NMR Spectrum of Compound G 28 
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Figure 3.13: COSY Spectrum of Compound G 28 
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3.1.8 Compound H: Mesuagenin C 191 
 
 
 
 
  
 
Separation using column chromatography, followed by HPLC, afforded compound H as 
a white amorphous powder. The HRESIMS measurement revealed an [M+Na]+ ion at 
m/z 483.2132 (calculated 483.2147), which corresponded to the molecular formula of 
C29H32O5. The absorptions at λmax 226, 295 and 331 nm in UV spectrum supported an 8-
acyl-5,7-dioxycoumarin type82. The IR spectrum showed absorptions at υmax 3452 (OH), 
1735 (δ-lactone), 1600 (chelated acyl group) and 1386 cm-1 (geminal dimethyl)85, 88. 
The IR spectrum showed absorptions at υmax 3470 (OH), 1741 (α-pyrone), 1602 
(chelated acyl group) and 1383 cm-1 (geminal dimethyl)47, 88. 
 
The 1H NMR spectrum of compound H exhibited the typical singlet of H-3 proton at δ 
6.00, and two sets of multiplets corresponding to five phenyl protons centred at δ 7.52 
(H-3' - H-5') and δ 7.40 (H-2' and H-6'). A singlet of a chelated hydroxyl proton at δ 
14.54 and an unchelated phenolic hydroxyl singlet at δ 5.98, which were exchangeable 
with D2O, were also apparent in the 
1H NMR spectrum. 
 
The 13C NMR spectrum of compound H revealed twenty-nine carbon signals; five 
methyls, three methylenes, nine methines and twelve quaternary carbons. In the 1H 
191 
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NMR spectrum, three methyl singlets were apparent at δ 1.68 (H-4''), δ 1.59 (H-9'') and 
δ 1.53 (H-10''), along with a doublet integrating for two protons at δ 3.30 (H-1'', J = 
7.3), two methylene protons which appeared as multiplets at δ 1.91 - 2.03 (H-5'' and H-
6''), and two broad methine triplets at δ 5.08 (H-2'', J = 6.7) and δ 4.99 (H-7'', J = 6.7). 
The linkage of these carbons was apparent from the HMBC spectrum. In the HMBC 
spectrum, the methyls of C-9'' and C-10'' showed cross peaks with δ 124.1 (C-7'') and δ 
131.7 (C-8''), and the methyls of C-4'' revealed cross peaks with δ 120.6 (C-2''), δ 128.2 
(C-3'') and δ 39.8 (C-5''). Moreover, the HMBC spectrum also showed cross 
correlations between the methylenes of C-5'' and C-6'' with δ 120.6 (C-2''), δ 128.2 (C-
3'') and δ 124.1 (C-7''). Also, the methylene protons of C-1'' correlated with a methine 
carbon (C-2'', δ 120.6) and two quaternary carbons, C-6 (δ 112.6) and C-7 (δ 167.1). All 
is evidence supported the presence of a geranyl substituent attached at position C-6 of 
the coumarin skeleton. 
 
The cross correlations deduced from the COSY spectrum revealed the presence of an 
iso-butyryl spin system with signals at δ 4.11 (1H, m, H-2''') and δ 1.28 (6H, d, J = 6.7, 
H-3''' and H-4'''). In the HMBC spectrum, the methine proton of C-2''' and the methyl 
protons of C-3''' and C-4''' gave cross-peaks with a keto function at δ 210.8, belonging to 
C-1'''. With this, it was identified that an iso-butanoyl chain was the other substituent of 
the 4-phenylcoumarin, and was attached at C-8.  
 
Literature search based on the SciFinder database confirmed that compound H is a new 
chemical entity, its IUPAC name is 5,7-dihydroxy-8-isobutyryl-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one, which have been named as 
mesuagenin C92 191. 
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Table 3.9: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound H 191 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.9     
3 6.00 (1H, s) 112.2   2, 4a, 1' 
4  - 157.3     
4a  - 100.7     
5-OH 5.98 (1H, s) 154.4   4, 4a, 6 
6  - 112.6     
7-OH 14.54 (1H, s) 167.1   6, 7, 8 
8  - 103.8     
8a  - 155.8     
1'  - 137.1     
2' 7.40 (1H, m, Ar) 127.6     
3'  129.6   1', 2' 
4'     7.52 (3H, m, Ar) 130.2     
5'  129.6     
6' 7.40 (1H, m, Ar) 127.6   4' 
1'' 3.30 (2H, d, J = 6.7) 21.7   6, 7, 2'' 
2'' 5.08 (1H, t, J = 7.4) 120.6 1'' 4'', 5'' 
3''  - 138.2     
4'' 1.68 (3H, s) 16.3   2'', 3'', 5'' 
5''  
     2.03 - 1.91 (4H, m) 
39.8   2'', 3'', 6'' 
6'' 26.6   5'', 7'' 
7'' 4.99 (1H, t, J = 7.3) 124.1 6''   
8''  - 131.7     
9'' 1.53 (3H, s) 17.6   7'', 8'', 10'' 
10'' 1.59 (3H, s) 25.8   7'', 8'', 9'' 
1'''  - 210.8     
2''' 4.11 (1H, m) 40.5 3''', 4''' 1''', 4''' 
3'''  
     1.28 (6H, d, J = 7.3) 
19.4 2''', 4''' 1''', 2''', 4''' 
4''' 19.4 2''', 3''' 3''' 
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Figure 3.14: 1H NMR Spectrum of Compound H 191 
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Figure 3.15: 13C NMR Spectrum of Compound H 191 
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3.1.9 Compound I: 5,7-Dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-
2,6-dienyl]-4-phenyl-2H-chromen-2-one 47 
 
 
 
 
 
 
Compound I was isolated as white crystals with m.p. 90-92°C using column 
chromatography, followed by HPLC separation. The HRESIMS revealed an [M+H]+ 
ion at m/z 475.2728 (calculated 475.2484), corresponding to the molecular formula of 
C30H34O5. The UV spectrum (EtOH) showed intense absorption bands at 226, 296 and 
333 nm reflecting an 8-acyl-5,7-dihydroxycoumarin type82. The IR spectrum showed 
absorptions at υmax 3471 cm-1 (OH), 1741 cm-1 (α-pyrone) and 1601 cm-1 (chelated acyl 
group)47, 88. 
 
13C NMR spectrum of compound I revealed the signals of five methyls, four 
methylenes, nine methines and twelve quaternary carbons (for a total of thirty carbons). 
In the 1H NMR spectrum, a typical H-3 singlet was observed at δ 6.00, characteristic of 
the C-3 proton of a 4-phenyl substituted coumarin. Moreover, two sets of multiplets 
corresponding to five protons assignable to H-3' - H-5', along with the H-2' and H-6' 
protons, were observed at δ 7.52 and δ 7.40, respectively. In addition, a proton singlet 
characteristic of a chelated hydroxyl at δ 14.59 (7-OH), and another hydroxyl singlet at 
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δ 5.98 (5-OH) was also observed. All these observations suggested the presence of an 8-
acyl-5,7-dihydroxy-4-phenylcoumarin type47. 
  
In the 1H NMR spectrum of compound I, three methyl singlets were apparent at δ 1.69 
(H-4''), δ 1.61 (H-9'') and δ 1.53 (H-10''), along with two broad triplets at δ 5.08 (1H, J 
= 6.7) and δ 4.99 (1H, J = 6.7), corresponding to the olefinic protons H-2'' and H-7'', 
respectively, in the HMBC spectrum. A doublet, integrating for two protons, was 
detected at δ 3.30 (H-1'', J = 7.3) in the 1H NMR spectrum. In the HMBC spectrum, 
these methylene protons correlated with a methine carbon (C-2'', δ 120.6) and two 
quaternary carbons, C-6 (δ 112.6) and C-7 (δ 167.0), suggesting a geranyl substituent 
attached at position C-6. 
 
Signals of two methylene protons as two sets of multiplets at δ 1.47 (1H, m, H-4'''α) and 
1.91 (1H, m, H-4'''β) were apparent in the 1H NMR spectrum. In the HMBC spectrum, 
these protons correlated with a carbonyl (C-1''', δ 210.7), a methine (C-2''', δ 47.1) and 
two methyls (C-3''', δ 16.72 and C-5''', δ 11.9). Protons of the two methyls (C-3''' and C-
5''') were observed as a doublet at δ 1.27 (J = 6.7) and as a triplet at δ 1.01 (J = 7.3), 
respectively. These elements confirmed the presence of the 2-methylbutanoyl moiety 
linked at C-8. 
 
By comparison of the observed data with the literature values, it was confirmed that  
compound I was 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-
dienyl]-4-phenyl-2H-chromen-2-one 47, (DMDP-1), which was previously isolated by 
Verotta et al. from Mesua ferrea in 200446. Compound I 47 was isolated as a mixture 
with compound J 48, in a crystal form, and was published in Acta Crystallographica 
Section E (Appendix). 
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2.03 - 1.93 (4H, m) 
 
Table 3.10: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound I 47 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 158.8     
3 6.00 (1H, s) 112.3   2, 4a, 1' 
4  - 157.3     
4a  - 100.6     
5-OH 5.98 (1H, s,) 154.4   6 
6  - 112.6     
7-OH 14.59 (1H, s) 167.0   6, 7, 8 
8  - 104.2     
8a  - 155.8     
1'  - 137.1     
2' 7.40 (1H, m, Ar) 127.6   4' 
3'     129.2   1' 
4'     7.52 (3H, m, Ar) 130.1     
5'   129.2     
6' 7.40 (1H, m, Ar) 127.6     
1'' 3.30 (2H, d, J = 7.3) 21.6   4, 6, 7, 2'', 3'' 
2'' 5.08 (1H, brt, J = 6.7) 120.6 1'' 1'', 4'', 5'' 
3''  - 138.1     
4'' 1.69 (3H, s) 16.3   2'', 3'', 5'' 
5''  
 
39.8   2'', 3'', 7'' 
6'' 26.6   3'', 5'', 7'', 8'' 
7'' 4.99 (1H, brt, J = 6.7) 124.0   10'' 
8''  - 131.7     
9'' 1.61 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.53 (3H, s) 25.8   7'', 8'', 9'' 
1'''  - 210.7     
2''' 3.94 (1H, m) 47.1 3''' 1''', 3''', 4''', 5''' 
3''' 1.27 (3H, d, J = 6.7) 16.7   1''', 2''', 4''' 
4'''α 1.47 (1H, m)  
       
5''' 1''', 2''', 3''', 5''' 
4'''β 1.91 (1H, m) 4'''α, 5''' 1''', 3''', 5''' 
5''' 1.01 (3H, t, J = 7.3) 11.9   2''', 4''' 
 
 
27.3 
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Figure 3.16: 1H NMR Spectrum of Compound I 47 
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Figure 3.17: 13C NMR Spectrum of Compound I 47 
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Figure 3.18: HMBC NMR Spectrum of Compound I 47 
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3.1.10 Compound J: 5,7-Dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-
2,6-dienyl]-4-phenyl-2H-chromen-2-one 48 
 
 
 
 
 
 
Compound J was separated as yellowish oil. The molecular formula of compound J was 
determined by the HRESIMS measurement of its [M+H]+ ion at m/z 475.2783 
(calculated 475.2484), as C30H34O5. The IR spectrum exhibited a strong peak at 3472 
cm-1, due to hydroxyl group stretching. Peaks were also observed at 1603 and 1742 cm-
1, indicating a chelated acyl group and an α-pyrone, respectively47. The UV spectrum 
(EtOH) supported an 8-acyl-5,7-dioxycoumarin moeity, with absorptions at λmax 272 
and 313 nm82. 
 
The gross features of the 1H NMR and 13C NMR spectra of compounds I and J 
confirmed a close structural relationship between these compounds. Indeed, the same 
substituents for the coumarin could be characterized in both compounds through COSY, 
HMQC and HMBC experiments, namely a monosubstituted phenyl, a chelated 
hydroxyl, an unchelated hydroxyl and a geranyl chain. 
 
However, compound I and J exhibited noticeable differences in the coupling patterns of 
protons of the acyl chain attached to C-8. The doublet and triplet signals of C-3''' and C-
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5''' methyls were absent in 1H NMR spectrum of compound J. Instead, a doublet 
integrating for six protons was present, suggesting a 3-methylbutanoyl moiety, instead 
of a 2-methylbutanoyl moiety, as in compound I. 
 
Extensive analysis of the spectroscopic data established the complete assignments of all 
the 1H and 13C signals of compound J, which eventually led to the identification of the 
compound as 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-
4-phenyl-2H-chromen-2-one (DMDP-2) 32, which was isolated from Mesua ferrea in 
2004 by Verotta et al.46. Compound I 47 was isolated as a mixture with compound J 48, 
in a crystal form, and was published in Acta Crystallographica Section E (Appendix). 
 
 
 
 
 
 
 
 
 
 
Figure 3.19: The HMBC Correlations of Compound J 48 
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2.03 - 1.92 (4H, m) 
 
Table 3.11: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound J 48 
 
Position δH, J (Hz)  δC COSY HMBC 
2   158.8     
3 5.99 (1H, s) 112.2   2, 4a, 1' 
4   157.4     
4a   100.6     
5-OH 5.98 (1H, s) 154.3   4, 4a, 6 
6   112.5     
7-OH 14.62 (1H, s) 166.9   6, 7, 8 
8   104.6     
8a   156.0     
1'   137.1     
2' 7.40 (1H, m, Ar) 127.6   4' 
3'      129.5   2', 1' 
4'     7.52 (3H, m, Ar) 130.1     
5'  129.5     
6' 7.40 (1H, m, Ar) 127.6     
1'' 3.30 (2H, d, J = 6.7) 21.6   4, 6, 7, 2'', 3'' 
2'' 5.08 (1H, brt, J = 7.3) 120.7 1'' 1'', 4'', 5'' 
3''   138.1     
4'' 1.69 (3H, s) 16.3   2'', 3'', 5'' 
5''  
      
39.8   2'', 3'', 4'', 6'' 
6'' 26.6   5'', 7'', 8'' 
7'' 4.99 (1H, brt, J = 7.3) 124.1     
8''   131.7     
9'' 1.59 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.53 (3H, s) 25.8   7'', 8'', 9'' 
1'''   206.2     
2''' 3.18 (2H, d, J = 6.7) 53.8 3''' 1''', 3''', 4''', 5''' 
3''' 2.31 (1H, m) 25.7 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.04 (6H, d, J = 6.7) 
22.9 3''', 5''' 3''', 5''' 
5''' 22.9 3''', 4''' 3''', 4''' 
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Figure 3.20: 1H NMR Spectrum of Compound J 48 
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3.1.11 Compound K: Ochrocarpin E 192 
 
 
 
 
 
 
Separation using column chromatography, followed by HPLC afforded compound K as 
a white amorphous powder. The HRESIMS measurement revealed an [M+Na]+ ion at 
m/z 431.1486 (calculated 431.1471), which corresponded to the molecular formula of 
C24H24O6. The absorptions at λmax 227, 298 and 331 nm in UV spectrum supported an 8-
acyl-5,7-dioxycoumarin type82. The IR spectrum showed absorptions at υmax 3452 (OH), 
1735 (δ-lactone), 1600 (chelated acyl group) and 1386 cm-1 (geminal dimethyl)85, 88. 
 
The 13C NMR spectrum of compound K showed twenty-four carbon signals; four 
methyls, one methylene, eight methines and eleven quaternary carbons. A typical H-3 
singlet was observed at δ 6.06 in the 1H spectrum, characteristic of the C-3 proton of a 
4-substituted coumarin. The presence of a mono-substituted phenyl group at C-4 was 
corroborated by the presence of two sets of multiplets, centred at δ 7.43 (H-3' - H-5') 
and 7.29 (H-2' and H-6'), corresponding to three and two aromatic protons, respectively. 
Furthermore, the 1H NMR spectrum supported the presence of a chelated hydroxyl by 
revealing a proton singlet characteristic of a chelated hydroxyl at δ 14.25 (7-OH), and 
the broad OH absorption depicted in the IR spectrum further supported this finding. 
192 
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These observations on the 1H NMR spectrum, together with the UV data, suggested the 
presence of an 8-acyl-5,7-dioxy-4-phenylcoumarin type skeleton47. 
 
The presence of two doublets of doublets at δ 2.94 (1H, J = 9.8, 15.9 Hz, H-1''α) and 
3.09 (1H, J = 9.8, 15.9 Hz, H-1''β) respectively, and a triplet at δ 4.51 (1H, J = 9.8 Hz, 
H-2''), indicated the presence of a dihydrofuran moiety. The HMBC resonances of δ 
1.00 (Me-4'') and 0.92 (Me-5'') showed cross peaks with δ 92.8 (C-2'') and δ 71.7 (C-3''), 
which indicated the connection of Me-4'' and Me-5'' with C-3''. In addition, the HMBC 
correlations showed that the dihydrofuran ring was located between C-5 (δ 161.9) and 
C-6 (δ 110.3) by exhibiting the following correlation, H-1''α,β/C-5, C-6, C-2'' and C-3''. 
 
The cross correlations deduced from COSY spectrum revealed the presence of iso-
butyryl spin system with signals at δ 4.11 (1H, m, H-2''') and δ 1.28 (6H, d, J = 6.72 Hz, 
H-3''' and H-4'''). In the HMBC spectrum, the methine proton and the methyl protons 
gave cross-peaks with a keto function at δ 210.8, belonging to C-1'''. With this, it was 
identified that an iso-butanoyl chain was the other substituent of the 4-phenylcoumarin, 
and was attached at C-8.  
 
Based on the analysis of all the spectral data and comparison with the literature values, 
compound K has been identified as ochrocarpin E 192, which was previously isolated 
from Ochrocarpos punctatus by Chaturvedula et al. in 200294. 
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Table 3.12: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound K 192 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.3     
3 6.06 (1H, s) 111.0   2, 4a, 1' 
4  - 155.1     
4a  - 99.0     
5  - 161.9     
6  - 110.3     
7-OH 14.25 (1H, s) 164.0   6, 7, 8 
8  - 104.2     
8a  - 157.2     
1'  - 138.2     
2' 7.29 (1H, m, Ar) 127.5   3' 
3'  129.0   1', 4' 
4'     7.43 (3H, m, Ar) 128.0     
5'  129.0     
6' 7.29 (1H, m, Ar) 127.5     
1''α 2.94 (1H, dd, J = 9.8, 15.9) 
27.0 
  5, 6, 2'', 3'' 
1''β 3.09 (1H, dd, J = 9.8, 15.9)   5, 6, 3'' 
2'' 4.51 (1H, t, J = 9.8) 92.8 1''α, 1''β   
3''-OH  - 71.7     
4'' 1.00 (3H, s) 23.3   2'', 3'', 5'' 
5'' 0.92 (3H, s) 24.9   2'', 3'', 4'' 
1'''  - 210.8     
2''' 4.11 (1H, m) 40.3 3''', 4''' 1''', 3''', 4''' 
3'''  
    1.28 (6H, d, J = 6.7) 
19.4   1''', 2''', 4''' 
4''' 19.4   1''', 2''', 3''' 
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Figure 3.21: 1H NMR Spectrum of Compound K 192 
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Figure 3.22: 13C NMR Spectrum of Compound K 192 
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3.1.12 Compound L: Mammea A/BB cyclo F 193 
 
 
 
 
 
 
Compound L was separated as a white amorphous solid. The molecular formula of 
compound L was determined by the HRESIMS measurement of its [M+Na]+ ion at m/z 
445.1664 (calculated 445.1627), as C25H26O6. The IR spectrum showed absorptions at 
υmax 3453 (OH), 1732 (δ-lactone) and 1603 cm-1 (chelated acyl group)85, 88. The 
absorptions at λmax 225, 298 and 330 nm in the UV spectrum supported an 8-acyl-5,7-
dioxycoumarin type85. 
 
The 13C NMR spectrum showed the signals of four methyls, two methylenes, eight 
methines and eleven quaternary carbons. The presence of a 4-phenylcoumarin type 
skeleton was indicated by the singlet of a typical H-3 proton which was vicinal to the 
lactone functionality of the coumarin skeleton, and was observed at δ 6.06 in the 1H 
NMR spectrum of compound L. In addition, two sets of multiplets corresponding to five 
protons, centred at δ 7.43 (H-3' - H-5') and δ 7.31 (H-2' and H-6'), were also observed in 
the 1H NMR spectrum. The 1H NMR spectrum also exhibited a singlet of a chelated 
hydroxyl proton at δ 14.29, which was exchangeable with D2O. All these observations 
suggested the presence of an 8-acyl-5,7-dioxy-4-phenylcoumarin type47. 
 
193 
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The 1H NMR spectrum also showed the presence of a triplet at δ 4.50 (1H, J = 9.8 Hz, 
H-2'') and two doublets of doublets at δ 3.09 (1H, J = 9.8, 15.9 Hz, H-1''β) and 2.49 
(1H, J = 9.8, 15.9 Hz, H-1''α) respectively, thus indicating the presence of a 
dihydrofuran moiety. The HMBC resonances at δ 1.00 (3H, s, H-4'') and 0.92 (3H, m, 
H-5'') showed cross peaks with δ 92.8 (C-2'') and δ 71.7 (C-3''), which indicated the 
connection of Me-4'' and Me-5'' with C-3''. In addition, the HMBC correlations 
established that the dihydrofuran ring was located between C-5 (δ 161.9) and C-6 (δ 
110.2) by exhibiting the following correlation, H-1''α,β/C-5, C-6, C-2'' and C-3''. 
 
Signals of non-equivalent geminal protons of C-4''' showed two methylene protons as 
two sets of multiplets at δ 1.49 (1H, m, H-4'''α) and 1.92 (1H, m, H-4'''β) in the 1H NMR 
spectrum. In the HMBC spectrum, these methylene protons correlated with a carbonyl 
(C-1''', δ 210.6), a methine (C-2''', δ 46.9) and two methyl group (C-3''', δ 16.7 and C-5''', 
δ 11.9). Protons of the two methyl group (C-3''' and C-5''') were observed as a doublet at 
δ 1.27 (J = 6.8 Hz) and as a triplet at δ 1.01 (J = 7.4 Hz), respectively. These signals 
confirmed the presence of the 2-methylbutanoyl moiety linked at C-8. 
  
The observed data of compound L indicated that this compound is mammea A/BB cyclo 
F 193, which was first isolated from Calophyllum dispar in 2011 by Guilet et al.85.
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Table 3.13: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound L 193 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.2     
3 6.06 (1H, s) 111.1   2, 4a, 1' 
4  - 155.1     
4a  - 98.7     
5  - 161.9     
6  - 110.2     
7-OH 14.29 (1H, s) 164.0   6, 7, 8, 1''' 
8  - 104.7     
8a  - 157.2     
1'  - 138.2     
2' 7.31 (1H, m, Ar) 127.5   3' 
3'  128.9   1', 4' 
4'     7.43 (3H, m, Ar) 128.0     
5'  128.9     
6' 7.31 (1H, m, Ar) 127.5     
1''α 2.49 (1H, dd, J = 9.8, 15.9) 
27.0 
  5, 6, 2'', 3'' 
1''β 3.09 (1H, dd, J = 9.8, 15.9)   5, 6, 3'' 
2'' 4.50 (1H, t, J = 9.8) 92.8 1''α, 1''β 5, 4'' 
3''-OH  - 71.7     
4'' 1.00 (3H, s) 23.3   2'', 3'', 5'' 
5'' 0.92 (3H, s) 24.9   2'', 3'', 4'' 
1'''  - 210.6     
2''' 3.96 (1H, m) 46.9 3''' 1''', 3''', 4''', 5''' 
3''' 1.27 (3H, d, J = 6.8) 16.7  1''', 2''', 4''' 
4'''α 1.49 (1H, m) 27.3 4'''β, 5''' 1''', 2''', 3''', 5''' 
4'''β 1.92 (1H, m) 4'''α, 5''' 1''', 2''', 3''', 5''' 
5''' 1.01 (3H, t, J = 7.4) 11.9   2''', 4''' 
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Figure 3.23: 1H NMR Spectrum of Compound L 193 
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Figure 3.24: 13C NMR Spectrum of Compound L 193 
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3.1.13 Compound M: Mammea A/BA cyclo F 194 
 
 
 
 
 
 
Compound M was obtained as a white amorphous powder and the HRESIMS 
measurement revealed an [M+Na]+ ion at m/z 445.1660 (calculated 445.1627), which 
corresponded to the molecular formula of C25H26O6. The UV absorptions (EtOH) at λmax 
227, 300 and 331 nm indicated that compound M possess an 8-acyl-5,7-dioxycoumarin 
skeleton82. The IR spectrum showed absorptions at υmax 3444 (OH), 1744 (δ-lactone), 
1602 (chelated acyl group) and 1384 cm-1 (geminal dimethyl)47. 
 
A total of twenty-five carbons were observed in the 13C NMR spectrum of compound 
M; four methyls, two methylenes, eight methines and eleven quaternary carbons. The 
1H NMR spectrum of compound M was reminiscent with those of compound L, thus 
suggesting a similarity between these compounds. The same substituents were 
characterized in both compounds, namely a typical H-3 signal of a 4-phenylcoumarin (δ 
6.05, s, H-3), a monosubstituted phenyl (δ 7.43 and 7.30, 5H, m, H-2'-H6'), a cyclized 
furan group [δ 3.09 (1H, dd, J = 9.8, 15.9 Hz, H-1''β), 2.49 (1H, dd, J = 9.8, 15.9 Hz, H-
1''α), 4.49 (1H, t, J = 9.8 Hz, H-2''), 0.99 (3H, s, H-4'') and 0.91 (3H, s, H-5'')] and a 
chelated hydroxyl group (δ 14.29, s, 7-OH). 
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The 1H and 13C NMR spectra of M were reminiscent of those of compound L, in which 
compound M possessed a monosubstituted phenyl, a cyclized furan and a chelated 
hydroxyl group. These observations suggested a close skeletal resemblance between 
compounds L and M.  
 
However, the 1H NMR spectrum showed obvious differences in the proton resonances 
of the remaining substituent; a methylene at δ 3.16 (2H, d, J = 6.7 Hz, H-2'''), δ 2.30 
(1H, m, H-3''') and δ 1.05 (6H, d, J = 7.3 Hz, H-4''' and H-5'''). The observation from 
COSY spectrum revealed the presence of an iso-butyryl spin system (C-2'''-C-3'''-C-4'''-
C-5''') with cross peaks between H-2'''/H-3''', H-3'''/H-4''' and H-5'''. In the HMBC 
spectrum of compound M, the methylene protons caused cross-peaks with a keto 
function at δ 206.2 (C-1'''). With this, it was identified that a 3-methylbutanoyl chain 
was the substituent of the coumarin nucleus at C-8. 
 
Based on the analysis of all the spectral data and comparison with the literature values, 
compound M has been identified as mammea A/BA cyclo F 194, which was previously 
purified from Calophyllum dispar in 201185.  
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Table 3.14: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound M 194 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.1     
3 6.05 (1H, s) 111.1   2, 4a, 1' 
4  - 155.0     
4a  - 98.7     
5  - 162.0     
6  - 110.1     
7-OH 14.29 (1H, s) 163.8   6, 7, 8 
8  - 105.1     
8a  - 157.5     
1'  - 138.2     
2' 7.30 (1H, m, Ar) 127.5   3' 
3'  128.9   1', 4' 
4'     7.43 (3H, m, Ar) 128.0     
5'  128.9     
6' 7.30 (1H, m, Ar) 127.5     
1''α 2.49 (1H, dd, J = 9.8, 15.9) 
26.9 
  5, 6, 2'', 3'' 
1''β 3.09 (1H, dd, J = 9.8, 15.9)   5, 6, 3'' 
2'' 4.49 (1H, t, J = 9.8) 92.8 1''α, 1''β, 4'', 5''   
3''-OH  - 71.7     
4'' 0.99 (3H, s) 23.3   2'', 3'', 5'' 
5'' 0.91 (3H, s) 24.9   2'', 3'', 4'' 
1'''  - 206.2     
2''' 3.16 (2H, d, J = 6.7) 53.5 3''', 4''', 5''' 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 4''', 5''' 4''', 5''' 
4'''  
     1.05 (6H, d, J = 6.7) 
22.8   2''', 3''', 5''' 
5''' 22.8   4''' 
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Figure 3.25: 1H NMR Spectrum of Compound M 194 
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Figure 3.26: 13C NMR Spectrum of Compound M 194 
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3.1.14 Compound N: Mesuagenin F 195 
 
 
 
 
 
 
Separation by using column chromatography, followed by HPLC afforded compound N 
as a yellow oil with []26D +8.9 (c 0.0001, EtOH). The HRESIMS spectrum revealed a 
[M+Na]+ ion at m/z 513.2253 (calculated 513.2253), which was associated with the 
molecular formula of C30H34O6. The UV spectrum (EtOH) supported an 8-acyl-5,7-
dioxycoumarin type, with absorptions at λmax 226 and 298 nm82. The IR spectrum 
showed absorptions at υmax 3447 (OH), 1717 (α,β-unsaturated lactone) and 1604 cm-1 
(chelated acyl group)47.  
 
The 13C NMR spectrum showed the signals of five methyls, four methylenes, nine 
methines and twelve quaternary carbons. The 1H NMR spectrum showed the typical 
singlet of a H-3 proton at δ 6.05. In addition, two sets of multiplets corresponding to 
five protons centred at δ 7.41 (H-3'-H-5') and 7.29 (H-2', H-6'), respectively were 
observed, indicating the presence of an unsubstituted phenyl ring. The HMBC spectrum 
showed correlations of the H-3 proton with δ 138.2 (C-1') and 155.1 (C-4), thus 
suggesting that the phenyl ring was attached to C-4. A split singlet at δ 14.29 in 1H 
NMR spectrum can be ascribed to a hydroxyl chelated to an acyl group. All these 
195 
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observations, in addition with the UV absorptions data, suggested the presence of an 8-
acyl-5,7-dioxy-4-phenylcoumarin skeleton82. 
 
The 1H NMR spectrum of compound N also showed the presence of a triplet at δ 4.53 
(1H, J = 9.8 Hz, H-2'') and two doublets of doublets at 3.04 (1H, J = 9.8, 15.9 Hz, H-
1''β) and 2.96 (1H, J = 9.8, 15.9 Hz, H-1''α) respectively, thus indicating the presence of 
a dihydrofuran moiety. The 1H NMR resonances at δ 1.24 (2H, m, H-5''),  1.97 (2H, m, 
H-6''), 5.03 (1H, brt, J = 7.3, H-7''), 1.59 (3H, s, H-9'') and 1.67 (3H, s, H-10'') together 
with the 13C signals at δ 36.1 (C-5''), 21.7 (C-6''), 123.9 (C-7''), 132.3 (C-8''), 17.7 (C-
9'') and 25.8 (C-10'') indicated the presence of an isoprenyl group attached to C-3'' (δ 
73.4). In addition, the HMBC correlations clearly proved that the substituted 
dihydrofuran ring was located between C-5 (δ 161.9) and C-6 (δ 110.2) by exhibiting 
the following correlation, H-1''α,β/C-5, C-6, C-2'' and C-3''. 
 
Signals of non-equivalent geminal protons of C-4''' showed two methylene protons as 
two sets of multiplets at δ 1.50 (1H, m, H-4'''α) and 1.92 (1H, m, H-4'''β) in the 1H NMR 
spectrum. In the HMBC spectrum, these methylene protons correlated with a carbonyl 
(C-1''', δ 210.5), a methine (C-2''', δ 46.9) and two methyls (C-3''', δ 16.6 and C-5''', δ 
11.9). Protons of the two methyls (C-3''' and C-5''') were observed as a doublet at δ 1.26 
(J = 6.7 Hz) and as a split triplet at δ 1.00 (J = 7.4 Hz), respectively. These information 
led to the conclusion that a 2-methylbutanoyl moiety is linked to C-8 of the coumarin 
skeleton. 
 
Based on the above data, it is proposed that compound N has the structure shown in 
195. A thorough literature search using the SciFinder database identified compound N 
as a new chemical entity, with was named as mesuagenin F 195. 
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Table 3.15: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound N 195 
 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.2     
3 6.05 (1H, s) 111.1   2, 4a, 1' 
4  - 155.1     
4a  - 98.8     
5  - 161.9     
6  - 110.2     
7-OH 14.27 (1H, split s) 164.0   6, 7, 8 
8  - 104.7 (split peaks)     
8a  - 157.2     
1'  - 138.2     
2' 7.30 (1H, m, Ar) 127.5   3' 
3'  128.9   1' 
4'     7.41 (3H, m, Ar) 128.0   2', 6' 
5'  128.9   6' 
6' 7.30 (1H, m, Ar) 127.5   5' 
1''α 2.96 (1H, dd, J = 9.8, 15.9) 
26.5 
H-1''β 
5, 6, 2'', 3'' 
1''β 3.04 (1H, dd, J = 9.8, 15.9) H-1''α 
2'' 4.53 (1H, t, J = 9.8) 92.3   5'' 
3''-OH  - 73.4    
4'' 0.87 (3H, split s) 21.8 (split peaks)   2'', 3'', 5'' 
5'' 1.24 (2H, m) 36.1   2'', 3'', 4'', 6'', 7'' 
6'' 1.97 (2H, m) 21.7   5'', 7'', 8'' 
7'' 5.03 (1H, brt, J = 7.3) 123.9 6'' 6'', 9'', 10'' 
8''  - 132.3 7''   
9'' 1.59 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.67 (3H, s) 25.8   7'', 8'', 9'' 
1'''  - 210.5     
2''' 3.94 (1H, m) 46.9 3''' 1''', 3''', 4''', 5''' 
3''' 1.26 (3H, d, J = 6.7) 16.6 (split peaks)  1''', 2''', 4''' 
4'''α 1.50 (1H, m) 
27.3 (split peaks) 
4'''β, 5''' 1''', 2''', 3''', 5''' 
4'''β 1.92 (1H, m) 4'''α, 5''' 1''', 2''', 3''', 5''' 
5''' 1.00 (3H, split t, J = 7.4) 11.9   2''', 3''', 4''' 
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Figure 3.27: 1H NMR Spectrum of Compound N 195 
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Figure 3.28: 13C NMR Spectrum of Compound N 195 
 
1''' 
7 8a 
4 1' 
8'' 
2'' 
4a 
8 
6 
3 7'' 
2', 6' 
3'' 2''' 
5'' 
1'' 9'' 
3''' 
5''' 
6'' 
10'' 
2 
3', 5' 
4''' 4'' 
5 
Chapter 3                                                               Chemical Constituents from M. elegans and M. kunstleri 
128 
3.1.15 Compound O: Mesuagenin D 196 
 
 
 
 
 
 
Compound O was obtained as a yellow oil with []26D +7.7 (c 0.0001, EtOH), and has a 
molecular formula of C30H34O6 based on the HRESIMS measurement; a 
pseudomolecular [M+Na]+ ion at m/z 513.2253 (calculated 513.2253). The IR spectrum 
showed absorptions at υmax 3445 (OH), 1718 (α,β-unsaturated lactone), 1603 (chelated 
acyl group) and 1385 cm-1 (geminal dimethyl)47. The UV spectrum (EtOH) supported 
an 8-acyl-5,7-dioxycoumarin type, with absorptions at λmax 226 and 298 nm82.  
 
The 13C NMR spectrum of compound O displayed a total of thirty carbons; five 
methyls, four methylenes, nine methines and twelve quaternary carbons. The 1H and 13C 
NMR spectra of compounds O and N showed similar patterns, which suggested a close 
structural relationship between these compounds. Indeed, the same substituents for the 
coumarin skeleton could be characterized in both compounds; a typical H-3 singlet of a 
4-phenylcoumarin (δ 6.04, s, H-3), a monosubstituted phenyl (δ 7.42 and 7.30, 5H, m, 
H-2'-H6'), a furan-cyclized geranyl group [δ 3.09 (1H, dd, J = 9.8, 15.9 Hz, H-1''α), 2.49 
(1H, dd, J = 9.8, 15.9 Hz, H-1''β), 4.53 (1H, t, J = 9.8 Hz, H-2''), 0.87 (3H, s, H-4''), 
1.24 (2H, dd, J = 7.8, 16.6 Hz, H-5''), 1.94 (2H, m, H-6''), 5.01 (1H, brt, J = 7.3 Hz, H-
196 
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7''), 1.59 (3H, s, H-9'') and 1.67 (3H, s, H-10'')] and a chelated hydroxyl (δ 14.29, s, 7-
OH). 
 
However, close analysis of the 1H and 13C NMR spectra of compound O showed 
evident differences in the coupling patterns of the substituent group at position C-8 as 
compared to compound N. The cross correlations detected from the COSY spectrum of 
compound O revealed the presence of an iso-butyryl spin system with signals at δ 3.16 
(2H, d, J = 6.7 Hz, H-2'''), 2.30 (1H, m, H-3''') and 1.04 (6H, d, J = 7.3 Hz, H-4''' and H-
5'''). In the HMBC spectrum of compound O, the H-2''' methylene protons caused cross-
peaks with C-8 at δ 105.06 and a keto function at δ 206.13 (C-1'''). This information led 
to the deduction that a 3-methylbutanoyl chain is the substituent at C-8. 
 
Based on the above observed data, it was determined that compound O has the structure 
as shown 196. A thorough literature search using the SciFinder database identified 
compound O as a new chemical entity, with the IUPAC name 7-hydroxy-8-(3-
methylbutanoyl)-6-(1-hydroxy-1-methylprenyl)-4-phenyl-2H-furo[2’,3’:3,4]benzo[1,2-
b]pyran-2-one 196, which was named as mesuagenin D92.  
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Table 3.16: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound O 196 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.2     
3 6.04 (1H, s) 111.1   2, 4a, 1' 
4  - 155.0     
4a  - 98.8     
5  - 162.0     
6  - 110.2     
7-OH 14.29 (1H, s) 163.8   6, 7, 8 
8  - 105.1     
8a  - 157.4     
1'  - 138.2     
2' 7.30 (1H, m, Ar) 127.5   3' 
3'  128.9   1' 
4'    7.42 (3H, m, Ar) 128.0   2' 
5'   128.9     
6'  7.30 (1H, m, Ar) 127.5     
1''α 3.09 (1H, dd, J = 9.8, 15.9) 
26.5 
2'' 5, 6, 2'', 4'' 
1''β 2.49 (1H, dd, J = 9.8, 15.9) 2'' 5, 6, 2'', 4'' 
2'' 4.53 (1H, t, J = 9.8) 92.4 1''α, 1''β   
3''-OH  - 73.4     
4'' 0.87 (3H, s) 21.9   1'', 3'', 5'' 
5'' 1.24 (2H, dd, J = 7.8, 16.6) 36.1   1'', 3'', 6'' 
6'' 1.94 (2H, m) 21.8   5'', 7'', 8'' 
7'' 5.01 (1H, brt, J = 7.3) 123.9 6'' 6'', 9'', 10'' 
8''  - 132.3 7''   
9'' 1.59 (3H, s) 17.7   7'', 8'', 10'' 
10'' 1.67 (3H, s) 25.8   7'', 8'', 9'' 
1'''  - 206.1     
2''' 3.16 (2H, d, J = 6.7) 53.5 3''' 8, 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 4''', 5''' 4''', 5''' 
4'''   22.8 3''', 5''' 2''', 3''', 5''' 
5'''     1.04 (6H, d, J = 7.3) 22.8 3''', 4''' 2''', 3''', 4''' 
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Figure 3.29: 1H NMR Spectrum of Compound O 196 
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Figure 3.30: 13C NMR Spectrum of Compound O 196 
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Figure 3.31: COSY Spectrum of Compound O 196 
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3.1.16 Compound P: Isodisparfuran 197 
 
 
 
 
 
 
Separation using column chromatography, followed by HPLC, afforded compound P as 
a white amorphous solid. The HRESIMS measurement of its [M+Na]+ ion at m/z 
385.1057 (calculated 385.1052) corresponded to the molecular formula of C22H18O5. 
The UV spectrum of compound P could readily be associated with an 8-acyl-5,7-
dioxycoumarin type, due to absorptions at λmax 230, 287 and 337 nm82. The IR spectrum 
showed absorptions at υmax 1736 cm-1, indicating the presence of an α-pyrone group. 
The IR spectrum also exhibited absorptions at υmax 1605 and 1383 cm-1, corroborating 
the presence of a chelated acyl group and a geminal dimethyl group47, 85. 
 
The 13C NMR spectrum of compound P showed twenty-two carbon resonances; two 
methyls, one methylene, nine methines and ten quaternary carbons. In the 1H NMR 
spectrum of compound P, the typical H-3 singlet of a 4-substituted coumarin was 
observed at δ 6.22. This characteristic singlet of H-3 was further corroborated with the 
presence of two sets of multiplets, centered at δ 7.50 (H-3' - H-5') and 7.42 (H-2' and H-
6'), which corresponded to two and three aromatic protons of the monosubstituted 
phenyl ring attached to C-4. The 1H NMR spectrum of compound P also revealed the 
presence of a chelated hydroxyl group at δ 14.86, which was exchangeable with D2O. 
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All the observations supported the presence of an 8-acyl-5,7-dioxy-4-phenylcoumarin 
type skeleton.  
 
Two distinct olefinic protons were apparent in the 1H NMR of compound P as two 
doublets; δ 7.32 (1H, J = 1.4 Hz, H-2'') and 6.96 (1H, J = 1.4 Hz, H-1''). H-2'' was more 
deshielded than H-1'', due to the presence of a more electronegative oxygen atom 
adjacent to C-2''. These olefinic protons correlated with C-5 (δ 153.7) and C-6 (δ 115.0) 
in the HMBC spectrum of compound P, suggesting a two-carbon substituent at position 
C-5 and C-6.  
 
The cross correlation of the COSY spectrum of compound P revealed an iso-butyryl 
spin system, with signals at δ 3.29 (2H, d, J = 6.7 Hz, H-2'''), δ 2.37 (1H, m, H-3''') and 
δ 1.08 (6H, d, J = 6.7 Hz, H-4''' and H-5'''). Furthermore, in the HMBC spectrum, the 
methylene protons gave cross-peaks with a keto function at δ 207.3 (C-1'''). These 
observations in the COSY and HMBC spectra of compound P led to the identification 
of the remaining substituent of C-8 of the 4-phenylcoumarin skeleton as a 3-
methylbutanoyl chain. 
 
The observed data of compound P  indicated that this compound was isodisparfuran A 
197, as reported in the literature, and was first isolated from Calophyllum dispar 
(Clusiaceae) in 2001 by Guilet et al.85. 
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Table 3.17: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound P 197 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.2     
3 6.22 (1H, s) 112.0   2, 4a, 1' 
4  - 154.2     
4a  - 100.0     
5  - 153.7   
6  - 115.0     
7-OH 14.86 (1H, s) 162.7  6, 7, 8 
8  - 106.1     
8a  - 154.5     
1'  - 137.1     
2' 7.42 (1H, m, Ar) 127.9   4, 4' 
3'     128.1    
4'    7.50 (3H, m, Ar) 129.4       1', 2', 6' 
5'   128.1     
6'  7.42 (1H, m, Ar) 127.9   4, 4' 
1'' 6.96 (1H, d, J = 1.4) 104.9 1'' 5, 6, 2'' 
2'' 7.32 (1H, d, J = 1.4) 144.6 2'' 5, 6, 1'' 
1'''  - 207.3     
2''' 3.29 (2H, d, J = 6.7) 53.7 3''' 1''', 3''', 4''', 5''' 
3''' 2.37 (1H, m) 25.6 2''', 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.08 (6H, d, J = 6.7) 
22.7 5''' 2''', 3''', 5''' 
5''' 22.7 4''' 2''', 3''', 4''' 
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Figure 3.32: 1H NMR Spectrum of Compound P 197 
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Figure 3.33: 13C NMR Spectrum of Compound P 197 
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Figure 3.34: HMBC Spectrum of Compound P 197 
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3.1.17 Compound Q: Mesuagenin G 198 
 
 
 
 
 
 
Compound Q was obtained as a white amorphous solid, and the HRESIMS 
measurement of its [M+Na]+ ion at m/z 403.1163 (calculated 403.1158) suggested a 
molecular formula of C22H20O6. The UV spectrum supported an 8-acyl-5,7-
dioxycoumarin type, with absorptions at λmax 230, 287 and 337 nm82. The IR spectrum 
showed absorptions at υmax 3451 (OH), 1744 (α,β-unsaturated lactone) and 1605 cm-1 
(chelated acyl group)47, 85. 
 
The 13C NMR spectrum of compound Q displayed a total of twenty-two carbons; two 
methyls, two methylenes, eight methines and ten quaternary carbons. The 1H NMR 
spectrum of compound Q showed striking similarities with the 1H NMR spectrum of 
compound P, with similar substituents observed at positions C-4 (monosubstituted 
phenyl; δ 7.40 and 7.34, 5H, m, H-2'-H6'), C-7 (chelated hydroxyl group; δ 14.26, s, 7-
OH) and C-8 [3-methylbutanoyl; δ 3.17 (2H, d, J = 6.7 Hz, H-2'''), 2.30 (1H, m, H-3''') 
and 1.04 (6H, d, J = 6.7 Hz, H-4''' and H-5''')]. 
 
Close inspection of the 1H and 13C NMR spectra of compound Q showed a marked 
difference in the coupling patterns of the substituent groups at positions C-5 and C-6 as 
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compared to compound P. The sp2 carbons C-1'' and C-2'' in compound P were replaced 
with an sp3 methine at δ 33.5 and a deshielded sp3 methylene at δ 103.5 in the 13C 
spectrum of compound Q. The methylene protons of C-1'' appeared as a set of two 
broad doublets at δ 2.95 (H-1''α) and 3.19 (H-1''β). This suggests that C-2'' is an 
oxymethine and the corresponding protons, H-2'' and 2''-OH resonated at δ 5.96 and 
3.63, as broad singlets, respectively. These observations showed that the double bond of 
C-5 and C-6 in the furan ring has been hydroxylated. 
 
Based on the thorough search through SciFinder database, it was found that compound 
Q was a new chemical entity, with the IUPAC name 2,4-dihydroxy-5-(3-
methylbutanoyl)-9-phenyl-2H-furo[2,3-f]chromen-7(3H)-one, which was named as 
mesuagenin  198. 
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Table 3.18: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of    
Compound Q 198 
 
 
Position δH, J (Hz)  δC COSY HMBC 
2  - 159.2     
3 6.05 (1H, s) 111.6   2, 4a, 1' 
4  - 155.1     
4a  - 98.8     
5  - 153.7   
6  - 108.4     
7-OH 14.26 (1H, s) 163.8  6, 7, 8 
8  - 105.4     
8a  - 157.6     
1'  - 137.7     
2' 7.34 (1H, m, Ar) 127.8   4, 4' 
3'     128.1    
4'    7.40 (3H, m, Ar) 129.0   2', 6' 
5'   128.1     
6'  7.34 (1H, m, Ar) 127.8   4, 4' 
1''α 2.95 (1H, brd) 
33.5 
1''β 2'', 5, 6 
1''β 3.19 (1H, brd) 1''α 5, 6, 7 
2'' 5.96 (1H, brs) 
103.5 
1''β  
2''-OH 3.63 (1H, brs)   
1'''  - 206.3     
2''' 3.17 (2H, d, J = 6.7) 53.6 3''' 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 2''', 4''', 5''' 2''', 4''', 5''' 
4''' 
1.04 (6H, d, J = 6.7)  
22.8 3''', 5''' 2''', 3''', 5''' 
5''' 22.8 3''', 4''' 2''', 3''', 4''' 
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Figure 3.35: 1H NMR Spectrum of Compound Q 198 
7-OH 
2', 6' 3 
2'' 
2''' 
1''α 3''' 
4''', 5''' 
3'-5' 
1''β 
2''-OH 
Chapter 3                                                               Chemical Constituents from M. elegans and M. kunstleri 
144 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.36: 13C NMR Spectrum of Compound Q 198 
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Figure 3.37: HSQC Spectrum of Compound Q 198
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3.1.18 Compound R: Mesuagenin H 199 
 
 
 
 
 
 
Compound R was obtained as a white amorphous solid using column chromatography 
fractionation, followed by HPLC separation. The HRESIMS measurement of its 
[M+Na]+ ion at m/z 387.1204 (calculated 387.1208) suggested a molecular formula of 
C22H20O5. The UV spectrum supported an 8-acyl-5,7-dioxycoumarin type, with 
absorptions at λmax 230, 285 and 335 nm82. The IR spectrum showed absorptions at υmax 
1740 (α,β-unsaturated lactone) and 1603 cm-1 (chelated acyl group)47, 85.  
 
A total of twenty-two carbons were observed in the 13C NMR spectrum of compound R; 
two methyls, three methylenes, seven methines and ten quaternary carbons. The 1H 
NMR spectrum of compound R was similar to that of compound P, thus suggesting a 
close relationship between these compounds. Indeed, the same substituents were 
characterized in both compounds, namely a monosubstituted phenyl (δ 7.32 and 7.42, 
5H, m, H-2'-H6'), a chelated hydroxyl group (δ 14.79, s, 7-OH) and a 3-methylbutanoyl 
[δ 3.19 (2H, d, J = 6.7 Hz, H-2'''), δ 2.31 (1H, m, H-3''') and δ 1.05 (6H, d, J = 6.7 Hz, 
H-4''' and H-5''']. 
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However, close examination of the 1H NMR spectrum of compound R showed a 
noticeable difference in the coupling pattern of the substituent groups at positions C-5 
and C-6 as compared to compound P. This observation was made clear in the 1H NMR 
spectrum of compound R, with methylene peaks observed at δ 2.93 (t, J = 5.5 Hz, H-1'') 
and δ 3.89 (t, J = 5.5 Hz, H-2''). The furan ring at position C-5 and C-6 in compound R 
has been hydrogenated as compared to compound P, which possessed an unsaturated 
furan ring. 
 
A careful search through SciFinder database led to the conclusion that compound R was 
a new chemical entity, with the IUPAC name 2,4-dihydroxy-5-(3-methylbutanoyl)-9-
phenyl-2H-furo[2,3-f]chromen-7(3H)-one, which was named as mesuagenin H 199. 
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Table 3.19: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound R 199 
 
Position δH, J (Hz)  δC COSY HMBC 
2 - 159.2 
  3 6.02 (1H, s) 112.3 
 
2, 4a, 1' 
4 - 156.2 
  4a - 102.1 
  5 - 160.2 
  6 - 111.0 
  7-OH 14.79 (1H, s) 166.8 
 
6, 7, 8 
8 - 104.3 
  8a - 156.6 
  1' - 139.5 
  2' 7.32 (1H, m, Ar) 127.2 
 
4, 5' 
3' 
 
128.1 
 
1', 6' 
4'     7.42 (3H, m, Ar) 128.6 
 
1', 2', 6' 
5' 
 
128.1 
 
1', 2' 
6' 7.32 (1H, m, Ar) 127.2 
 
3', 4' 
1'' 2.93 (2H, t, J = 5.5) 25.3 2'' 5, 6, 7, 2'' 
2'' 3.89 (2H, t, J = 5.5) 64.1 1'' 6 
1''' - 206.2 
  2''' 3.19 (2H, d, J = 6.7) 53.6 3''' 1''', 3''', 4''', 5''' 
3''' 2.31 (1H, m) 25.8 2''', 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.05 (6H, d, J = 6.7) 
22.8 3''' 2''', 3''', 5''' 
5''' 22.8 3''' 2''', 3''', 4''' 
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Figure 3.38: 1H NMR Spectrum of Compound R 199 
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Figure 3.39: 13C NMR Spectrum of Compound R 199
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3.1.19 Compound S: Mesuagenin I 200 
 
 
 
 
 
 
 
 
Separation using column chromatography, followed by HPLC afforded compound S as 
a white amorphous solid. The HRESIMS measurement of its [M+Na]+ ion at m/z 
529.2209 (calculated 529.2202) suggested a molecular formula of C30H34O7. The UV 
spectrum (EtOH) supported an 8-acyl-5,7-dioxycoumarin type, with absorptions at λmax 
233, 287 and 333 nm82. The IR spectrum showed absorptions at υmax 3415 (free 
hydroxyl), 1740 (α,β-unsaturated lactone), 1603 (chelated acyl) and 1385 cm-1 
(geminal-dimethyl)47, 85. 
 
The 13C NMR spectrum of compound S showed thirty carbon resonances; five methyls, 
four methylenes, nine methines and twelve quaternary carbons. In the 1H NMR 
spectrum of compound S, the typical H-3 singlet of a 4-substituted coumarin was 
observed at δ 6.03. This characteristic singlet of H-3 was further corroborated with the 
presence of two sets of multiplets, centered at δ 7.39 and 7.27, corresponding to three 
(H-3'-H5') and two aromatic (H-2', H-6') protons, respectively. The 1H NMR spectrum 
of compound S also displayed the presence of a chelated hydroxyl group at δ 14.29, 
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which was exchangeable with D2O. All the observations supported the presence of an 8-
acyl-5,7-dioxy-4-phenylcoumarin type skeleton, which was also indicated by the UV 
data. 
 
Compound S showed similar NMR profiles with those of compound O. However, C-3'' 
of compound S appeared to be more downfield at δ 83.1 as compared to compound O, 
which was at δ 73.4. In addition, C-7'' also appeared as a sp3 methine at δ 85.5 in 
compound S, as compared to an sp2 methine at δ 123.9 in compound O. An oxymethine 
was also in evidence in the 13C NMR spectrum of compound S at δ 71.0 (C-8''). These 
observations indicated that a hydroxylated, cyclized prenyl ring was attached to C-2'' of 
the furan moiety in compound S. The connectivity of the prenyl ring in the molecule 
was further supported by the following correlations in the HMBC spectrum of 
compound S, H-5''/C-2'', 3'', 4'', 6'' and 7''.  
 
In the NOESY spectrum of compound S, cross correlation was observed between H-2'' 
and H-4'', which suggested that these two protons were located in the same plane. 
Additionally, H-7'' was also correlated with H-4'', which placed H-2'', H-4'' and H-7'' in 
the same plane.  
 
A careful search through SciFinder database led to the result that compound S was 
indeed a new chemical compound, which was named as mesuagenin I 200. 
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Table 3.20: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound S 200 
 
Position δH, J (Hz)  δC NOESY HMBC 
2 - 159.2 
  3 6.03 (1H, s) 111.3 
 
2, 4a, 1' 
4 - 155.1 
  4a - 98.6 
  5 - 162.6 
  6 - 109.9 
  7-OH 14.29 (1H, s) 163.7 
 
6, 7, 8 
8 - 105.0 
  8a - 157.6 
  1' - 137.8 
  2' 7.27 (1H, m, Ar) 127.7 
  3' 
 
127.9 
 
1' 
4'     7.39 (3H, m, Ar) 128.8 
 
2', 6' 
5' 
 
127.9 
 
1' 
6' 7.27 (1H, m, Ar) 127.7 
  1'' 3.07 (2H, d, J = 9.2) 26.8 2'', 4'', 5'' 5, 6, 2'', 3'' 
2'' 4.57 (1H, t, J = 9.2) 89.2 1'', 4'', 5'', 6'' 5, 4'', 5'' 
3'' - 83.1 
  4'' 0.97 (3H, s) 20.6 
 
2'', 3'', 5'' 
5'' 1.43 (2H, dd, J = 6.1, 8.6) 35.1 
 
2'', 3'', 4'', 6'', 7'' 
6'' 1.74 (2H, m) 25.9 
 
3'', 7'', 8'' 
7'' 3.71 (1H, dd, J = 6.1, 8.6) 85.5 4'', 5'', 6'', 9'', 10'' 
 8'' - 71.0 
  9'' 1.03 (3H, s) 24.4 
 
7'', 8'', 10'' 
10'' 1.12 (3H, s) 27.4 
 
7'', 8'', 9'' 
1''' - 206.1 
  2''' 3.16 (2H, d, J = 6.7) 53.5 
 
1''', 3''', 4''', 5''' 
3''' 2.31 (1H, m) 25.7  1''', 2''', 4''', 5''' 
4'''  
      1.05 (6H, d, J = 6.7) 
22.8  3''', 5''' 
5''' 22.8  3''', 4''' 
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Figure 3.40: 1H NMR Spectrum of Compound S 200 
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Figure 3.41: NOESY Spectrum of Compound S 200 
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3.1.20 Compound T: Mesuagenin J 201 
 
 
 
 
 
 
 
Compound T was obtained as a yellowish oil and has a molecular formula of C27H26O7 
based on the HRESIMS measurement; [M+Na]+ ion at m/z 485.1577 (calculated 
485.1576). The IR spectrum accumulated using a neat film technique showed evidence 
of strong absorptions at υmax 3445 (OH group), 1743 (α-pyrone), 1603 (chelated acyl 
group) and 1384 cm-1 (geminal dimethyl group)47, 88. Interestingly, the IR spectrum 
accumulated using the ATR technique showed strong absorption at υmax 1770 cm-1, 
which indicated the presence of a five-membered dihydrofuran-2(3H)-one 
functionality95. The UV spectrum (EtOH) of compound T could readily be associated 
with an 8-acyl-5,7-dioxycoumarin type, due to absorptions at λmax 230, 285 and 339  
nm82. 
 
A total of twenty-seven carbon signals were observed in the 13C NMR spectrum of 
compound T; three methyls, four methylenes, eight methines and twelve quaternary 
carbons. The number of carbon signals for compound T was considered abnormal 
compared to the usual thirty-carbon compounds from this study. However, the spectral 
data of compound T showed similarities with compound O, namely a typical H-3 signal 
201
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of a 4-phenylcoumarin (δ 6.05, s, H-3), a monosubstituted phenyl (δ 7.41 and 7.27, 5H, 
m, H-2'-H6'), a chelated hydroxyl group (δ 14.30, s, 7-OH) and a 3-methylbutanoyl 
moeity [δ 3.17 (2H, d, J = 6.8 Hz, H-2'''), 2.30 (1H, m, H-3''') and 1.05 (6H, d, J = 6.8 
Hz, H-4''' and H-5''')]. 
 
The differences in the coupling pattern of the remaining substituents of C-5/C-6 were 
noticeable by the absence of the methyls C-9'' and C-10'' in the 1H and 13C NMR spectra 
of compound T as compared to compound O. Moreover, split coupling patterns were 
visible for methylenes of C-5'' and C-6''; δ 1.75 (1H, m, H-5''α), 1.85 (1H, m, H-5'' β), 
2.28 (1H, m, H-6''α) and 2.45 (1H, m, H-6''β). A carbonyl peak was also visible in the 
13C NMR spectrum of compound T at δ 175.4 (C-7''). These observations indicated the 
presence of a five-membered dihydrofuran-2(3H)-one ring in the molecule, which was 
supported by the IR spectrum using the ATR technique earlier95. 
 
The furan ring resonances connected to C-5/C-6 were visible in the 1H NMR spectrum 
of compound T; a set of double doublets at δ 2.89 (1H, dd, J = 8.8, 16.1 Hz, H-1''α) and 
3.19 (1H, dd, J = 8.8, 16.1 Hz, H-1''β), and another double doublet at δ 4.74 (1H, dd, J = 
8.8, 10.2 Hz, H-2''). The connectivity between the five-membered dihydrofuran-2(3H)-
one ring (C-3'' - C-7'') and the furan ring of C-5/C-6 was evident in the HMBC spectrum 
of compound T, H-1''α,β/C-5, C-6, C-2'' and C-3''. 
 
In the NOESY spectrum of compound T, cross correlation was observed between H-2'' 
and H-4'', which suggested that these two protons were located in the same plane.  
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The observed spectral data of compound T and a thorough search in the SciFinder 
database revealed that this compound was a new chemical entity, which was named as 
mesuagenin J 201. 
  
Table 3.21: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound T 201 
 
Position δH, J (Hz)  δC COSY HMBC 
2 - 158.9 
  3 6.05 (1H, s) 111.6 
 
2, 4a, 1' 
4 - 155.0 
  4a - 98.9 
  5 - 161.7 
  6 - 109.1 
  7-OH 14.30 (1H, s) 163.6 
 
6, 7, 8, 1''' 
8 - 105.4 
  8a - 157.7 
  1' - 137.5 
  2' 7.27 (1H, m, Ar) 127.4 
 
4, 4' 
3' 
 
128.0 
 
1' 
4'     7.41 (3H, m, Ar) 129.3 
 
2', 6' 
5' 
 
128.0 
 
1' 
6' 7.27 (1H, m, Ar) 127.4 
 
4, 4' 
1''α 2.89 (1H, dd, J = 8.8, 16.1) 
27.2 
2'', 1''β 5, 6, 2'', 3'' 
1''β 3.19 (1H, dd, J = 8.8, 16.1) 2'', 1''α 5, 6, 2'', 3'' 
2'' 4.74 (1H, dd, J = 8.8, 10.2) 89.1 1''α, 1''β 5'' 
3'' - 85.4 
  4'' 1.19 (3H, s) 22.3 
 
2'', 3'', 5'' 
5''α 1.75 (1H, m) 
28.9 
5''β, 6''α, 6''β 2'', 3'', 4'', 7'' 
5''β 1.85 (1H, m) 5''α, 6''α, 6''β 2'', 3'', 4'', 7'' 
6''α 2.28 (1H, m) 
28.3 
5''α, 5''β, 6''β 3'', 7'' 
6''β 2.45 (1H, m) 5''α, 5''β, 6''α 3'', 7'' 
7'' - 175.4 
  1''' - 206.3 
  2''' 3.17 (2H, d, J = 6.8) 53.6 3''' 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 2''', 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.05 (6H, d, J = 6.8) 
22.8 3''', 5''' 2''', 3''', 5''' 
5''' 22.8 3''', 5''' 2''', 3''', 4''' 
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Figure 3.42: 1H NMR Spectrum of Compound T 201 
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Figure 3.43: 13C NMR Spectrum of Compound T 201
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3.1.21 Compound U: Mesuagenin K 202 
 
 
 
 
 
 
 
Compound U was isolated as a yellowish oil using column chromatography 
fractionation, followed by HPLC isolation. The HRESIMS spectrum revealed a 
pseudomolecular ion of [M+Na]+ at m/z 529.2142 (calculated 529.2202), which 
corresponded to the molecular formula of C30H34O7. The UV spectrum (EtOH) 
supported an 8-acyl-5,7-dihydroxycoumarin type, with absorptions at λmax 237, 284 and 
335 nm82.The IR spectrum showed absorptions at υmax 1388 cm-1 belonging to geminal 
dimethyl and 1597 cm-1 which belongs to chelated acyl group. The IR spectrum also 
exhibited a strong peak at 1738 cm-1 due to the presence of an α-pyrone, and a broad 
peak at 3356 cm-1 due to OH stretching47, 88. 
 
The 13C NMR spectrum showed the presence of four methyls, five methylenes, nine 
methines and twelve quaternary signals. In the 1H NMR spectrum, the typical H-3 
singlet of 4-phenylcoumarin moiety was observed at δ 6.03. The presence of a mono-
substituted phenyl group at C-4 of a 4-phenylcoumarin was corroborated by the 
presence two sets of multiplets, centred at δ 7.29 and δ 7.39, corresponding to two (H-2' 
and H-6') and three (H-3', H-4' and H-5') aromatic protons, respectively. The 1H NMR 
202 
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spectrum also displayed the presence of hydroxyl group peaks revealing a broad singlet 
at δ 9.51 (5-OH) and a sharp singlet peak at δ 14.82 (7-OH), in which both were 
exchangeable with D2O. In addition, the broad OH absorption depicted from the IR 
spectrum further supported this observation. These data suggested the presence of an 8-
acyl-5,7-dihydroxy-4-phenylcoumarin type.  
 
In addition, the 1H NMR spectrum of compound U showed a set of double doublets at δ 
2.42 (1H, dd, J = 9.4, 15.4 Hz, H-1''α) and 3.17 (1H, dd, J = -, 15.4 Hz, H-1''β), and a 
doublet at δ 3.75 (1H, d, J = 9.4 Hz, H-2''). These peaks, along with the presence, of the 
5-OH broad singlet at δ 9.51, were devoid from the normal cyclised furan ring system 
as present in compound J. The connectivity of C-1'' with the coumarin skeleton at 
position C-6 could be deduced by the following correlations in the HMBC spectrum, H-
1''α,β/C-5, C-6, C-7 and C-2''.  
 
A methyl singlet at δ 1.31 (H-4'') and a broad singlet of a hydroxyl at δ 3.39 (3''-OH) 
were also apparent in the 1H NMR spectrum of compound U. A pyran system can also 
be inferred by these peaks displayed in the 1H NMR spectrum; δ 1.62 (1H, m, H-5''α), 
1.84 (1H, m, H-6''α), 2.04 (1H, m, H-6''β), 2.05 (1H, m, H-5''β) and 4.25 (1H, dd, J = 
5.4, 10.7 Hz, H-7''). In the HMBC spectrum of compound U, the connection between H-
2'' and H-5'' in the cyclic system were visible when H-2'' showed correlations with C-3'' 
(δ 85.8) and C-5'' (δ 30.6).  
 
Furthermore, a propene unit was also visible in the 1H NMR spectrum as a methyl 
singlet at δ 1.70 (H-9'') and two singlets of a methylene group at δ 4.81 (H-10''α) and 
4.98 (H-10''β). All these peaks gave cross correlations with each other, and also with C-
7'' (δ 84.4) in the HMBC spectrum, thus establishing the connectivity between the pyran 
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system and the propene unit. All these observations led to the identification of a 3-
hydroxy-3-methyl-6-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl)methyl substituent to be 
present in the molecule. 
 
The COSY spectrum revealed cross correlations between δ 3.24 (2H, dd, J = 5.5, 6.7 
Hz, H-2'''), δ 2.33 (1H, m, H-3''') and δ 1.06 (6H, d, J = 6.7 Hz, H-4''' and H-5'''). In the 
HMBC spectrum of compound U, the methylene protons (H-2''') and the methine proton 
(H-3''') gave cross-peaks with a keto function at δ 206.3, belonging to C-1'''. With this, it 
was identified that a 3-methylbutanoyl chain was the other substituent of the 4-
phenylcoumarin, which was attached at C-8.  
 
Cross correlations between the protons H-2''/H-4'' and H-7'' were observed in the 
NOESY spectrum of compound U, which suggested that these two protons were in the 
same plane. Based on this information, the relative stereochemistry of the carbon 
centers C-2'', C-3'' and C-7'' was assigned. 
 
In view of the above data, and with a thorough search in the SciFinder database, it was 
deduced that compound U is a new chemical entity with the proposed structure, which 
was named as mesuagenin K 202. 
 
 
 
 
 
 
Chapter 3                                                               Chemical Constituents from M. elegans and M. kunstleri 
164 
 
Table 3.22: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 600 MHz) of   
Compound U 202 
 
Position δH, J (Hz)  δC COSY HMBC 
2 - 159.2 
  3 6.03 (1H, s) 112.3 
 
2, 4a, 1' 
4 - 156.6 
  4a - 102.5 
  5-OH 9.51 (1H, brs) 160.6 
 
4a 
6 - 110.3 
  7-OH 14.82 (1H, s) 166.6 
 
6, 7, 8, 1''' 
8 - 104.2 
  8a - 156.7 
  1' - 140.1 
  2' 7.29 (1H, m, Ar) 127.2 
  3' 
 
127.7 
 
1' 
4'     7.39 (3H, m, Ar) 128.1 
 
2', 6' 
5' 
 
127.7 
 
1' 
6' 7.29 (1H, m, Ar) 127.2 
  1''α 2.42 (1H, dd, J = 9.4, 15.4) 
25.2 
2'' 5, 6, 7, 2'' 
1''β 3.17 (1H, dd, J =  - , 15.4) 2'' 5, 6, 7, 2'', 3'' 
2'' 3.75 (1H, d, J = 9.4) 78.6 1''α, β, 4'', 5''α 6, 3'', 4'', 5'' 
3''-OH 3.39 (1H, brs) 85.8 
  4'' 1.31 (3H, s) 24.1 1''α, β, 2'', 5''α, 
6''α, 10''β 
2'', 3'', 5''  
5''α 1.62 (1H, m) 
30.6 
 
4'', 7'' 
5''β 2.05 (1H, m) 
 
2'', 3'', 4'', 6'' 
6''α 1.84 (1H, m) 
31.4 
 
5'', 7'', 8'' 
6''β 2.04 (1H, m) 
  7'' 4.25 (1H, dd, J = 5.4, 10.7) 84.4 5''α, 6''α, 9'', 10''β 6'', 10'' 
8'' - 145.3 
  9'' 1.70 (3H, s) 17.8 7'', 10''α, β 6'', 7'', 8'', 10'' 
10''α 4.81 (1H, s) 
110.9 
7'', 9'' 7'', 8'', 9'' 
10''β 4.98 (1H, s) 7'', 9'' 7'', 8'', 9'' 
1''' - 206.3 
  2''' 3.24 (2H, dd, J = 5.5, 6.7) 53.6 3''', 4''', 5''' 1''', 3''', 4''', 5''' 
3''' 2.33 (1H, m) 25.8 2''', 4''', 5''' 1''', 2''', 4''', 5''' 
4'''  
      1.06 (6H, d, J = 6.7) 
22.8 2''', 3''' 3''', 5''' 
5''' 22.8 2''', 3''' 3''', 4''' 
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Figure 3.44: 1H NMR Spectrum of Compound U 202 
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Figure 3.45: 13C NMR Spectrum of Compound U 202 
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3.1.22 Compound V: Mesuagenin L 203 
 
 
 
 
 
 
Compound V was separated as a white amorphous solid. The molecular formula of 
compound V was determined by the HRESIMS measurement of its [M+Na]+ ion at m/z 
529.2145 (calculated 529.2202), as C30H34O7. The UV spectrum (EtOH) supported an 
8-acyl-5,7-dioxycoumarin type, with absorptions at λmax 233, 285 and 337 nm82. The IR 
spectrum showed absorptions at υmax 3451 (free OH), 1743 (α,β-unsaturated lactone), 
1603 (chelated acyl group) and 1385 cm-1 (geminal dimethyl group)47, 85.  
 
The 13C NMR spectrum of compound V displayed a total of thirty carbons; three 
methyls, six methylenes, nine methines and twelve quaternary carbons. The 1H NMR 
spectrum of compound V showed striking similarities with the 1H NMR spectrum of 
compound J, with similar substituents observed at position C-4 (monosubstituted 
phenyl; δ 7.31 and 7.40, 5H, m, H-2'-H6'), C-7 (chelated hydroxyl group; δ 14.80, s, 7-
OH) and C-8 [3-methylbutanoyl; δ 3.20 (2H, t, J = 6.7 Hz, H-2'''), δ 2.32 (1H, m, H-3''') 
and δ 1.06 (6H, d, J = 6.7 Hz, H-4''' and H-5''')]. 
 
However, examination of the 1H NMR spectrum of compound V showed an obvious 
difference in the coupling pattern of the substituent group at position C-6. The singlet of 
203 
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H-4'' methyl at δ 1.31 in the 1H NMR spectrum of compound J was missing in the 1H 
NMR spectrum of compound V. On the other hand, two singlets of an sp2 methylene, 
integrating for one proton each, were visible in the 1H NMR spectrum of compound V; 
δ 4.92 (1H, s, H-4''α) and δ 5.07 (1H, s, H-4''β). Furthermore, in the HMBC spectrum of 
compound V, both the H-4''α and H-4''β resonances correlated with δ 76.6 (C-2'') and δ 
28.3 (C-5''). Therefore, it was deduced that a double bond was present between C-3'' (δ 
150.6) and C-4'' (δ 110.3).  
 
The methyl of C-10'' was also missing in the 1H NMR spectrum of compound V as 
compared to compound J. However, this methyl was replaced by an sp2 methylene; δ 
4.87 (1H, s, H-10''α) and δ 4.95 (1H, s, H-10''β). The sp2 methylene protons of C-10'' 
correlated with δ 76.0 (C-7'') and δ 17.8 (C-9'') in the HMBC spectrum, thus confirming 
its location.  
 
After a thorough search in the SciFinder database, it was found that compound V was a 
new chemical entity, which was named as mesuagenin L 203. 
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Table 3.23: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 600 MHz) of   
Compound V 203 
 
Position δH, J (Hz)  δC COSY HMBC 
2 - 159.2 
  3 6.03 (1H, s) 112.2 
 
2, 4a, 1' 
4 - 156.3 
  4a - 102.2 
  5-OH 9.40 (1H, brs) 160.5 
  6 - 110.0 
  7-OH 14.80 (1H, s) 166.8 
 
6, 7, 8 
8 - 104.1 
  8a - 156.6 
  1' - 139.8 
  2' 7.31 (1H, m, Ar) 127.1 
 
4, 4' 
3' 
 
127.8 
 
1' 
4'      7.40 (3H, m, Ar) 128.2 
 
2', 6' 
5' 
 
127.8 
 
1' 
6' 7.31 (1H, m, Ar) 127.1 
 
4, 4' 
1''α 2.72 (2H, dd, J = 8.5, 14.9) 
29.3 
2'', 1''β 5, 6, 7, 2'' 
1''β 3.12 (2H, dd, J = - , 14.9) 2'', 1''α 5, 6, 7, 3'' 
2'' 4.33 (1H, d, J = 8.5) 76.6 1''α, β 6, 3'', 5'' 
3'' - 150.6 
  4''α 4.92 (1H, s) 
110.3 
 
2'', 5'' 
4''β 5.07 (1H, s) 
 
2'', 3'', 5'' 
5''α 2.17 (1H, m) 
28.3 
5''β, 6''α, β 3'', 4'', 6'' 
5''β 2.27 (1H, m) 5''α, 6''α, β 2'', 3'', 4'', 6'' 
6''α 1.68 (1H, m) 
33.1 
5''α, β, 6''β 5'', 7'' 
6''β 1.80 (1H, m) 5''α, β, 6''α 
 7'' 4.10 (1H, dd, J = 4.8, 7.6) 76.0 9'', 6''α, β 6'', 10'' 
8'' - 147.1 
  9'' 1.73 (3H, s) 17.8 7'', 10''α, β 7'', 8'', 10'' 
10''α 4.87 (1H, s) 
111.4 
9'' 7'', 9'' 
10''β 4.95 (1H, s) 9'' 7'', 8'', 9'' 
1''' - 206.1 
  2''' 3.20 (2H, t, J = 6.7) 53.5 3''', 4''', 5''' 1''', 3''', 4''', 5''' 
3''' 2.32 (1H, m) 25.7 2''', 4''', 5''' 2''', 4''', 5''' 
4'''  
     1.06 (6H, d, J = 6.7) 
22.7 2''', 3''' 2''', 3''', 5''' 
5''' 22.7 2''', 3''' 2''', 3''', 4''' 
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Figure 3.46: 1H NMR Spectrum of Compound V 203 
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3.1.23 Compound W: Mesuagenin M 204 
 
 
 
 
 
 
Compound W was obtained as a white amorphous solid using column chromatography 
fractionation, followed by HPLC separation. The HRESIMS measurement of its 
[M+Na]+ ion at m/z 529.2146 (calculated 529.2202) suggested a molecular formula of 
C30H34O7. The UV spectrum (EtOH) supported an 8-acyl-5,7-dioxycoumarin type, with 
absorptions at λmax 233, 285 and 337 nm82. The IR spectrum showed absorptions at υmax 
1740 (α,β-unsaturated lactone) and 1603 cm-1 (chelated acyl group)47, 85.  
 
Compound W showed similar profiles with those of compound O. Interestingly, 
compound W has an extra 16 molecular mass unit with respect to compound O. This 
suggested the presence of an additional hydroxyl group in compound W. An inspection 
of the 1H and 13C NMR spectra of compound W and compound O led to the following 
observations. Firstly, the existence of an extra oxymethine carbon and proton at δ 75.7 
(C-7'') and 4.02 (1H, brt, J = 6.6 Hz, H-7''), respectively. Secondly, the presence of a 
terminal sp2 carbon at δ 111.2 (C-10'') in compound W. These observations indicated 
that the sp2 C-7'' methine in compound O has been hydroxylated to an sp3 carbon in 
compound W. In addition, the methyl C-10'' in compound O was dehydrogenated into a 
methylene carbon in compound W.  
204 
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In the NOESY spectrum of compound W, a cross correlation was observed between H-
2'' and H-4'', suggesting that these two protons were situated in the same plane. 
 
A careful search through the SciFinder database led to the result that compound W was 
a new chemical compound, which was named as mesuagenin M 204. 
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Table 3.24: 1H NMR, 13C NMR, NOESY and HMBC (in CDCl3, 600 MHz) of   
Compound W 204 
 
Position δH, J (Hz)  δC NOESY HMBC 
2 - 159.1 
  3 6.06 (1H, s) 111.1 2', 6' 2, 4a, 1' 
4 - 154.9 
  4a - 98.6 
  5 - 161.9 
  6 - 110.1 
  7-OH 14.32 (1H, s) 163.7 
 
6, 7, 8, 1''' 
8 - 105.0 
  8a - 157.4 
  1' - 138.1 
  2' 7.30 (1H, m, Ar) 127.5 3 
 3'  
      7.42 (3H, m, Ar) 
127.9 
 
1' 
4' 128.7 
 
2', 6' 
5' 127.9 
 
1' 
6' 7.30 (1H, m, Ar) 127.5 3 
 1''α 3.02 (1H, dd, J = 9.8, 15.4) 
26.4 
2'' 5, 6, 2'', 3'' 
1''β 3.06 (1H, dd, J = 9.8, 15.4) 2'' 5, 6, 1'' 
2'' 4.56 (1H, t, J = 9.8) 91.9 1''α, 1''β, 4'' 1'', 4'', 5'' 
3''-OH - 72.8 
  4'' 0.86 (3H, s) 21.7 2'' 2'', 3'', 5'' 
5'' 1.30 (2H, m) 32.2 
 
1'', 2'', 3'', 4'', 6'' 
6'' 1.49 (2H, m) 28.0 
 
5'', 7'' 
7'' 4.02 (1H, brt, J = 6.6) 75.7 10''β 5'', 9'', 10'' 
8'' - 147.2 
  9'' 1.72 (3H, s) 17.9 10''α 7'', 8'', 10'' 
10''α 4.87 (1H, s) 
111.2 
9'' 7'', 8'', 9'' 
10''β 4.94 (1H, s) 7'' 7'', 8'', 9'' 
1''' - 206.1 
  2''' 3.18 (2H, d, J = 6.7) 53.4 3''', 4''', 5''' 1''', 3''', 4''', 5''' 
3''' 2.31 (1H, m) 25.6 2''', 4''', 5''' 1''', 2''', 4''', 5''' 
4'''  
     1.06 (6H, d, J = 6.7) 
22.7 2''', 3''' 3''', 5''' 
5''' 22.7 2''', 3''' 3''', 4''' 
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Figure 3.47: 1H NMR Spectrum of Compound W 204 
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Figure 3.48: 13C NMR Spectrum of Compound W 204
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3.1.24 Compound X: Mesuagenin N 205 
 
 
 
 
 
 
 
 
Compound X was obtained as a yellowish oil and has a molecular formula of C30H34O7 
based on the HRESIMS measurement; [M+Na]+ ion at m/z 529.2206 (calculated 
529.2202). The IR spectrum showed strong absorptions at υmax 3445 (free OH group), 
1743 (α-pyrone), 1603 (chelated acyl group) and 1384 cm-1 (geminal dimethyl group).47, 
88. The UV spectrum (EtOH) of compound X could be associated with an 8-acyl-5,7-
dioxycoumarin type due to absorptions at λmax 230, 285 and 339  nm82. 
 
A total of thirty carbons were observed in the 13C NMR spectrum of compound X; five 
methyls, three methylenes, ten methines and twelve quaternary carbons. The 1H NMR 
spectrum of compound X was similar to those of compound O, thus suggesting a close 
relationship between these compounds. The same substituents could be characterized in 
the two compounds, namely a typical H-3 signal of a 4-phenylcoumarin (δ 6.05, s, H-3), 
a monosubstituted phenyl (δ 7.43 and 7.31, 5H, m, H-2'-H6'), a chelated hydroxyl group 
(δ 14.31, s, 7-OH) and a 3-methylbutanoyl group [δ 3.17 (2H, d, J = 6.8 Hz, H-2'''), 2.30 
(1H, m, H-3''') and 1.05 (6H, d, J = 6.8 Hz, H-4''' and H-5''')]. 
205 
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Close analysis of the 1H and 13C NMR spectra of compound X and compound O 
showed differences in the coupling patterns of the substituent group at position C-5/C-6. 
In fact, the existence of a double bond between C-6'' and C-7'' were observed with a 
different coupling pattern of H-6'' and H-7'' in the 1H NMR spectrum of compound X as 
compared to compound O; δ 5.55 (1H, m, H-6'') and 5.58 (1H, d, J = 15.6 Hz, H-7''). 
The manifestation of a strong singlet integrating for six protons at δ 1.29 made clear the 
presence of the H-9'' and H-10'' methyls in compound X. These observations showed 
that compound X has a slightly different hydroxylated prenyl group attached to C-5'' as 
compared to compound O. Furthermore, the HMBC spectrum of compound X disclosed 
that this hydroxylated prenyl group was attached to C-5'' (δ 40.1) by exhibiting the 
following correlations: H-6''/C-5'', C-7'' and C-8''. 
 
In the NOESY spectrum of compound X, cross correlation was observed between H-2'' 
and H-4'', which suggested that these two protons were located in the same plane. 
 
The observed spectral data of compound X and a thorough search in the SciFinder 
database revealed that this compound was a new chemical entity, which was named as 
mesuagenin N 205. 
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Table 3.25: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of   
Compound X 205 
 
Position δH, J (Hz)  δC COSY HMBC 
2 - 159.1 
  3 6.05 (1H, s) 111.2 
 
2, 4a, 1' 
4 - 155.0 
  4a - 98.8 
  5 - 162.0 
  6 - 110.1 
  7-OH 14.31 (1H, s) 163.8 
 
6, 7, 8, 1''' 
8 - 105.1 
  8a - 157.4 
  1' - 138.2 
  2' 7.31 (1H, m, Ar) 127.5 
 
4, 4' 
3' 
 
128.0 
 
1' 
4'     7.43 (3H, m, Ar) 128.9 
 
2', 6' 
5' 
 
128.0 
 
1' 
6' 7.31 (1H, m, Ar) 127.5 
 
4, 4' 
1'' 3.03 (2H, d, J = 9.3) 26.3 2'' 5, 6, 7, 2'', 3'' 
2'' 4.52 (1H, t, J = 9.3) 91.5 1'' 5, 6, 4'', 5'' 
3'' - 73.1 
  4'' 0.85 (3H, s) 22.2 
 
2'', 3'', 5'' 
5'' 1.97 (2H, m) 40.1 6'' 2'', 3'', 4'', 6'', 7'' 
6'' 5.55 (1H, m) 120.5 5'' 5'', 7'', 8'' 
7'' 5.58 (1H, d, J = 15.6) 142.8 
 
6'', 9'', 10'' 
8'' - 70.8 
  9'' 1.29 (3H, s) 29.9 
 
6'', 7'', 8'' 
10'' 1.29 (3H, s) 29.9 
 
6'', 7'', 8'' 
1''' - 206.1 
  2''' 3.17 (2H, d, J = 6.8) 53.5 3''' 1''', 3''', 4''', 5''' 
3''' 2.30 (1H, m) 25.7 2''', 4''', 5''' 1''', 2''', 4''', 5''' 
4'''  
     1.05 (6H, d, J = 6.8) 
22.8 3''', 5''' 2''', 3''', 5''' 
5''' 22.8 3''', 4''' 2''', 3''', 4''' 
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Figure 3.49: 1H NMR Spectrum of Compound X 205 
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Figure 3.50: 13C NMR and DEPT135 Spectra of Compound X 205 
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Figure 3.51: HMBC Spectrum of Compound X 205 
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CHAPTER 4 
 SEMI-SYNTHESIS OF 4-PHENYLCOUMARIN ANALOGUES 
 
The present chapter deals with the structural elucidation of seventeen semi-synthesized 
4-phenylcoumarin analogues from Mesua elegans (King) Kosterm. Three types of semi-
synthetic work were carried out successfully, namely acetylation, methylation and 
bromobenzoylation. These work were done, to evaluate the effects of hydroxyl group in 
the AChE inhibitory activity and SAR studies, which shall be discussed in chapter 5 
later. The following sections describe the fractions or the parent compounds involved in 
the semi-synthesis work, and the respected compounds isolated from these semi-
synthetic studies. 
 
4.1 Semi-synthesis of 4-Phenylcoumarin Analogues 
Fractions 1 and 1a from the hexane extract of M. elegans were subjected to three types 
of chemical modifications; acetylation, methylation and benzoylation. The findings are 
discussed briefly in the following sections. 
 
4.1.1 Acetylation 
Fraction F1 (hexane:ethyl acetate 95:5) from the hexane extract of the bark of Mesua 
elegans was subjected to the acetylation process. This fraction essentially contained five 
chemical constituents; compound F (mammea A/BB) 55, compound G (mammea 
A/BA) 28, compound H (mesuagenin C) 191, compound I [5,7-dihydroxy-8-(2-
methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one 
(DMDP-1)] 47 and compound J [5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one (DMDP-2)] 48. The semi-
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synthesized compounds were isolated from this fraction and the following Table 4.1 
shows the names of the isolates. 
 
Table 4.1: Acetylation Isolates and Their Names. 
Acetylation Isolates Names of Isolates 
Compound A1 7-hydroxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-
4-phenyl-2H-chromen-5-yl acetate 206 
 
Compound A2 7-hydroxy-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-
4-phenyl-2H-chromen-5-yl acetate 207 
 
Compound A3 6-[(E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxy-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 208 
 
Compound A4 6-[(E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxy-8-(3-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 209 
 
Compound A5 8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-phenyl-
2H-chromene-5,7-diyl diacetate 210 
 
Compound A6 8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-phenyl-
2H-chromene-5,7-diyl diacetate 211 
 
Compound A7 6-[(E)-3,7-dimethylocta-2,6-dienyl]-8-(isobutyryl)-2-oxo-4-
phenyl-2H-chromene-5,7-diyl diacetate 212 
 
Compound A8 6-[(E)-3,7-dimethylocta-2,6-dienyl]-8-(2-methylbutanoyl)-2-oxo-
4-phenyl-2H-chromene-5,7-diyl diacetate 213 
 
Compound A9 6-[(E)-3,7-dimethylocta-2,6-dienyl]-8-(3-methylbutanoyl)-2-oxo-
4-phenyl-2H-chromene-5,7-diyl diacetate 214 
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4.1.2 Methylation 
Methylation was carried out using fraction F1 (hexane:ethyl acetate 95:5) from the 
hexane extract of the bark of Mesua elegans. The parent compounds F - J in this 
fraction were methylated to afford compounds M1 - M4. Table 4.2 depicts the isolates 
of the methylation process. 
 
Table 4.2: Methylation Isolates and Their Names. 
Methylation Isolates Names of Isolates 
Compound M1 5,7-dimethoxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-4-
phenyl-2H-chromen-2-one 215 
 
Compound M2 5,7-dimethoxy-6-[(E)-(3,7-dimethylocta-2,6-dienyl]-8-
isobutyryl-4-phenyl-2H-chromen-2-one 216 
 
Compound M3 5,7-dimethoxy-6-[(E)-3,7-dimethylocta-2,6-dienyl]-8-(2-
methylbutanoyl)-4-phenyl-2H-chromen-2-one 217 
 
Compound M4 5,7-dimethoxy-6-[(E)-(3,7-dimethylocta-2,6-dienyl]-8-(3-
methylbutanoyl)-4-phenyl-2H-chromen-2-one 218 
 
 
4.1.3 Bromobenzoylation 
Fraction F1-2 from the hexane extract of the bark of Mesua elegans was been subjected 
to the bromobenzoylation process. This fraction contained two major chemical 
constituents; compound I [5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one (DMDP-1)] 47 and compound J 
[5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-
chromen-2-one (DMDP-2)] 48. Table 4.3 below designates the isolates from the 
bromobenzoylation reaction. 
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Table 4.3: Bromobenzoylation Isolates and Their Names. 
Bromobenzoylation Isolates Names of Isolates 
Compound B1 (E)-6-(3,7-dimethylocta-2,6-dienyl)-7-hydroxy-8-(3-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl 2-
bromobenzoate 219 
 
Compound B2 (E)-6-(3,7-dimethylocta-2,6-dienyl)-7-hydroxy-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl 2-
bromobenzoate 220 
 
Compound B3 (E)-6-(3,7-dimethylocta-2,6-dienyl)-8-(3-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl 
bis(2-bromobenzoate) 221 
 
Compound B4 (E)-6-(3,7-dimethylocta-2,6-dienyl)-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl 
bis(2-bromobenzoate) 222 
 
 
 
4.2 Structural Elucidation of Compounds from the Semi-synthesis of 4-
Phenylcoumarin Analogues 
All the semi-synthesized compounds were subjected to isolation using chromatographic 
techniques, including preparative thin layer chromatography (PTLC) and high 
performance liquid chromatography (HPLC). The isolates were then elucidated using 
spectroscopic techniques, namely 1D and 2D NMR, IR and UV. The following sub-
chapters explain the structural elucidation of these compounds. 
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4.2.1 Compound A1: 7-Hydroxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-
oxo-4-phenyl-2H-chromen-5-yl acetate 206 
 
 
 
 
 
Compound A1 was acetylated in fraction F1 (hexane:ethyl acetate 95:5) of the hexane 
extract of M. elegans. Compound A1 was then isolated by PTLC and HPLC as a yellow 
oil. The HRESIMS spectrum exhibited pseudomolecular [M+Na]+ ion at m/z 471.1496 
(calculated 471.1784), which suggested a molecular formula of C27H28O6. The UV 
spectrum (EtOH) of compound A1 showed peaks at 221, 295 and 330 nm, which 
showed a resemblance with the UV absorbance of the parent compound F (226, 297, 
331 nm), supporting the same skeletal structure. The IR spectrum showed absorption at 
υmax 3480 cm-1, indicating the presence of hydroxyl group, which was apparent in the 
parent compound F. The IR spectrum of compound A1 also exhibited absorption at υmax 
1735 cm-1, which showed the presence of α-pyrone and ester groups. 
 
The 13C NMR spectrum showed twenty seven carbon signals (five methyls, two 
methylenes, eight methines and twelve quaternary carbons), which was an addition of 
two carbons compared to the parent compound F, which has twenty five carbons. In the 
1H NMR spectrum of compound A1, the proton signal for the 5-OH which was apparent 
in the parent compound F’s 1H NMR spectrum at δ 5.94 was missing, indicating that 
acetylation had taken place at position 5-OH of the parent compound F. In addition, a 
methyl signal was apparent in the 1H NMR spectrum of compound A1, at δ 1.26 (3H, s, 
206 
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H-2''''), which was absent in 1H NMR spectrum of the parent compound F, suggesting 
the presence of the an acetyl group in compound A1.  
 
The observed data of compound A1 suggested that this was an acetylated derivative of 
the parent compound F at position C-5, with the IUPAC name 7-hydroxy-8-(2-
methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 206.  
 
Table 4.4: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A1 206 
Position δH, J (Hz)  δC 
2 - 158.4 
3 6.05 (1H, s) 114.3 
4 - 154.4 
4a - 105.3 
5 - 150.2 
6 - 121.3 
7-OH 14.36 (1H, s) 166.4 
8 - 107.8 
8a - 154.8 
1' - 138.3 
2' 7.31 (1H, m, Ar) 127.8 
3' 
 
128.3 
4'     7.44 (3H, m, Ar) 128.7 
5' 
 
128.3 
6' 7.31 (1H, m, Ar) 127.8 
1'' 3.12 (1H, brd, J = 42.5) 23.0 
2'' 4.98 (1H, brt, J = 6.8) 120.4 
3'' - 133.0 
4'' 1.67 (3H, s) 17.9 
5'' 1.63 (3H, s) 25.6 
1''' - 211.4 
2''' 3.97 (1H, sext, J = 6.8) 47.5 
3''' 1.29 (3H, d, J = 6.8) 16.6 
4'''α 1.49 (1H, m)  
    27.1 4'''β 1.96 (1H, m) 
5''' 1.02 (3H, t, J = 7.3) 11.8 
1'''' - 168.3 
2'''' 1.26 (3H, s) 19.1 
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Figure 4.1: 1H NMR Spectrum of Compound A1 206 
7-OH 
3'-5' 
2', 6' 
3 
2'' 
1'' 
2''' 
4'''β  
2'''' 
4'' 
5'' 
3''' 
5''' 
4'''α 
Chapter 4                                                                            Semi-synthesis of 4-Phenylcoumarin Analogues 
189 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: 13C NMR Spectrum of Compound A1 206 
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4.2.2 Compound A2: 7-Hydroxy-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-
oxo-4-phenyl-2H-chromen-5-yl acetate 207 
 
 
 
 
 
 
Compound A2 was isolated as a yellow oil after being acetylated in fraction F1 
(hexane:ethyl acetate 95:5) of the hexane extract of M. elegans, in which compound G 
was the parent compound within this fraction. The HRESIMS spectrum displayed 
pseudomolecular [M+Na]+ ion at m/z 471.1549 (calculated 471.1784), suggesting a 
molecular formula of C27H28O6. The IR spectrum showed absorptions at υmax 1735 cm-1 
(α, β-unsaturated lactone and ester groups), which were similar to those in the parent 
compound G. The UV spectrum (EtOH) of compound A2 also supported the same 
skeletal structure as compound G, by exhibiting peaks at 225, 297 and 333 nm. 
 
A total of twenty-seven carbon resonances were observed in the 13C NMR spectrum of 
compound A2 (five methyls, two methylenes, eight methines and twelve quaternary 
carbons), as compared to the parent compound G which has twenty five carbons. In the 
1H NMR spectrum of compound A2, an additional methyl signal at δ 1.26 (3H, s, H-2'''') 
was noticeable, which was absent in the parent compound G. On the other hand, the 5-
OH signal at δ 5.95 in the 1H NMR spectrum of compound G was missing in the 1H 
NMR spectrum of compound A2. This indicated that the acetylation had taken place at 
207 
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position C-5 of the coumarin skeleton of compound A2. Furthermore, hydroxyl group 
of C-7 has a strong hydrogen bond with the neighbouring ketone group (C-1'''), 
therefore making this hydroxyl group more difficult to be acetylated.  
 
Comparison of the spectral data between compound A2 and the parent compound G 
indicated that this was an acetylated derivative of the parent compound G at position C-
5, with the IUPAC name 7-hydroxy-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-
oxo-4-phenyl-2H-chromen-5-yl acetate 207.  
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Table 4.5: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A2 207 
Position δH, J (Hz)  δC 
2 - 158.4 
3 6.05 (1H, s) 114.4 
4 - 154.4 
4a - 105.3 
5 - 150.3 
6 - 121.4 
7-OH 14.42 (1H, s) 166.3 
8 - 108.2 
8a - 155.1 
1' - 138.3 
2' 7.32 (1H, m, Ar) 127.9 
3' 
 
128.4 
4'     7.45 (3H, m, Ar) 128.8 
5' 
 
128.4 
6' 7.32 (1H, m, Ar) 127.9 
1'' 3.12 (1H, brd, J coupling 
obscured by peak H-2''') 
23.0 
2'' 4.97 (1H, brt, J = 6.8) 120.4 
3'' - 133.1 
4'' 1.67 (3H, s) 17.9 
5'' 1.63 (3H, s) 25.7 
1''' - 207.0 
2''' 3.23 (2H, d, J = 6.8) 54.0 
3''' 2.35 (1H, m) 25.4 
4'''  
     1.05 (6H, d, J = 6.8) 
22.7 
5''' 22.7 
1'''' - 168.5 
2'''' 1.26 (3H, s) 19.2 
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Figure 4.X: 1H NMR Spectrum of Compound A2H2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: 1H NMR Spectrum of Compound A2 207
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4.2.3 Compound A3: 6-[(E)-3,7-Dimethylocta-2,6-dienyl]-7-hydroxy-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 208 
 
 
 
 
 
 
Fraction F1 (hexane:ethyl acetate 95:5) of the hexane extract of M. elegans was 
subjected to acetylation, and compound A3 was isolated from the product of this semi-
synthetic process through PTLC and HPLC as a yellow oil. The HRESIMS spectrum 
exhibited a pseudomolecular [M+Na]+ ion at m/z 539.2714 (calculated 539.2410), 
suggesting a molecular formula of C32H36O6. The IR spectrum showed absorptions at 
υmax 3452 cm-1 (hydroxyl group), 1739 cm-1 (α-pyrone and ester groups) and 1600 cm-1 
(chelated acyl group), comparable to those in the parent compound I. The UV 
absorbance of compound A3 was similar to the parent compound I, with intense 
absorption bands at 225, 295 and 334 nm.  
 
The 13C NMR spectrum of compound A3 showed an addition of two carbons compared 
to the parent compound I, with a total of thirty-two carbon signals (six methyls, four 
methylenes, nine methines and thirteen quaternary carbons). In the 1H NMR spectrum 
of compound A3, the proton signal for the 5-OH which was apparent in the 1H NMR 
spectrum of compound I at δ 5.94 was missing, indicating that the acetylation took place 
at position C-5 of the parent compound I. In addition, a methyl signal was apparent in 
208 
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the 1H NMR spectrum of compound A3, at δ 1.26 (3H, s, H-2''''), which was absent in 
the 1H NMR spectrum of parent compound I, thus suggesting the presence of the acetyl 
group in compound A3.  
 
The observed data of compound A3 suggested that this was an acetylated derivative of 
the parent compound I at position C-5, with the IUPAC name 6-[(E)-3,7-dimethylocta-
2,6-dienyl]-7-hydroxy-8-(2-methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 
208. 
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Table 4.6: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A3 208 
Position δH, J (Hz)  δC 
2 - 158.5 
3 6.05 (1H, s) 114.3 
4 - 154.4 
4a - 105.4 
5 - 150.3 
6 - 121.5 
7-OH 14.30 (1H, s) 166.5 
8 - 107.9 
8a - 154.9 
1' - 138.4 
2' 7.31 (1H, m, Ar) 127.5 
3' 
 
128.5 
4'     7.44 (3H, m, Ar) 128.8 
5' 
 
128.5 
6' 7.31 (1H, m, Ar) 127.5 
1'' 3.17 (2H, brs) 22.9 
2'' 4.97 (1H, brt, J = 6.7) 120.3 
3'' - 136.6 
4'' 1.66 (3H, s) 16.3 
5'' 1.93 (2H, m) 39.5 
6'' 1.98 (2H, m) 26.6 
7'' 5.02 (1H, brt, J = 6.7) 124.1 
8'' - 131.5 
9'' 1.55 (3H, s) 17.7 
10'' 1.62 (3H, s) 25.7 
1''' - 211.5 
2''' 3.96 (1H, sext, J = 6.3) 47.5 
3''' 1.29 (3H, d, J = 6.3) 16.6 
4'''α 1.49 (1H, m)  
    27.2 4'''β 1.89 (1H, m) 
5''' 1.02 (3H, t, J = 7.3) 11.9 
1'''' - 168.4 
2'''' 1.26 (3H, s) 19.2 
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Figure 4.4: 1H NMR Spectrum of Compound A3 208 
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Figure 4.5: 13C NMR Spectrum of Compound A3 208 
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4.2.4 Compound A4: 6-[(E)-3,7-Dimethylocta-2,6-dienyl]-7-hydroxy-8-(3-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 209 
 
 
 
 
 
 
Compound A4 was an acetylated derivative of the parent compound J and was isolated 
as a white amorphous powder. The HRESIMS spectrum revealed a pseudomolecular 
[M+Na]+ ion at m/z 539.2690 (calculated 539.2410), suggesting a molecular formula of 
C32H36O6. The UV spectrum showed maximum absorption bands at 221, 297 and 333 
nm, similar to the parent compound J (227, 299 and 332 nm), indicating the same 
skeletal structure. The IR spectrum showed absorptions at υmax 3470 cm-1, indicating the 
presence of a hydroxyl group. The IR spectrum of compound A4 also exhibited peaks at 
υmax 1749 cm-1, which showed the presence of α,β-unsaturated lactone and ester groups.  
 
The 13C NMR spectrum of compound A4 showed thirty-two carbon signals (six 
methyls, four methylenes, nine methines and thirteen quaternary carbons), which 
represents the addition of two new carbons as compared to the parent compound J. In 
the 1H NMR spectrum of compound A4, an additional methyl signal was apparent at δ 
1.27 (3H, s, H-2''''). On the other hand, signal of 5-OH was missing in compound A4 as 
compared to the 1H NMR spectrum of parent compound J. This suggested that 
acetylation had occurred at C-5 in compound A4. Apart from these differences in the 1H 
209 
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NMR spectrum of compound A4, the proton signals for the other substituents (4-phenyl, 
geranyl and 3-methylbutanoyl) remained similar.  
 
The observed data of compound A4 suggested that this was an acetylated derivative of 
the parent compound J at position C-5, with the IUPAC name 6-[(E)-3,7-dimethylocta-
2,6-dienyl]-7-hydroxy-8-(3-methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl acetate 
209. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4                                                                            Semi-synthesis of 4-Phenylcoumarin Analogues 
201 
 
Table 4.7: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A4 209 
Position δH, J (Hz)  δC 
2 - 158.3 
3 6.06 (1H, s) 114.3 
4 - 154.3 
4a - 105.3 
5 - 150.3 
6 - 121.3 
7-OH 14.43 (1H, s) 166.3 
8 - 108.2 
8a - 155.0 
1' - 138.3 
2' 7.31 (1H, m, Ar) 127.8 
3' 
 
128.3 
4'     7.44 (3H, m, Ar) 128.7 
5' 
 
128.3 
6' 7.31 (1H, m, Ar) 127.8 
1'' 3.17 (2H, brs) 22.8 
2'' 4.98 (1H, brt, J = 6.7) 120.2 
3'' - 136.6 
4'' 1.68 (3H, s) 16.2 
5'' 1.90 (2H, m) 39.6 
6'' 2.09 (2H, m) 26.5 
7'' 5.02 (1H, brt, J = 6.7) 124.1 
8'' - 131.4 
9'' 1.56 (3H, s) 17.6 
10'' 1.64 (3H, s) 25.7 
1''' - 206.9 
2''' 3.25 (2H, d, J = 6.6) 54.0 
3''' 2.37 (1H, sext, J = 6.6) 25.4 
4'''  
     1.06 (6H, d, J = 6.6) 
22.7 
5''' 22.7 
1'''' - 168.3 
2'''' 1.27 (3H, s) 19.1 
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Figure 4.6: 1H NMR Spectrum of Compound A4 209 
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Figure 4.7: 13C NMR Spectrum of Compound A4 209 
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Figure 4.8: HMBC Spectrum of Compound A4 209
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4.2.5 Compound A5: 8-(2-Methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-
phenyl-2H-chromene-5,7-diyl diacetate 210 
 
 
 
 
 
 
Compound A5 was acetylated from fraction F1 (hexane:ethyl acetate 95:5) of the 
hexane extract of M. elegans and isolated by PTLC and HPLC as a yellow oil. The 
HRESIMS spectrum exhibited a pseudomolecular [M+Na]+ ion at m/z 513.1870 
(calculated 513.1889), suggesting a molecular formula of C29H30O7. The IR spectrum of 
compound A5 exhibited an absorption at υmax 1732 cm-1, which showed the presence of 
α-pyrone and ester groups. The UV spectrum (EtOH) of compound A5 showed peaks at 
221, 295 and 330 nm, which showed resemblance with the UV absorbance of the parent 
compound F (226, 297, 331 nm), supporting the same skeletal structure. 
 
An additional four carbons were apparent in the 13C NMR spectrum of compound A5, 
as compared to the parent compound F, which has only twenty-five carbons. This 
indicated that both hydroxyl groups in the parent compound had been acetylated (5-OH 
and 7-OH). This observation was further supported by the absence of both hydroxyl 
peaks in the 1H NMR spectrum of compound A5, as compared to the parent compound 
F. In addition, two methyl singlets were apparent in the 1H NMR spectrum of 
compound A5; δ 1.23 (3H, s, H-2'''') and δ 2.24 (3H, s, H-2'''''). The chemical shift of H-
210 
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2''''' was at higher field than the chemical shift of H-2'''' due to the hydrogen bond of H-
2''''' with the ketone group at C-1'''. 
 
Based on a comparison of the spectral data between compound A5 and the parent 
compound F, the structure of compound A5 was determined to be 8-(2-
methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl 
diacetate 210. 
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Table 4.8: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A5 210 
Position δH, J (Hz)  δC 
2  - 158.1 
3 6.19 (1H, s) 118.4 
4 - 153.1 
4a - 111.8 
5 - 147.2 
6 - 126.0 
7 - 150.4 
8 - 122.2 
8a - 149.2 
1' - 137.4 
2' 7.32 (1H, m, Ar) 127.8 
3' 
 
128.8 
4'     7.45 (3H, m, Ar) 129.0 
5' 
 
128.8 
6' 7.32 (1H, m, Ar) 127.8 
1'' 2.98 (1H, brd, J coupling 
obscured by peak H-2''') 
25.6 
2'' 4.86 (1H, brt, J = 6.8) 120.3 
3'' - 133.0 
4'' 1.61 (3H, s) 25.6 
5'' 1.61 (3H, s) 25.6 
1''' - 204.4 
2''' 3.16 (1H, sext, J = 6.8) 48.9 
3''' 1.23 (3H, brs) 18.0 
4'''α 1.49 (1H, brs)  
    24.4 4'''β 1.90 (1H, brs) 
5''' 1.01 (3H, brs) 11.6 
1'''' - 168.4 
2'''' 1.23 (3H, s) 19.1 
1''''' - 168.6 
2''''' 2.24 (3H, s) 20.5 
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Figure 4.9: 1H NMR Spectrum of Compound A5 210
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4.2.6 Compound A6: 8-(3-Methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxo-4-
phenyl-2H-chromene-5,7-diyl diacetate 211 
 
 
 
 
 
 
Compound A6 was acetylated from the parent compound G, and then later separated, by 
PTLC and HPLC, as a white amorphous powder. The HRESIMS spectrum displayed 
pseudomolecular [M+Na]+ ion at m/z 513.1847 (calculated 513.1889), signifying a 
molecular formula of C29H30O7. The UV spectrum (EtOH) of compound A2 also 
supported the same skeletal structure as in compound G, by exhibiting peaks at 225, 297 
and 330 nm. The IR spectrum of compound A2 showed noteworthy absorption at υmax 
1735 cm-1 (α,β-unsaturated lactone and ester groups). The IR peak for the hydroxyl 
group was absent in the IR spectrum, as compared to the parent compound G which 
displayed a hydroxyl group absorption at 3482 cm-1. This suggested that acetylation had 
occurred at both the 5-OH and 7-OH hydroxyl groups. 
 
The 13C NMR spectrum showed twenty-nine carbon signals (six methyls, two 
methylenes, eight methines and thirteen quaternary carbons), indicating an additional 
four carbons as compared to the parent compound G which had twenty five carbons. 
The additional four carbon resonances in the 13C NMR spectrum of compound A6 
further supported the IR observations. Moreover, two additional methyl singlets were 
211 
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observed in the 1H NMR spectrum of compound A6; δ 1.25 (3H, s, H-2'''') and δ 2.26 
(3H, s, H-2'''''). On the other hand, the 5-OH and 7-OH signals were missing in the of 
compound A6, as compared to the 1H NMR spectrum of the parent compound G. These 
observations indicated that the acetylation had taken place at positions C-5 and C-7 of 
the coumarin skeleton of compound A6.  
 
Comparison of the spectral data between compound A6 and parent compound G 
indicated that this was an acetylated derivative of the parent compound G at positions 
C-5 and C-7, with the IUPAC name 8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-
oxo-4-phenyl-2H-chromene-5,7-diyl diacetate 211. 
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Table 4.9: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A6 211 
Position δH, J (Hz)  δC 
2 - 158.2 
3 6.20 (1H, s) 118.3 
4 - 153.1 
4a - 111.6 
5 - 147.1 
6 - 125.8 
7 - 150.2 
8 - 122.8 
8a - 148.8 
1' - 137.4 
2' 7.32 (1H, m, Ar) 127.8 
3' 
 
128.8 
4'     7.45 (3H, m, Ar) 129.0 
5' 
 
128.8 
6' 7.32 (1H, m, Ar) 127.8 
1'' 2.93 (1H, brd, J coupling 
obscured by peak H-2''') 
24.3 
2'' 4.86 (1H, brt, J = 6.8) 120.8 
3'' - 133.1 
4'' 1.63 (3H, s) 17.9 
5'' 1.63 (3H, s) 25.6 
1''' - 200.2 
2''' 2.92 (2H, d, J= 6.7) 53.2 
3''' 2.33 (1H, m) 24.4 
4'''  
    1.03 (6H, d, J = 6.7) 
22.6 
5''' 22.6 
1'''' - 168.4 
2'''' 1.25 (3H, s) 19.1 
1''''' - 168.6 
2''''' 2.26 (3H, s) 20.6 
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Figure 4.10: 1H NMR Spectrum of Compound A6 211 
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Figure 4.11: 13C NMR Spectrum of Compound A6 211
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4.2.7 Compound A7: 6-[(E)-3,7-Dimethylocta-2,6-dienyl]-8-(isobutyryl)-2-oxo-4-
phenyl-2H-chromene-5,7-diyl diacetate 212 
 
 
 
 
 
 
Compound A7 was isolated as a white amorphous powder after being acetylated from 
compound H. The molecular formula of C33H36O7 for compound A7 was established 
from the HRESIMS measurement which revealed a pseudomolecular [M+Na]+ ion at 
m/z 567.2281 (calculated 567.2359). The IR spectrum showed absorptions at υmax 1739 
cm-1, indicating the presence of α-pyrone and ester groups. The UV absorbance of 
compound A7 was similar to the parent compound H, with intense absorption bands at 
225, 295 and 333 nm.  
 
The 13C NMR spectrum of compound A7 showed an addition of four carbons as 
compared to the parent compound H, with a total of thirty-three carbon signals (seven 
methyls, three methylenes, nine methines and fourteen quaternary carbons). In the 1H 
NMR spectrum of compound A7, both 5-OH and 7-OH signals were missing as 
compared to the 1H NMR spectrum of the parent compound. Instead, two methyl signals 
were apparent in the 1H NMR spectrum of compound A7; δ 1.25 (3H, s, H-2'''') and δ 
2.25 (3H, s, H-2'''''). These indications suggested that acetylation had taken place at 
positions C-5 and C-7 of the parent compound H. Apart from the apparent differences in 
212 
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the 1H NMR spectra between compound A7 and the parent compound H, there were no 
other significant differences between the spectra of these two compounds.  
 
After analysis and comparison of the spectral data of compound A7 and the parent 
compound H, the structure of compound A7 was established as 6-[(E)-3,7-
dimethylocta-2,6-dienyl]-8-(isobutyryl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl 
diacetate 212. 
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Table 4.10: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A7 212 
Position δH, J (Hz)  δC 
2 - 158.2 
3 6.20 (1H, s) 118.3 
4 - 153.2 
4a - 111.7 
5 - 147.1 
6 - 126.0 
7 - 150.1 
8 - 122.1 
8a - 149.2 
1' - 137.4 
2' 7.33 (1H, m, Ar) 128.0 
3' 
 
128.8 
4'     7.46 (3H, m, Ar) 129.0 
5' 
 
128.8 
6' 7.33 (1H, m, Ar) 128.0 
1'' 3.00 (1H, brd, J = 70.2) 24.3 
2'' 4.89 (1H, brt, J = 6.7) 120.1 
3'' - 136.7 
4'' 1.62 (3H, s) 16.4 
5'' 1.93 (2H, m) 39.5 
6'' 1.98 (2H, m) 26.5 
7'' 5.03 (1H, brt, J = 6.7) 123.9 
8'' - 131.7 
9'' 1.56 (3H, s) 17.8 
10'' 1.65 (3H, s) 25.8 
1''' - 204.8 
2''' 3.31 (1H, m) 42.2 
3'''  
    1.25 (6H, brd, J = 6.7) 
18.1 
4''' 18.1 
1'''' - 168.4 
2'''' 1.25 (3H, s) 19.1 
1''''' - 168.6 
2''''' 2.25 (3H, s) 20.6 
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Figure 4.12: 1H NMR Spectrum of Compound A7 212
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4.2.8 Compound A8: 6-[(E)-3,7-Dimethylocta-2,6-dienyl]-8-(2-methylbutanoyl)-2-
oxo-4-phenyl-2H-chromene-5,7-diyl diacetate 213 
 
 
 
 
 
 
Fraction F1 (hexane:ethyl acetate 95:5) of the hexane extract of M. elegans was 
subjected to acetylation, and compound A8 was isolated from the product of this semi-
synthesis process as a white amorphous powder. The HRESIMS spectrum exhibited 
pseudomolecular [M+Na]+ ion at m/z 581.2495 (calculated 581.2515), signifying a 
molecular formula of C34H38O7. The UV absorbance of compound A8 was similar to 
that of the parent compound I, with intense absorption bands at 223, 297 and 335 nm. 
The IR spectrum showed absorptions at υmax 1732 cm-1, indicating the presence of α-
pyrone and ester groups. 
 
Thirty-four carbon peaks were apparent in the 13C NMR spectrum of compound A8 as 
seven methyls, four methylenes, nine methines and fourteen quaternary carbons. An 
addition of four carbons as compared to the parent compound I, which merely has 30 
carbons indicated that acetylation had taken place at two different sites. The absence of 
the 5-OH and 7-OH peaks in the 1H NMR spectrum of compound A8 further supported 
this indication. Moreover, two methyl singlets were observed in the 1H NMR spectrum 
of compound A8 at δ 1.23 (3H, s, H-2'''') and at δ 2.24 (3H, s, H-2''''').  
213 
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These observations led to the conclusion that compound A8 was a di-acetylated product 
of the parent compound I, with the IUPAC name of 6-[(E)-3,7-dimethylocta-2,6-
dienyl]-8-(2-methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl diacetate 213. 
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Table 4.11: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A8 213 
Position δH, J (Hz)  δC 
2  - 158.0 
3 6.19 (1H, s) 118.3 
4 - 153.0 
4a - 111.7 
5 - 147.1 
6 - 126.0 
7 - 150.3 
8 - 122.2 
8a - 149.2 
1' - 137.4 
2' 7.32 (1H, m, Ar) 127.8 
3' 
 
128.3 
4'     7.45 (3H, m, Ar) 128.9 
5' 
 
128.3 
6' 7.32 (1H, m, Ar) 127.8 
1'' 2.99 (1H, brd, J coupling 
obscured by H-2''') 
22.9 
2'' 4.87 (1H, brt, J = 6.84) 120.1 
3'' - 136.6 
4'' 1.61 (3H, s) 16.3 
5'' 1.93 (2H, m) 39.4 
6'' 1.98 (2H, m) 26.4 
7'' 5.02 (1H, brt, J = 6.72) 123.9 
 8'' - 131.6 
9'' 1.55 (3H, s) 17.7 
10'' 1.64 (3H, s) 25.6 
1''' - 204.3 
2''' 3.18 (1H, m) 48.8 
3''' 1.23 (3H, brs) 16.2 
4'''α 1.49 (1H, m)  
     25.4 4'''β 1.89 (1H, m) 
5''' 1.01 (3H, brs) 11.5 
1'''' - 168.2 
2'''' 1.23 (3H, s) 19.0 
1''''' - 168.4 
2''''' 2.24 (3H, s) 20.4 
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Figure 4.13: 1H NMR Spectrum of Compound A8 213 
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Figure 4.14: 13C NMR Spectrum of Compound A8 213 
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4.2.9 Compound A9: 6-[(E)-3,7-Dimethylocta-2,6-dienyl]-8-(3-methylbutanoyl)-2-
oxo-4-phenyl-2H-chromene-5,7-diyl diacetate 214 
 
 
 
 
 
 
Compound A9 was acetylated from the parent compound J and obtained through PTLC 
and HPLC separations as a white amorphous powder. The molecular formula of 
C34H38O7 was established for compound A9 from the HRESIMS spectrum, which 
exhibited a pseudomolecular [M+Na]+ ion at m/z 581.2503 (calculated 581.2515). The 
UV absorbance of compound A9 was reminiscent with the parent compound J, with 
absorbance peaks at 225, 295 and 333 nm, thus supporting the same skeletal structure of 
the parent compound J. In the IR spectrum of compound A9, as compared to the IR 
spectrum of parent compound J, the absence of hydroxyl group signal led to the 
suggestion that the 5-OH and 7-OH hydroxyl groups were acetylated.  
 
These observations from the IR spectrum of compound A9 were further supported by 
the absence of 5-OH and 7-OH peak signals in the 1H NMR spectrum of compound A9, 
as compared to the parent compound J. In addition, two methyl singlets were observed 
in the 1H NMR spectrum of compound A9; δ 1.24 (3H, s, H-2'''') and δ 2.25 (3H, s, H-
2'''''). This observation further supported the inference that acetylation had occurred at 
the 5-OH and the 7-OH. Moreover, the observations from 1H NMR and IR spectra of 
214 
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compound A9 was further reinforced by the 13C NMR spectrum of compound A9, 
which displayed thirty-four carbon resonances (seven methyls, four methylenes, nine 
methines and fourteen quaternary carbons) as compared to the parent compound J which 
had thirty carbons. Apart from the apparent differences in the 1H and 13C NMR spectra 
of compound A9, the other substituents of the coumarin skeleton (4-phenyl, geranyl and 
3-methylbutanoyl) remained unchanged.  
 
Detailed analysis of the 1D and 2D NMR data of compound A9 led to the complete 
NMR assignment of compound A9, which was established as 6-[(E)-3,7-dimethylocta-
2,6-dienyl]-8-(3-methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl diacetate 214.  
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Table 4.12: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound A9 214 
Position δH, J (Hz)  δC 
2 - 158.2 
3 6.19 (1H, s) 118.2 
4 - 153.2 
4a - 111.6 
5 - 147.1 
6 - 125.9 
7 - 150.2 
8 - 122.8 
8a - 148.8 
1' - 137.4 
2' 7.31 (1H, m, Ar) 128.0 
3' 
 
128.8 
4'     7.45 (3H, m, Ar) 129.0 
5' 
 
128.8 
6' 7.31 (1H, m, Ar) 128.0 
1'' 3.00 (1H, brd, J = 65.4) 24.2 
2'' 4.86 (1H, brt, J = 6.8) 120.1 
3'' - 136.8 
4'' 1.62 (3H, s) 16.4 
5'' 1.93 (2H, m) 39.5 
6'' 1.98 (2H, m) 26.5 
7'' 5.01 (1H, brt, J = 6.8) 123.9 
8'' - 131.7 
9'' 1.55 (3H, s) 17.7 
10'' 1.64 (3H, s) 25.7 
1''' - 200.2 
2''' 2.90 (2H, d, J = 6.4) 53.2 
3''' 2.32 (1H, m) 24.3 
4'''  
     1.02 (6H, d, J = 6.4) 
22.6 
5''' 22.6 
1'''' - 168.4 
2'''' 1.24 (3H, s) 19.1 
1''''' - 168.6 
2''''' 2.25 (3H, s) 20.6 
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Figure 4.15: 1H NMR Spectrum of Compound A9 214 
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Figure 4.16: 13C NMR Spectrum of Compound A9 214 
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Figure 4.17: HMBC Spectrum of Compound A9 214 
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4.2.10 Compound M1: 5,7-Dimethoxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-
enyl)-4-phenyl-2H-chromen-2-one 215 
 
 
 
 
 
 
Compound M1 was methylated from fraction F1 (hexane:ethyl acetate 95:5) of the 
hexane extract of M. elegans. Compound M1 was isolated through PTLC and HPLC as 
a colourless oil. The HRESIMS spectrum exhibited pseudomolecular [M+Na]+ at m/z 
457.1875 (calculated 457.1991), suggesting a molecular formula of C27H30O5. The UV 
spectrum (EtOH) of compound M1 showed peaks at 225, 297 and 331nm, which 
showed a resemblance with the UV absorbance of the parent compound F (226, 297, 
331 nm), supporting the same skeletal structure. In the IR spectrum of compound M1, 
the hydroxyl group peaks were not observed, suggesting that methylation had taken 
place on both of the hydroxyl groups.  
 
The 13C NMR spectrum of compound M1 showed six methyl signals, whereas the 
parent compound F only displayed four methyl signals. In the 1H NMR spectrum of 
compound M1, proton signals for the 5-OH and 7-OH, which were apparent in the 1H 
NMR spectrum of the parent compound F at δ 5.94 and δ 14.57, respectively, were 
missing. On the contrary, two methoxy signals were apparent in the 1H NMR spectrum 
of compound M1 at δ 2.97 (3H, s, H3-1'''') and δ 3.79 (3H, s, H3-1'''''), which were 
215 
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absent in the spectrum of the parent compound F. These observations from the spectral 
data led to the conclusion that compound M1 was methylated at positions C-5 and C-7.   
 
The observed data of compound M1 suggested that this was a di-methylated derivative 
of the parent compound F at positions C-5 and C-7, with the IUPAC name 5,7-
dimethoxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-4-phenyl-2H-chromen-2-one 
215. 
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Table 4.13: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound M1 215 
Position δH, J (Hz)  δC 
2  - 159.3 
3 6.17 (1H, s) 116.2 
4 - 154.4 
4a - 109.8 
5 - 157.4 
6 - 127.0 
7 - 159.0 
8 - 121.8 
8a - 150.5 
1' - 138.3 
2' 7.37 (1H, m, Ar) 127.8 
3' 
 
128.3 
4'     7.41 (3H, m, Ar) 128.7 
5' 
 
128.3 
6' 7.37 (1H, m, Ar) 127.8 
1'' 3.30 (1H, d, J = 6.4)  21.7 
2'' 5.09 (1H, brt, J = 6.4) 120.8 
3'' - 133.0 
4'' 1.71 (3H, s) 17.9 
5'' 1.67 (3H, s) 25.6 
1''' - 206.2 
2''' 3.01 (1H, m) 49.0 
3''' 1.24 (3H, d, J = 7.0) 16.3 
4'''α 1.49 (1H, m)  
    27.0 4'''β 1.90 (1H, m) 
5''' 1.02 (3H, t, J = 7.3) 11.8 
1'''' 2.97 (1H, s) 62.2 
1''''' 3.79 (3H, s) 63.6 
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Figure 4.18: 1H NMR Spectrum of Compound M1 215 
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4.2.11 Compound M2: 5,7-Dimethoxy-6-[(E)-(3,7-dimethylocta-2,6-dienyl]-8-
isobutyryl-4-phenyl-2H-chromen-2-one 216 
 
 
 
 
 
 
Fraction F1 (hexane:ethyl acetate 95:5) of the hexane extract of M. elegans was 
subjected to methylation, and compound M2 was isolated through PTLC and HPLC 
separations from the product of this semi-synthetic process as a white amorphous 
powder. The molecular formula of C31H36O5 was obtained from the HRESIMS 
spectrum of compound M2, which exhibited a pseudomolecular [M+Na]+ ion at m/z 
511.2587 (calculated 511.2460). The UV absorbance of compound M2 was similar with 
the parent compound H, to that of intense absorption peaks at 223, 295 and 335 nm. The 
IR spectrum showed an absorption at υmax 1735cm-1 indicating the presence of α-pyrone 
group. 
 
The 13C NMR spectrum of compound M2 displayed thirty-one carbon signals (seven 
methyls, three methylenes, nine methines and twelve quaternary carbons), as compared 
to the parent compound H which has twenty-nine carbons signals. This observation 
suggests that the hydroxyl groups at 5-OH and 7-OH were methylated. In addition, the 
absence of the 5-OH and 7-OH resonances in the 1H NMR spectrum of compound M2 
further supported this observation. Moreover, two methoxy singlets were observed in 
216 
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the 1H NMR spectrum of compound M2 at δ 2.96 (3H, s, H3-1'''') and at δ 3.78 (3H, s, 
H3-1'''''), which further suggested that C-5 and C-7 of compound M2 had been 
methylated. Apart from the marked differences between the 1H NMR spectra of 
compound M2 and the parent compound H, signals for the other substituents of the 
coumarin skeleton showed similarities (4-phenyl, geranyl and butanoyl groups). 
 
These observations led to the conclusion that compound M2 was indeed a di-methylated 
product of the parent compound H, for which the IUPAC name of 5,7-dimethoxy-6-
[(E)-(3,7-dimethylocta-2,6-dienyl]-8-isobutyryl-4-phenyl-2H-chromen-2-one was 
assigned 216.  
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Table 4.14: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound M2 216 
Position δH, J (Hz)  δC 
2 - 159.3 
3 6.16 (1H, s) 116.2 
4 - 154.4 
4a - 109.8 
5 - 157.5 
6 - 126.9 
7 - 158.8 
8 - 122.2 
8a - 150.3 
1' - 129.9 
2' 7.37 (1H, m, Ar) 127.5 
3' 
 
128.0 
4'     7.41 (3H, m, Ar) 128.8 
5'   128.0 
6' 7.37 (1H, m, Ar) 127.5 
1'' 3.31 (2H, d, J = 6.4) 23.2 
2'' 5.08 (1H, brt, J = 6.4) 122.8 
3'' - 136.1 
4'' 1.70 (3H, s) 16.3 
5'' 1.97 (2H, m) 39.5 
6'' 2.03 (2H, m) 26.7 
7'' 5.02 (1H, brt, J = 6.8) 124.1 
8'' - 131.6 
9'' 1.56 (3H, s) 17.7 
10'' 1.62 (3H, s) 25.9 
1''' - 202.9 
2''' 3.17 (1H, m) 42.2 
3'''  
    1.26 (6H, d, J = 6.7) 
18.0 
4''' 18.0 
1'''' 2.96 (3H, s) 62.3 
1''''' 3.78 (3H, s) 63.4 
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Figure 4.19: 1H NMR Spectrum of Compound M2 216 
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4.2.12 Compound M3: 5,7-Dimethoxy-6-[(E)-3,7-dimethylocta-2,6-dienyl]-8-(2-
methylbutanoyl)-4-phenyl-2H-chromen-2-one 217 
 
 
 
 
 
 
Compound M3 was methylated from the parent compound I and was isolated through 
PTLC and HPLC separations as a white amorphous powder. The HRESIMS spectrum 
revealed a pseudomolecular [M+Na]+ ion at m/z 525.2533 (calculated 525.2617), 
suggesting a molecular formula of C32H38O5. The UV spectrum showed maximum 
absorption bands at 225, 297 and 332 nm, which were similar to the parent compound I 
(226, 296 and 333 nm), indicating the same skeletal structure. In the IR spectrum of 
compound M3, the hydroxyl group absorption were not observed, suggesting that 
methylation had taken place on both of the hydroxyl groups.  
 
An additional two carbons were apparent in the 13C NMR spectrum of compound M3, 
as compared to the parent compound I. This indicated that both of the hydroxyl groups 
in the parent compound I (at 5-OH and 7-OH) had been methylated. This observation 
was further supported by the absence of both hydroxyl peaks in the 1H NMR spectrum 
of compound M3, as compared to parent compound I. In addition, two methoxy singlets 
were apparent in the 1H NMR spectrum of compound M3 at δ 2.97 (3H, s, H3-1'''') and δ 
3.78 (3H, s, H3-1'''''). The chemical shift of H-1''''' was more down field than the 
217 
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chemical shift of H-1'''' due to the hydrogen bond of H-2''''' with the ketone group at C-
1'''.  
 
With the comparison of spectral data between compound M3 and the parent compound I, 
the structure of compound M3 was determined as 5,7-dimethoxy-6-[(E)-3,7-
dimethylocta-2,6-dienyl]-8-(2-methylbutanoyl)-4-phenyl-2H-chromen-2-one 217. 
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Table 4.15: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound M3 217 
Position δH, J (Hz)  δC 
2  - 159.3 
3 6.16 (1H, s) 116.2 
4 - 154.4 
4a - 109.9 
5 - 157.6 
6 - 127.0 
7 - 159.0 
8 - 121.9 
8a - 150.5 
1' - 138.1 
2' 7.37 (1H, m, Ar) 127.6 
3' 
 
128.0 
4'     7.41 (3H, m, Ar) 128.8 
5' 
 
128.0 
6' 7.37 (1H, m, Ar) 127.6 
1'' 3.20 (1H, d, J = 6.4) 23.1 
2'' 5.07 (1H, brt, J = 6.4) 122.7 
3'' - 136.1 
4'' 1.69 (3H, s) 16.3 
5'' 1.95 (2H, m) 39.6 
6'' 2.01 (2H, m) 26.5 
7'' 5.01 (1H, brt, J = 6.8) 124.1 
8'' - 131.6 
9'' 1.54 (3H, s) 17.7 
10'' 1.61 (3H, s) 25.7 
1''' - 206.3 
2''' 3.00 (1H, m) 49.3 
3''' 1.22 (3H, d, J = 6.8) 14.9 
4'''α 1.49 (1H, m)  
     25.1 4'''β 1.90 (1H, m) 
5''' 1.00 (3H, t, J = 7.4) 11.7 
1'''' 2.95 (3H, s) 62.3 
1''''' 3.78 (3H, s) 63.6 
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Figure 4.20: 1H NMR Spectrum of Compound M3 217 
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Figure 4.21: 13C NMR Spectrum of Compound M3 217
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4.2.13 Compound M4: 5,7-Dimethoxy-6-[(E)-(3,7-dimethylocta-2,6-dienyl]-8-(3-
methylbutanoyl)-4-phenyl-2H-chromen-2-one 218 
 
 
 
 
 
 
Compound M4 was isolated by using HPLC as a white amorphous powder after being 
methylated from the parent compound J. The molecular formula of C32H38O5 was 
obtained from the HRESIMS spectrum of compound M4, which exhibited a 
pseudomolecular [M+Na]+ ion at m/z 525.2603 (calculated 525.2617). The UV 
absorbance of compound M4 was similar to that the parent compound J, with intense 
absorption bands at 223, 297, 333 nm. The IR spectrum showed absorptions at υmax 
1730 cm-1, indicating the presence of an α,β-unsaturated lactone group. However, the IR 
spectrum of compound M4 did not show the presence of the absorptions of hydroxyl 
group, which signifies that the hydroxyl groups in the parent compound J had been 
methylated.  
 
The 13C NMR spectrum of compound M4 displayed thirty-two carbon signals (seven 
methyls, four methylenes, nine methines and twelve quaternary carbons), as compared 
to the parent compound J which had thirty carbons signals. Two methoxy singlets were 
apparent in the 1H NMR spectrum of compound M4 at δ 2.95 (3H, s, H3-1'''') and δ 3.79 
218 
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(3H, s, H3-1'''''), in addition to the missing signals of the 5-OH and 7-OH as compared to 
the parent compound J. 
 
The observations from the spectral data of compound M4 led to the identification of this 
compound as 5,7-dimethoxy-6-[(E)-(3,7-dimethylocta-2,6-dienyl]-8-(3-
methylbutanoyl)-4-phenyl-2H-chromen-2-one 218. 
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Table 4.16: 1H NMR, 13C NMR, COSY and HMBC (in CDCl3, 400 MHz) of 
Compound M4 218 
Position δH, J (Hz)  δC COSY HMBC 
2 - 159.3 
  3 6.16 (1H, s) 116.2 
 
2, 4a, 1' 
4 - 154.4 
  4a - 109.8 
  5 - 157.5 
  6 - 126.9 
  7 - 158.8 
  8 - 122.2 
  8a - 150.4 
  1' - 138.0 
  2' 7.37 (1H, m, Ar) 127.6 
 
1', 3'-6' 
3' 
 
128.0 
 
 
4'     7.41 (3H, m, Ar) 128.8 
 
    1', 2', 6' 
5' 
 
128.0 
  6' 7.37 (1H, m, Ar) 127.6 
 
1', 3'-6' 
1'' 3.29 (2H, d, J = 6.4) 23.1 4'' 6, 7, 2'', 3'' 
2'' 5.07 (1H, brt, J = 6.4) 122.7 1'' 1'', 4'', 5'' 
3'' - 136.1 
  4'' 1.69 (3H, s) 16.3 
 
2'', 3'', 5'' 
5'' 1.95 (2H, m) 39.6 
 
2'', 3'', 4'', 6'' 
6'' 2.01 (2H, m) 26.6 
 
3'', 5'', 7'', 8'' 
7'' 5.01 (1H, brt, J = 6.8) 124.1 6'', 9'', 10'' 9'', 10'' 
8'' - 131.6 
  9'' 1.55 (3H, s) 17.7 
 
7'', 8'', 10'' 
10'' 1.61 (3H, s) 25.8 
 
7'', 8'', 9'' 
1''' - 202.3 
  2''' 2.82 (2H, d, J = 6.8) 54.2 3''' 1''', 3''', 4''', 5''' 
3''' 2.34 (1H, m) 24.2 4''', 5''' 1''', 2''', 4''', 5''' 
4'''  
    1.04 (6H, d, J = 6.4) 
22.7 
 
2''', 3''', 5''' 
5''' 22.7 
 
2''', 3''', 4''' 
1'''' 2.95 (3H, s) 62.3 
  1''''' 3.79 (3H, s) 63.5     
 
 
 
 
Chapter 4                                                                            Semi-synthesis of 4-Phenylcoumarin Analogues 
245 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: 1H NMR Spectrum of Compound M4 218 
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Figure 4.23: 13C NMR Spectrum of Compound M4 218 
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Figure 4.24: HMBC NMR Spectrum of Compound M4 218 
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4.2.14 Compound B1: (E)-6-(3,7-Dimethylocta-2,6-dienyl)-7-hydroxy-8-(3-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl 2-bromobenzoate 219 
 
 
 
 
 
 
 
Compound B1 was purified by using HPLC as a yellow oil after being 
bromobenzoylated. The HRESIMS spectrum exhibited a pseudomolecular [M+Na]+ ion 
at m/z 679.1543 (calculated 679.1671), suggesting a molecular formula of C37H37BrO6. 
The experimental mass seems to be far away from accuracy. Due to the fact that this 
was a semi-synthetic derivative, low accuracy was still accepted and other data were 
continued to be analysed, which supported the structural features of compound B1. The 
IR spectrum of compound B1 exhibited a strong absorption at υmax 1731 cm-1, indicating 
the presence of α-pyrone and ester groups. An IR absorption peak at υmax 3483 cm-1 was 
also apparent in the IR spectrum of compound B1, which suggested the presence of a 
hydroxyl group. The UV spectrum (EtOH) of compound B1 displayed absorptions at 
221, 300 and 330 nm, which showed a resemblance to the UV absorbance of the parent 
compound J (227, 299 and 332 nm), supporting the same skeletal structure. 
 
Thirty-seven carbon signals were apparent in the 13C NMR spectrum of compound B1 
(five methyls, four methylenes, thirteen methines and fifteen quaternary carbons), 
219 
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whereas the 13C NMR spectrum of the parent compound J showed thirty carbon signals. 
This indicated an additional seven carbon signals in compound B1, signifying the 
addition of the benzoyl group in the structure.  
 
In the 1H NMR spectrum of compound B1, the resonance for the 5-OH in the parent 
compound J, was absent. However, the resonance for the 7-OH was observed at δ 14.45 
in the 1H NMR spectrum of compound B4. With 2-bromobenzoyl chloride as the 
starting material for this benzoylation, it was ascertained that the bromobenzoylation 
took place at position 5-OH, and not at 7-OH. In the 1H NMR spectrum of compound 
B1, evidence for the presence of a 2-bromobenzoyl moiety was also found at δ 7.48 (1H, 
d, J = 8.3 Hz, H-4''''), 7.17 (1H, t, J = 8.3 Hz, H-5''''), 7.30 (1H, t, J = 8.3 Hz, H-6'''') and 
7.57 (1H, d, J = 8.3 Hz, H-7'''').  
 
Inspection of the spectral data established the identity of compound B1 as (E)-6-(3,7-
dimethylocta-2,6-dienyl)-7-hydroxy-8-(3-methylbutanoyl)-2-oxo-4-phenyl-2H-
chromen-5-yl 2-bromobenzoate 219.  
 
 
 
 
 
 
 
Chapter 4                                                                            Semi-synthesis of 4-Phenylcoumarin Analogues 
250 
 
Table 4.17: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound B1 219 
Position δH, J (Hz)  δC 
2 - 161.3 
3 6.05 (1H, s) 114.1 
4 - 158.4 
4a - 105.7 
5 - 150.4 
6 - 114.2 
7-OH 14.45 (1H, s) 155.1 
8 - 108.2 
8a - 154.5 
1' - 137.9 
2' 7.06 (1H, brd) 127.6 
3' 7.23 (1H, t, J = 7.8) 128.0 
4' 6.77 (1H, t, J = 7.8) 128.5 
5' 7.23 (1H, t, J = 7.8) 128.0 
6' 7.06 (1H, brd) 127.6 
1''α 3.16 (1H, brdd, J = 5.9, 14.6)  
     22.9 1''β 3.40 (1H, brdd, J = 5.9, 14.6) 
2'' 5.00 (1H, brs) 120.3 
3'' - 136.7 
4'' 1.62 (3H, s) 16.2 
5'' 1.85 (2H, m) 39.5 
6'' 1.92 (2H, m) 26.5 
7'' 5.00 (1H, brs) 124.1 
8'' - 131.4 
9'' 1.49 (3H, s) 17.7 
10'' 1.53 (3H, s) 25.4 
1''' - 206.9 
2''' 3.28 (2H, dd, J = 7.3, 7.3) 53.9 
3''' 2.38 (1H, m) 25.6 
4'''  
     1.08 (6H, d, J = 6.8) 
22.7 
5''' 22.7 
1'''' - 166.3 
2'''' - 133.9 
3'''' - 121.6 
4'''' 7.48 (1H, d, J = 8.3) 133.8 
5'''' 7.17 (1H, t, J = 8.3) 133.0 
6'''' 7.30 (1H, t, J = 8.3) 135.1 
7'''' 7.57 (1H, d, J = 8.3) 126.7 
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Figure 4.25: 1H NMR Spectrum of Compound B1 219 
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Figure 4.26: 13C NMR Spectrum of Compound B1 219 
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Figure 4.27: COSY Spectrum of Compound B1 219
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4.2.15 Compound B2: (E)-6-(3,7-Dimethylocta-2,6-dienyl)-7-hydroxy-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromen-5-yl 2-bromobenzoate 220 
 
 
 
 
 
 
 
Compound I which was part of a misture of fraction F1-2, was subjected for 
bromobenzoylation, and compound B2 was the product of this semi-synthetic process. 
Compound B2 was isolated as a yellow oil with the molecular formula C37H37BrO6, 
which was obtained from the HRESIMS measurement which showed a 
pseudomolecular [M+Na]+ ion at m/z 679.1439 (calculated 679.1671). The experimental 
mass seems to be far away from accuracy. Due to the fact that this was a semi-synthetic 
derivative, low accuracy was still accepted and other data were continued to be 
analysed, which supported the structural features of compound B2. The UV spectrum 
(EtOH) of compound B2 was reminiscent to the parent compound I, with absorption 
peaks at 225, 298 and 333 nm. The IR spectrum of compound B2 displayed absorption 
peaks at υmax 1731 (α-pyrone and ester groups) and 3483 cm-1 (hydroxyl group), which 
were similar to the parent compound I.  
 
In the 1H NMR spectrum of compound B2, the singlet for 7-OH was observed at δ 
14.29, whereas the singlet for 5-OH was absent. However, additional signals were 
220 
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apparent in the aromatic region of the 1H NMR spectrum of compound B2 at δ 7.41 (1H, 
dd, J = 1.7, 7.9 Hz,  H-4''''), 7.23 (1H, dt, J = 1.7, 7.8 Hz, H-5''''), 7.19 (1H, dt, J = 1.7, 
7.8 Hz, H-6'''') and 7.50 (1H, dd, J = 1.7, 7.9 Hz, H-7''''). These observations suggested 
that benzoylation has occurred at the 5-OH, instead of at the 7-OH. The proton of 7-OH 
is strongly hydrogen bonded with the nearby ketone group (C-1'''), making it more 
difficult to be benzoylated. 
 
These observations led to the establishment of the structure of compound B2 as (E)-6-
(3,7-dimethylocta-2,6-dienyl)-7-hydroxy-8-(2-methylbutanoyl)-2-oxo-4-phenyl-2H-
chromen-5-yl 2-bromobenzoate 220. 
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Table 4.18: 1H NMR (in CDCl3, 400 MHz) of Compound B2 220 
Position δH, J (Hz)  
2 - 
3 5.99 (1H, s) 
4 - 
4a - 
5 - 
6 - 
7-OH 14.29 (1H, s) 
8 - 
8a - 
1' - 
2' 6.96 (1H, brd) 
3' 7.10 (1H, dt, J = 1.2, 7.7) 
4' 6.70 (1H, dt, J = 1.2, 7.5) 
5' 7.10 (1H, dt, J = 1.2, 7.7) 
6' 6.96 (1H, brd) 
1''α 3.10 (1H, brs) 
1''β 3.31 (1H, brs) 
2'' 4.94 (1H, brs) 
3'' - 
4'' 1.55 (3H, s) 
5'' 1.76 (2H, m) 
6'' 1.81 (2H, m) 
7'' 4.94 (1H, brs) 
8'' - 
9'' 1.42 (3H, s) 
10'' 1.47 (3H, s) 
1''' - 
2''' 3.93 (1H, m) 
3''' 1.25 (2H, d, J = 6.7) 
4'''α 1.40 (1H, m) 
1.74 (1H, m) 4'''β 
5''' 0.98 (3H, t, J = 7.4) 
1'''' - 
2'''' - 
3'''' - 
4'''' 7.41 (1H, dd, J = 1.7, 7.9) 
5'''' 7.23 (1H, dt, J = 1.7, 7.8) 
6'''' 7.19 (1H, dt, J = 1.7, 7.8) 
7'''' 7.50 (1H, dd, J = 1.7, 7.9) 
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Figure 4.X: 1H NMR Spectrum of Compound F4-syn-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.28: 1H NMR Spectrum of Compound B2 220 
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4.2.16 Compound B3: (E)-6-(3,7-Dimethylocta-2,6-dienyl)-8-(3-methylbutanoyl)-2-
oxo-4-phenyl-2H-chromene-5,7-diyl bis(2-bromobenzoate) 221 
 
 
 
 
 
 
 
Compound B3 was bromobenzoylated from the parent compound J which was in a 
mixture, and was purified by using HPLC as a yellowish oil. The molecular formula of 
C44H40Br2O7 of compound B3 was established from the HRESIMS spectrum which 
showed a pseudomolecular [M+Na]+ ion at m/z 861.0873 (calculated 861.1038). The IR 
spectrum of compound B3 displayed an absorption peak at υmax 1731 cm-1, indicating 
the presence of α-pyrone and ester groups. On the contrary, an absorption peak 
indicating the presence of hydroxyl group was absent in the IR spectrum of compound 
B3, suggesting the bromobenzoylation of both hydroxyl groups. The UV absorbance 
peaks (EtOH) at 225, 297 and 330 nm of compound B3 resembled the UV spectrum of 
the parent compound J, which supported the same skeletal structure.  
 
The signals of the 5-OH and 7-OH were absent in the 1H NMR spectrum of compound 
B3, as compared to the parent compound J. This observation supported the absence of 
hydroxyl group peaks in the IR spectrum of compound B3. Moreover, the aromatic 
region showed more complicated proton signals, suggesting the presence of two 2-
221 
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bromobenzene unit in compound B3; a set of δ 7.51 (1H, d, J = 8.3 Hz, H-4''''), 7.23 (1H, 
t, J = 8.3 Hz, H-5''''), 7.30 (1H, t, J = 8.3 Hz, H-6'''') and  7.57 (1H, d, J = 8.3 Hz, H-7''''), 
of the 2-bromobenzene unit attached to C-5, which appears to be more upfield than the 
2-bromobenzene unit attached to C-7; δ 7.73 (1H, dd, J = 2.4, 7.0 Hz, H-4'''''), 7.45 (1H, 
t, J = 8.0 Hz, H-5'''''), 7.42 (1H, t, J = 8.0 Hz, H-6''''') and 8.07 (1H, dd, J = 2.4, 7.0 Hz, 
H-7''''').  
 
The observed spectral data of compound B3, and comparison with the parent compound 
J, led to the identification of this compound as (E)-6-(3,7-dimethylocta-2,6-dienyl)-8-
(3-methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl bis(2-bromobenzoate) 221.  
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Table 4.19: 1H NMR and 13C NMR (in CDCl3, 400 MHz) of Compound B3 221 
Position δH, J (Hz)  δC 
2 - 158.1 
3 6.22 (1H, s) 112.3 
4 - 153.3 
4a - 118.1 
5 - 147.2 
6 - 124.2 
7 - 150.3 
8 - 118.1 
8a - 148.6 
1' - 136.9 
2' 7.12 (1H, brd) 127.6 
3' 7.18 (1H, t, J = 7.8) 128.6 
4' 6.79 (1H, t, J = 7.8) 129.4 
5' 7.18 (1H, t, J = 7.8) 128.6 
6' 7.12 (1H, brd) 127.6 
1''α 3.13 (1H, brd, J = 13.5)       
     24.3 1''β 3.36 (1H, brd, J = 13.5) 
2'' 4.95 (1H, brs) 120.0 
3'' - 137.0 
4'' 1.60 (3H, s) 16.3 
5'' 1.75 (2H, m) 39.3 
6'' 1.83 (2H, m) 26.3 
7'' 4.95 (1H, brs) 123.9 
8'' - 131.4 
9'' 1.23 (3H, s) 17.6 
10'' 1.51 (3H, s) 25.6 
1''' - 200.0 
2''' 2.98 (2H, d, J = 6.7) 53.2 
3''' 2.30 (1H, m) 24.2 
4'''  
      0.98 (6H, d, J = 6.7) 
22.5 
5''' 22.5 
1'''' - 161.5 
2'''' - 132.6 
3'''' - 122.9 
4'''' 7.51 (1H, d, J = 8.3) 133.8 
5'''' 7.23 (1H, t, J = 8.3) 135.1 
6'''' 7.30 (1H, t, J = 8.3) 127.4 
7'''' 7.57 (1H, d, J = 8.3) 126.3 
1''''' - 162.9 
2''''' - 133.1 
3''''' - 123.0 
4''''' 7.73 (1H, dd, J = 2.4, 7.0) 133.9 
5''''' 7.45 (1H, t, J = 8.0) 135.3 
6''''' 7.42 (1H, t, J = 8.0) 127.6 
7''''' 8.07 (1H, dd, J = 2.4, 7.0) 126.4 
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Figure 4.29: 1H NMR Spectrum of Compound B3 221 
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Figure 4.30: 13C NMR Spectrum of Compound B3 221 
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4.2.17 Compound B4: (E)-6-(3,7-Dimethylocta-2,6-dienyl)-8-(2-methylbutanoyl)-2-
oxo-4-phenyl-2H-chromene-5,7-diyl bis(2-bromobenzoate) 222 
 
 
 
 
 
 
 
Compound B4 was isolated through HPLC as a yellowish oil after being 
bromobenzoylated from the parent compound I which was in a mixture of fraction F1-2. 
The HRESIMS spectrum of compound B4 revealed a pseudomolecular [M+Na]+ ion at 
m/z 861.0733 (calculated 861.1038), signifying the molecular formula C44H40Br2O7. 
The same skeletal structure of compound B4 with the parent compound I was supported 
by the UV absorbance peaks (EtOH) of compound B4 at 225, 297 and 330 nm. This 
observation was further supported by the IR at υmax 1731 cm-1, which indicated the 
presence of α-pyrone and ester groups.  
 
The complex signals of the 2-bromobenzene protons in the aromatic region of the 1H 
NMR spectrum of compound B4 indicated that both hydroxyl groups were 
bromobenzoylated, supported by the absence of the 5-OH and 7-OH resonances, as 
compared to the parent compound I. These spectral data observations led to the 
identification of compound B4 as (E)-6-(3,7-dimethylocta-2,6-dienyl)-8-(2-
methylbutanoyl)-2-oxo-4-phenyl-2H-chromene-5,7-diyl bis(2-bromobenzoate) 222. 
222 
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Table 4.20: 1H NMR (in CDCl3, 400 MHz) of Compound B4 222 
Position δH, J (Hz)  
2 - 
3 6.15 (1H, s) 
4 - 
4a - 
5 - 
6 - 
7 - 
8 - 
8a - 
1' - 
2' 7.02 (1H, brd) 
3' 7.11 (1H, dt, J = 1.2, 7.7) 
4' 6.71 (1H, dt, J = 1.2, 7.5) 
5' 7.11 (1H, dt, J = 1.2, 7.7) 
6' 7.02 (1H, brd) 
1''α 3.08 (1H, brd, J = 13.5) 
1''β 3.30 (1H, brd, J = 13.5) 
2'' 4.86 (1H, brt, J = 8.3) 
3'' - 
4'' 1.53 (3H, s) 
5'' 1.67 (2H, m) 
6'' 1.76 (2H, m) 
7'' 4.91 (1H, brt, J = 8.3) 
8'' - 
9'' 1.19 (3H, s) 
10'' 1.43 (3H, s) 
1''' - 
2''' 3.16 (1H, m) 
3''' 1.16 (2H, d, J = 5.4) 
4'''α 1.37 (1H, m) 
4'''β 1.64 (1H, m) 
5''' 0.92 (3H, t, J = 7.8) 
1'''' - 
2'''' - 
3'''' - 
4'''' 7.45 (1H, dd, J = 1.6, 8.0) 
5'''' 7.25 (1H, dt, J = 1.8, 7.8) 
6'''' 7.20 (1H, dt, J = 1.8, 7.8) 
7'''' 7.52 (1H, dd, J = 1.6, 8.0) 
1''''' - 
2''''' - 
3''''' - 
4''''' 7.67 (1H, dd, J = 2.2, 7.0) 
5''''' 7.35 (1H, t, J = 8.0) 
6''''' 7.37 (1H, t, J = 8.0) 
7''''' 7.94(1H, dd, J = 2.2, 7.0) 
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Figure 4.31: 1H NMR Spectrum of Compound B4 222 
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CHAPTER 5 
 AChE ACTIVITY AND SAR STUDIES OF 4-PHENYLCOUMARINS 
 
Alzheimer’s disease (AD), the most common form of dementia in the elderly, is a 
neurodegenerative disease characterized by progressive memory impairment, cognitive 
deficits and behavioral changes96. In the deaths caused by AD, Finland ranks as number 
one, with the death rate of 34.9/100000, followed by Iceland and United States, with 
death rates of 25.1/100,000 and 24.8/100,000, respectively. Malaysia ranks as the 185th 
country, with a death rate of 0.2/100,000 (data source: WHO, 2011). As general health 
care improves, and with the increase of the elderly population, the number of AD 
patients is anticipated to increase dramatically97. 
 
The molecular causes of this condition remain unknown in spite of the existence of 
several theories regarding the pathogenesis of AD; cholinergic, amyloid, tau, calcium 
hypothesis and isoprenoid change98. Now, the most widely accepted biochemical theory 
of the disease is the cholinergic hypothesis, which states that the decline in cognitive 
and mental functions associated with AD is related to the loss of cortical cholinergic 
neurotransmission. AD is associated with a loss of the presynaptic markers of the 
cholinergic system in the brain regions related to memory and learning, and is 
characterized by the presence of amyloid deposits and neurofibrillary tangles in the 
brain of afflicted individuals99. One coherent way to enhance cholinergic 
neurotransmission is to inhibit an enzyme responsible for the metabolic breakdown of 
acetylcholine (ACh). Acetylcholinesterase (AChE) enzyme inhibition is an important 
target for the management of AD, and AChE inhibitors are the main stay drugs for its 
management100. 
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Within the most successful AChE inhibitors introduced as drugs, small molecules of 
natural origin have occupied a prominent position. Indeed, two (galanthamine 223 and 
rivastigmine 224) out of the three (these two and donepezil 225) recommended drugs 
for AD symptomatic treatment have a direct or indirect natural origin101. In addition, 
tacrine 226 and ensaculin 227 also show a modest induction of the improvement in 
memory and cognitive functions, and have been used to treat AD clinically102,103. These 
have pointed out the significance of exploring nature as a source of bioactive 
compounds that may serve as the leads or scaffolds for further chemical elaboration.  
 
In line with that, the present work deals with the bioassay-guided isolation of AChE 
inhibitors from the bark of M. elegans (King) Kosterm. The hexane extract from the 
bark gave 90% inhibition of AChE at 10 μg/mL concentration. The hexane : ethyl 
acetate (95 : 5) fraction of this active hexane extract gave 100% inhibition at 10 μg/mL 
concentration. Further isolation and structural elucidation of compounds from this 
fraction were carried out. In addition to the bioassay-guided isolation of AChE 
inhibitors, other chemical constituents from M. elegans were also isolated, which 
possessed the same 4-phenylcoumarin skeletal features. In order to obtain more 
analogues, chemical modifications were performed on the active fraction and the major 
chemical constituents from this plant. A structure-activity relationship (SAR) study has 
been carried out with the natural and modified 4-phenylcoumarins. This chapter will 
discuss the results and the related SAR study of these compounds. 
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5.1    Bioassay-guided Study of Acetylcholinesterase Inhibitory Activity of M. 
elegans 
The hexane, ethyl acetate and methanol extracts from the bark of Mesua elegans were 
subjected to acetyl cholinesterase (AChE) inhibitory evaluations. The hexane, ethyl 
acetate and methanol extracts exhibited inhibition percentages of 90%, 80%, and less 
than 50%, at 10 μg/mL concentration, respectively. The hexane extract was further 
investigated for its chemical contents since it was the most potent among the extracts. 
 
The hexane extract was fractionated into eight fractions (Table 5.1), in which the 
fraction hexane : ethyl acetate (95 : 5) (F1) showed the highest inhibition percentage of 
100% at 10 μg/mL concentration. Therefore, this active fraction was subjected to further 
chromatographic separation. 
 
Bioassay-guided isolation of the active compounds from the active fraction resulted in 
the discovery of nine 4-phenylcoumarins, of which four of them (compounds D, E, I 
and O) showed significant activity. Compound E 190 gave the highest activity of 80% 
inhibition at 10 μg/mL concentration and an IC50 value of 0.70 μM. For these AChE 
inhibition evaluations, tacrine was used as the positive control. The inhibition 
percentage and IC50 values of the isolated compounds are listed in Table 5.2. The 
summary of the bioassay-guided procedure is shown in Scheme 8.1. 
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Table 5.1: Solvent Ratios Used for the Fractionation of the Crude Hexane Extract and 
the Inhibition Percentage of Each Fraction 
 
Fraction Solvent Ratio 
(Hexane : Ethyl Acetate) 
Inhibition Percentage 
 (at 10 g/mL) 
F1 95 : 5 100 
F2 90 : 10  
 
Less than 50 
F3 80 : 20 
F4 70 : 30 
F5 50 : 50 
F6 0 : 100 
Fraction 
Solvent Ratio 
(Ethyl Acetate : Methanol) 
Inhibition Percentage 
 (at 10 g/mL) 
F7 50 : 50  
Less than 50 F8 0 : 100 
 
 
Table 5.2: Inhibition Percentage and IC50 Values of Isolated Compounds 
 
Compounds 
Inhibition Percentage (at 10 g/mL) IC50  
(M) Test 1 Test 2 Average 
Compound B - - - - 
Compound D 80 70 75 1.06 
Compound E 80 80 80 0.70 
Compound G 20 40 30 - 
Compound H 20 30 25 - 
Compound I 70 70 70 3.06 
Compound J 20 40 30 - 
Compound M 30 50 40 - 
Compound O 70 60 65 8.73 
Tacrine - - - 0.074 
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5.2 SAR Studies of 4-Phenylcoumarins as Acethylcholinesterase Inhibitors 
A total of twenty-seven 4-phenylcoumarins were evaluated for the inhibition of AChE 
(at 10 g/mL), in which ten compounds were natural products and seventeen 
compounds were semi-synthetic compounds. A SAR (structure-activity relationship) 
study was carried out with these 4-phenylcoumarins. 4-Phenylcoumarins with above 
50% inhibition of AChE were considered for this SAR discussion. From the results 
obtained (Table 5.3), the author has attempted a SAR study analysis, which will be 
discussed briefly in the coming paragraphs.  
 
Table 5.3: Average Inhibition Percentage (at 10 ug/mL) of the Natural and Semi-
synthesized Compounds  
 
Compound Average Inhibition % 
D 75.0 
E 80.0 
F 23.0 
G 30.0 
H 25.0 
I 70.0 
J 30.0 
L 46.0 
M 40.0 
O 65.0 
A1 41.0 
A2 15.5 
A3 29.5 
A4 29.5 
Compound Average Inhibition % 
A5 47.5 
A6 58.0 
A7 29.5 
A8 56.0 
A9 76.0 
M1 32.0 
M2 39.5 
M3 24.0 
M4 54.5 
B1 49.5 
B2 39.5 
B3 24.5 
B4 50.0 
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Figure 5.1: Compounds with AChE Inhibition Above 50% (at 10 g/mL) 
 
E (80.0%) A9 (76.0%) D (75.0%) 
I (70.0%) O (65.0%) 
(70.0%) 
A6 (58.0%) 
(70.0%) 
M4 (54.5%) B4 (50.0%) A8 (56.0%) 
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The most active compound was compound E showing 80.0% inhibition at 10 g/mL, 
which has a geranyl-pyran cyclized ring at positions C-5/C-6, and a 2-methylbutanoyl at 
position C-8. The activity dropped a little to 76.0% inhibition in compound A9, which 
has an open chain geranyl group attached at position C-6 and a 3-methylbutanoyl at 
position C-8, together with two acetate groups at position C-5 and C-7. Interestingly, 
the inhibition activity of compound D, which also possesses geranyl pyran substituent 
(an analogue of compound E), was comparable to compound A9.  
 
Moreover, it is worthy to note that the activity of compound I (70.0%), which has an 
open chain geranyl at position C-6, has decreased compared to compound E which has a 
the geranyl-pyran substituent at position C-5/C-6. It was also observed that geranyl-
furan substituted compound O was less active than geranyl-pyran substituted 
compounds E and D. For the furan substituted compounds at position C-5/C-6, it was 
noted that the prenyl-furan substituted compounds L and M were less active (below 
50% of AChE inhibition) than the geranyl-furan substituted compound O (65.0%), 
indicating that a longer chain is favourable for the activity. 
 
Overall, the natural compounds showed good activity, and one may assume that 
chemical modification of substituents of 4-phenylcoumarins may induce change in 
activity. This may be exemplified by the acetylated compound A9 (76.0%) and the 
methylated compound M4 (54.5%), which were more active than their parent compound 
J (30.0%). However, chemical modification may also decrease the activity of a more 
active natural compound. For instance in the case of compound I which has 70.0% 
AChE inhibition, has shown a decrease in activity upon acetylation (compound A8 - 
56.0%) and bromobenzoylation (compound B4 - 50.0%).  
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Generally, 4-phenylcoumarins with longer or bulkier substituents at position C-6 gave a 
higher percentage of inhibition as compared to the shorter substituents at the same 
position. For example, of the nine compounds which had an AChE inhibition activity of 
more than 50.0%, eight of the 4-phenylcoumarins were substituted by a geranyl or 
geranyl derivative at position C-5/C-6, as compared to one compound A6, which has a 
prenyl substituent at position C-6. On the other hand, compounds with a 2-
methylbutanoyl or 3-methylbutanoyl substituent at position C-8 were active, whereas 
compounds with a 2-methylpropanoyl group were inactive, which is also indicating that 
a longer chain for a substituent at C-8 could be more favorable. In brief, from this SAR 
analysis, one may suggest that a geranyl-pyran group is more favorable than a geranyl-
furan or a prenyl-furan substituent at C-5/C-6 of the 4-phenylcoumarin for enhancement 
of activity. Furthermore, a methylbutanoyl substituent is more favorable than a 
methylpropanoyl group for enhancement of the activity. Further chemical modifications 
of the natural compounds may still enhance the AChE inhibition activity, or may also 
reduce the activity of the compounds.  
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CHAPTER 6 
NEUROPROTECTIVE EFFECTS OF 4-PHENYLCOUMARINS 
 
A decade after stepping into the new millennium, neurodegenerative diseases still are 
one of the world’s most arduous and appalling health issues as a result of increasing 
demographic fluctuation towards the aged population, as well as growing apprehension 
for a better quality of life. Such awareness, together with the huge social and economic 
costs of the disease, has ignited in depth research efforts to combat, or at least delay the 
onset of neurodegenerative diseases104. In a normal cycle of tissue proliferation, the 
aged and older cells are set to decease in order to give way for the generation of new 
cells. Such a setting of programmed cell death, or better known as apoptosis, is the 
prime cause in neurodegenerative diseases as a number of these diseases are 
characterized by a progressive fading away of neurons105. 
 
Apoptosis holds a cardinal role in the maturation of the nervous system, as well as 
neural architecture, through the interplay between both anti- and pro-apoptotic proteins. 
Basically, neurons either will render an adaptive response or they would initiate 
apoptosis when they are exposed to stress signals or apoptotic stimuli, such as 
withdrawal of neurotrophic factor, ischemic stroke, misfolded proteins, mitochondrial-
complex inhibition, excessive calcium entry and excitotoxicity106. Apoptosis, or 
programmed cell death, is delineated with lucid and perspicuous morphological 
features, including cell shrinkage, chromatin condensation, loss of nuclear membrane 
integrity, plasma membrane blebbing or zeiosis, and eventually the breaking off of 
cellular fragments giving rise to the formation of apoptotic bodies106. Therefore, it is 
noteworthy that apoptosis orchestrates a crucial role in numerous neurodegenerative 
diseases, and targeting its pathway could confer a mode of prevention and treatment105. 
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The present part of the work reports and discusses the neuroprotective effects of the 
extracts, fractions and pure compounds isolated from the bark of Mesua kunstleri (King) 
Kosterm, through a bioassay-guided evaluation. 
 
6.1 Neuroprotective Activity Results 
6.1.1 Bioassay-guided Study of the Neuroprotective Effects of M. kunstleri 
The concentration-dependent effect of H2O2 challenge on cell viability for 10 hours 
using the MTT cell viability assay study was carried out107.  NG108-15 cells were 
treated with different concentrations of H2O2 (0.1 - 4 mM) for 10 hours and a significant 
reduction in cell viability in a dose-dependent manner was detected. After exposure to 2 
mM H2O2, NG108-15 cell viability was about 45.41 ± 3.42% that of control viability. 
Pretreatment (2 hours) with the hexane extract showed the highest percentage cell 
viability of 136.94 ± 2.03%, where as the ethyl acetate and methanol extracts showed 
115.47 ± 3.55% and 89.81 ± 2.31%, respectively. The hexane extract was then 
subjected to neuroprotective assay-guided approach because of its high neuroprotective 
activity, and six fractions were obtained after fractionation. Fraction BH1 possessed the 
strongest neuroprotective activity with the percentage cell viability of 131.29 ± 3.03%. 
Further fractionation of BH1 yielded two sub-fractions (BH1-a and BH1-b) with sub-
fraction BH1-b possessing stronger neuroprotective effect (101.07 ± 4.81%) as 
compared with fraction BH1-a. Hence, BH1-b was further chromatographed, and five 
pure compounds were isolated and identified. This neuroprotective assay-guided study 
has led to the isolation of five 4-phenylcoumarins from sub-fraction BH1-b, namely  
mammea A/BB 55, mammea A/BA 28, mesuagenin C 191, 5,7-dihydroxy-8-(2-
methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one 
(DMDP-1) 47 and 5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-
dienyl]-4-phenyl-2H-chromen-2-one (DMDP-2) 48 (Figure 6.1). Among these 
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compounds, mesuagenin C 191 showed potent neuroprotective activity against H2O2 
insult, and the results are depicted in Scheme 6.1.  
 
 
 
 
 
Figure 6.1: Compounds Isolated from Sub-fraction BH1-b from the Hexane Extract of 
M. kunstleri 
 
 
 
55 28 191 
47 
5 
48 
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Scheme 6.1: Fractionation and Isolation of the Bioactive Compounds from the Bark of 
M. kunstleri and Their Neuroprotective Effects at 200M 
 
6.1.2 Mesuagenin C Protective Effects Against H2O2-Induced Apoptosis in 
NG108-15 Cells 
NG108-15 cells were pretreated with the 4-phenylcoumarins at varying concentrations 
(3.125 - 200 μM) for 2 hours prior to exposure to H2O2 (2 mM). As summarized in 
Table 6.1 and Figure 6.2 (a), only mesuagenin C 191 significantly increased the cell 
viability, up to 78.99 ± 3.49% (200 μM) which was the greatest neuroprotection as 
compared to the rest of the compounds. Furthermore, mesuagenin C 191 dose-
dependently increased cell viability as shown in Figure 6.2 (b). These results allowed 
the conclusion that mesuagenin C 191 was effective for the protection of NG108-15 
cells. EGCG was selected as a standard reference in the neuroprotective evaluation 
(Figure 6.2 (c)). Mesuagenin C 191 showed lower neuroprotective activity when 
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compared to EGCG at 50 μM (Figure 6.2 (c)). However, the neuroprotective activity of 
mesuagenin C 191 at concentrations of 25 μM and above were significantly different 
(*P < 0.05) compared to the H2O2-treated group. 
 
Table 6.1: Neuroprotective Effects of 4-Phenylcoumarins (200 µM) Isolated from 
Hexane Extract of the Bark of M. kunstleri Against H2O2-Induced Apoptosis in NG108-
15 cells.  
 
 
Compounda      Cell Viability (%)b 
Control       100 
 
H2O2
c
         45.41 ± 3.42
# 
 
55        42.41 ± 2.35 
28        51.46 ± 1.42* 
191         78.99 ± 3.49* 
47        61.99 ± 1.58* 
48        56.47 ± 1.70* 
 
EGCG (50 µM)d      85.19 ± 2.17 
 
 
The values shown are the means ± SE of at least three independent experiments. 
 
aNG108-15 cells were pretreated with 4-phenylcoumarins (3.125 - 200 µM) for 2 hours 
prior to exposure to H2O2 (2 mM). After incubation, cells were assessed by MTT to 
determine the percentage viability. 
bCell viability was measured by MTT assay. 
cH2O2-treated value differed significantly from the untreated control at the level of #P < 
0.05. 
dEGCG was used as standard positive control at 50 µM. 
 
#Results differ significantly from H2O2-treated group compared to the control untreated 
group: P < 0.05. 
 
*Significantly different from the H2O2-treated group compared to the treatment group: P 
< 0.05 
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Figure 6.2: (a) Neuroprotective evaluation of 4-phenylcoumarins by MTT cell viability 
assay (b) Dose-dependent increase in cell viability by pretreatment with mesuagenin C 
190 in H2O2-induced cell death prior to 2 mM of H2O2 exposure for 10 hours. Dose-
dependent increase in cell viability by pretreatment with EGCG prior to 2 mM of H2O2 
exposure for 10 hours. (c) Comparison of mesuagenin C 191 and EGCG pretreated cell 
viability. Values are mean ± S.E. from at least three independent experiments. The 
asterisk indicated significantly different values from H2O2-treated cells (*P < 0.05). 
 
 
 
6.1.3 Effects of Mesuagenin C on Cell Viability and Neuritogenesis 
The effects of mesuagenin C 191 on neuritogenesis in NG108-15 cells were examined 
in both dose- and time-dependent experiments. The neuritogenic activity of mesuagenin 
C 191 was evaluated in the concentration range of 125 - 5000 nM for 12 - 48 hours of 
treatment. Following treatment with mesuagenin C 191 for 12 and 24 hours, the number 
of neurite-bearing cells was significantly increased in a dose-dependent manner, even at 
a lower concentration of 125 nM compared with untreated cells (Figure 6.3 (a)). As 
shown in Figure 6.3 (a), the number of neurite-bearing cells was rapidly promoted up to 
53.83 ± 2.05% as compared to untreated cells (P < 0.05). Upon incubation for 36 hours 
at concentration of 2500 nM, the number of neurite-bearing cells was increased up to 
57.22 ± 1.77%, which was the highest increment of neurite-bearing cells among the 
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different doses and time incubations. However, following incubation at 36 hours, 
treatment at 5000 nM recorded a decrease of the percentage of neurite-bearing cells 
(44.52 ± 2.48%), and this similar trend was observed when the cells were treated for 48 
h at concentrations of 2500 and 5000 nM (Figure 6.3 (a)). Interestingly, it was observed 
that treatment with mesuagenin C 191 at 1000 nM significantly induced neuritogenesis 
in NG108-15 cells in both a dose- and time-dependent manner (Figure 6.3 (a)). When 
compared with time-matched, untreated cells and other concentrations, mesuagenin C 
191 increased the number of neurite-bearing cells to 17.56, 31.85, 38.28 and 54.35% 
and based on this data, mesuagenin C 191 at a concentration of 1000 nM was used for 
the subsequent experiment. As compared to NGF-2.5S, a concentration of 5 ng/mL was 
found to be the optimal concentration that enhanced neurite outgrowth to 43.69 ± 1.78% 
as compared to the untreated group (Fig. 6.3 (b)). The evaluation of mesuagenin C 191 
toxicity in NG108-15 was assessed by the MTT assay107. Mesuagenin C 191 at 100 and 
200 nM increased NG108-15 cells proliferation with an increase of cell viability to 
103.44% and 110.06%. Nevertheless, the initial toxicity was seen at 3.125 µM at 48 
hour (Figure 6.3 (c)). Even though the cell viability was reduced to 50% with 
mesuagenin C 191 concentration of (IC50) 20.09 ± 1.58 µM, thus reassuring the 
concentration of mesuagenin C 191 (125-5000 nM) was safe, non-toxic and 20-fold 
lower (at 1000 nM) than its IC50 value in the neuritogenesis analysis.  
 
 
 
 
 
 
 
Chapter 6                                                                               Neuroprotective Effects of 4-Phenylcoumarins 
283 
 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6                                                                               Neuroprotective Effects of 4-Phenylcoumarins 
284 
 
 
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3:  Mesuagenin C 191 induced neuritogenesis in NG108-15 cells and its effects 
on NG108-15 cell viability. (a) NG108-15 cells were treated with mesuagenin C 191 for 
12, 24, 36 and 48 hours, analysed by phase-contrast microscopic analysis. Mesuagenin 
C 191 significantly induced neurite outgrowth in a dose-dependent manner (125-5000 
nM) after 12 - 48 hours. (b) The effects of NGF-2.5S on neurite outgrowth in NG108-15 
cells. NGF-2.5S was used as the positive control. (c) The cytotoxicity of mesuagenin C 
191 after 48 hours of treatment in NG108-15 cells. Values are mean ± S.E. from at least 
three independent experiments. The asterisk (*P < 0.05 and **P < 0.01) indicated 
significantly different values from untreated cells.  
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6.2 Neuroprotective Effects of 4-Phenylcoumarins and their SAR studies 
In the present study, it was found that the hexane fraction of M. kunstleri prevented 
H2O2-induced neurotoxicity in NG108-15 cells. In order to clarify the neuroprotective 
components of M. kunstleri, as part of a continuing study on neuroprotective effects of 
M. kunstleri, neuroprotective activity-guided isolation was carried out to search for the 
active fractions and compounds. The effects of various extracts on neuroprotective 
activity were compared and the crude hexane extract of M. kunstleri exerted the most 
potent neuroprotective activity against H2O2-induced toxicity in NG108-15 cells 
(Scheme 6.1). The activity of the crude hexane extract is 136.94 ± 2.03% of cell 
viability, which is higher than the activity of the most active fraction from this crude 
(BH1), which has 131.29 ± 3.03% of cell viability. Further sub-fractionation of the most 
active fraction gave rise to BH1-b being the most active sub-fraction with 101.07 ± 
4.81% of cell viability. The neuroprotective assay-guided fractionation and isolation of 
the active chemical constituent led to the identification of five compounds from the 
most potent sub-fraction BH1-b; mammea A/BB 55, mammea A/BA 28, mesuagenin C 
191, 5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-
phenyl-2H-chromen-2-one (DMDP-1) 47 and 5,7-dihydroxy-8-(3-methylbutanoyl)-6-
[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one (DMDP-2) 48. 
 
Isolated compounds from this subfraction gave rise to mesuagenin C 191 with the 
highest activity (78.99 ± 3.49% of cell viability). The activity values of the cell viability 
evaluation declined from the crude hexane extract to the pure isolated compounds, 
which led to the hypothesis of the involvement of a synergistic mechanism. All of the 
five compounds isolated in sub-fraction BH1-b possess an open chain prenylated or 
geranylated 4-phenylcoumarin skeleton. Based on the MTT assay, mesuagenin C 191 
illustrated the most significant neuroprotective activity towards H2O2-induced cell death 
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in the NG108-15 cells. These results suggested that the C-6 side chain of the 4-
phenylcoumarin is essential for the neuroprotective activity. Compounds possessing a 
free geranyl chain at position C-6 (191, 47 and 48) are active whereas compounds 
possessing free prenyl chain at the same position (55 and 28) are less active. Further 
isolation work was done on subfraction BH1-a, and cyclized prenylated (mammea 
A/BB cyclo D 186 and mammea A/BA cyclo D 187) and geranylated 4-
phenylcoumarins (mesuagenin E 188, mesuagenin A 189 and mesuagenin B 190) were 
purified and characterized (Fig. 6.4). These compounds were isolated from the less 
active subfraction BH1-a, which suggests that a cyclized prenyl and geranyl groups at 
position C-6 of the 4-phenylcoumarins are not essential for the activity.  
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Figure 6.4: Compounds Isolated from Sub-fraction BH1-a from the Hexane Extract of 
M. kunstleri 
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CHAPTER 7 
CONCLUSIONS 
 
Phytochemical analysis of the bark of two Malaysian Clusiaceae plants, Mesua elegans 
(King) Kosterm. and Mesua kunstleri (King) Kosterm., were carried out. A total of 
twenty-two compounds were isolated from M. elegans, of which thirteen are new; 
mesuagenin A 189, mesuagenin B 190, mesuagenin C 191, mesuagenin F 195, 
mesuagenin D 196, mesuagenin G 198, mesuagenin H 199, mesuagenin I 200, 
mesuagenin J 201, mesuagenin K 202, mesuagenin L 203, mesuagenin M 204 and 
mesuagenin N 205. From M. kunstleri, a total of ten compounds were isolated, of which 
one is new; mesuagenin E 188. These compounds were purified using several 
chromatographic techniques; column chromatography (CC), thin layer chromatography 
(TLC), preparative thin layer chromatography (PTLC), centrifugal partition 
chromatography (CPC) and high performance liquid chromatography (HPLC). The 
structures of the isolated compounds were elucidated using various spectroscopic 
methods; 1D NMR (1H, 13C and DEPT), 2D NMR (COSY, HSQC, HMBC and 
NOESY), UV, IR, HRESIMS, and by comparison with data from literature. 
 
Preliminary screening of the bark from M. elegans showed that the hexane extract 
possessed acetyl cholinesterase (AChE) inhibitory activity with the inhibition 
percentage of 90% at 10 g/mL. Bioassay-guided study of the active hexane 
extract afforded mesuagenin A 189, mesuagenin B 190, 5,7-dihydroxy-8-(2-
methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one 47 
and mesuagenin D 196 as good inhibitors of AChE, especially mesuagenin B 190 with 
an IC50 of 0.70 µM. Further isolation work carried out with this hexane extract afforded 
more natural 4-phenylcoumarins, and semi-synthesis work was done on the major 4-
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phenylcoumarins from this extract, which afforded seventeen semi-synthesized 4-
phenylcoumarins. All of the natural and semi-synthetic 4-phenylcoumarin analogues 
were subjected to an AChE inhibition SAR study. From this SAR analysis, it is 
suggested that a geranyl-pyran group is more favorable than a geranyl-furan or a prenyl-
furan substituent at C-5/C-6 of the 4-phenylcoumarin for enhancement of activity. 
Furthermore, a methylbutanoyl substituent is more favorable than a methylpropanoyl 
group for enhancement of the activity. Further chemical modifications of the natural 
compounds may enhance the AChE inhibition activity further, or, on the contrary, may 
also reduce the activity of the compounds. 
 
Bioassay-guided study was also carried out to isolate and evaluate the neuroprotective 
compounds from the hexane extract of the bark of M. kunstleri on H2O2-induced 
apoptosis in NG108-15 cells. Mesuagenin C 191 was isolated as the most active 
compound with 78.99 ± 3.49% of cell viability after NG108-15 cells were exposed to 2 
mM H2O2 and 2 hours of pretreatment with this compound. From the cell viability 
evaluation of the ten 4-phenylcoumarins (from sub-fraction BH1-a and BH1-b), it may 
be suggested that compounds possessing a free geranyl chain at position C-6 are more 
favourable for the neuroprotective activity than compounds possessing a free prenyl 
chain at the same position. It may also be proposed that a cyclized prenyl or geranyl 
group at position C-6 of the 4-phenylcoumarins is not essential for the activity. 
 
This study has shown that Mesua plants are rich producers of interesting bioactive 
compounds of the 4-phenylcoumarin type. Further studies can be performed on other 
Mesua species, and for the potent compounds, elucidation of their mechanism of actions 
may be investigated. 4-Phenylcoumarins may be potential lead compounds for further 
investigation as therapeutic agents for neurodegenerative diseases. 
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CHAPTER 8 
EXPERIMENTAL 
 
8.1 Plant Materials  
Mesua elegans          
The bark of Mesua elegans (King) Kosterm. was collected from Sungai Badak Forest 
Reserve, Sintok, Kedah, Malaysia on 27th April 2006 by Mr. Din bin Muhammad Nor. 
The sample (Figure 8.1) with voucher specimen number KL 5232, was identified by 
Mr. Teo Leong Eng and deposited in the herbarium of the Department of Chemistry, 
Faculty of Science, University of Malaya.  
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Figure 8.1: Mesua elegans (King) Kosterm. 
Plant description: 
The tree Mesua elegans (King) Kosterm. was 8 m tall and 15 cm in diameter. The bark 
was greyish brown and scaly with pinkish brown inner bark. The leaves were thinly 
coriaceous, from elliptic to lanceolate with apex acuminate acute and base acute to 
obtuse. The areas of the leaves are 6 - 10.5 cm x 2 - 3.5 cm with dark green above and 
glaucous below. The leaves have 16 - 20 pairs of nerves, which were faint and visible 
on both sides. The petioles were short, with the length of 3 - 5 mm long. The tree had 
inflorescence axillary and terminal, which were solitary or cymose. The flowers of the 
tree are white in colour. 
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Mesua kunstleri 
The bark of Mesua kunstleri (King) Kosterm. was collected from Rimba Teloi Forest 
Reserve, Kedah, Malaysia on 19th April 1995 by Mr. Din bin Muhammad Nor. The 
sample (Figure 8.2) with voucher specimen number KL 4485 was identified by Mr. Teo 
Leong Eng and deposited in the herbarium of the Department of Chemistry, Faculty of 
Science, University of Malaya.  
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Figure 8.2: Mesua kunstleri (King) Kosterm. 
Plant description: 
The tree Mesua kunstleri (King) Kosterm. was 14 m tall and 35 cm in diameter. The 
bark was grey and with pinkish red inner barks and brown exudate. The leaves were 
opposite simple, thinly coriaceous and in distant pairs, from elliptic to lanceolate with 
long acuminate acute and base shortly pointed. The areas of the leaves are 9.5 - 13 cm x 
2.5 - 4 cm with bright green above and slightly glaucous below. The leaves have 
prominent 20 pairs of nerves. The petioles were 7 mm in length. The tree had 
inflorescence axillary and terminal, which were solitary and sometimes several were 
together. The flowers of the tree are yellow-green in colour. 
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8.2 Instrumentation 
 NMR spectra were obtained using JEOL LA400 FT NMR, JEOL ECA400 FT 
NMR Spectrometer System, Bruker AVN400 FT NMR, Bruker AVN600 FT 
NMR, Bruker DMX500 WB and Bruker 300 NMR using deuterated chloroform 
as solvent. Chemical shifts were reported in ppm and coupling constants were 
given in Hertz (Hz).  
 Mass spectra were carried out on an Agilent Technologies 6530 Accurate-Mass 
Q-TOF LC/MS, with ZORBAX Eclipse XDB-C18 Rapid Resolution HT 4.6 
mm i.d. x 50 mm x 1.8 m column. HPLC grade methanol, acetonitrile and 
deionised water were used as mobile phase solvents. All solvents and samples 
were filtered with 0.2 μm nylon membrane filter (WHATMAN) prior to LCMS 
analysis. 
 UV spectra were recorded on a Shimadzu UV-Visible Recording 
Spectrophotometer using HPLC grade ethanol as solvent with mirror UV cell. 
 The infrared (IR) spectra were obtained through Perkin Elmer FT-IR 
Spectrometer Spectrum RX1 using chloroform as solvent. 
 
8.3 Chromatography 
8.3.1 Thin Layer Chromatography (TLC) 
Aluminum supported silica gel 60 F254 plates were used to visualize the spots of the 
isolated compounds. UV Light Model UVGL-58 Mineralight Lamp 230V~50/60 Hz 
was used to examine spots or bands on the TLC after spraying with the required 
reagents. 
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8.3.2 Column Chromatography (CC) 
 All solvents used in these experiments were industrial grade (distilled). Silica gel 60, 
230-400 mesh ASTM (Merck 9385) was used for column chromatography. A slurry of 
silica gel 60 (approximately 30:1 silica gel to sample ratio) in hexane solvent system 
was poured into a glass column of appropriate size with gentle tapping to remove 
trapped air bubbles. The crude extract was initially dissolved in a minimum amount of 
solvent and loaded on top the packed column. The extract was eluted with an 
appropriate solvent system at a certain flow rate. Fractions were collected in either test 
tubes or conical flasks and evaporated for the next step. Fractions with similar 
compounds were then combined after TLC monitoring. 
 
8.3.3 Preparative Thin Layer Chromatography (PTLC) 
PTLC silica gel 60 F254 glass plates of size 20 cm x 20 cm (Merck 1.05715.0001) were 
used for the separation of compounds. UV Light Model UVGL-58 Mineralight Lamp 
230V~50/60 Hz was used to examine bands on the PTLC. 
 
8.3.4 High Performance Liquid Chromatography (HPLC) 
Waters HPLC System was used for HPLC separation, equipped with Binary Gradient 
Module, System Fluidics Organizer and UV detector set at the range from 200-600 nm. 
HPLC injections were also performed with a Rheodyne 20 μL sample loop (Rheodyne 
Europe, Bensheim, Germany) associated with a Hewlett-Packard series 1100 HPLC 
degasser G1322A, QuatPump G13211A and DAD G1315A (Agilent Technologies, 
Massy, France). Chromatographic analysis and separations were performed on 
ZORBAX Eclipse Plus C18 (4.6 mm i.d. x 150 mm x 3.5 m), ZORBAX Eclipse Plus 
C18 (9.4 mm i.d. x 250 mm x 3.5 µm), Chromolith Performance RP-18 (4.6 mm i.d. x 
100 mm), Chromolith RP-18 endcapped (10 mm i.d. x 100 mm), Genesis C18 (4.6 mm 
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i.d. x 150 mm x 4.0 m), Genesis C18 (10 mm i.d. x 150 mm x 4.0 m) and Purospher 
C18 (4.6 mm i.d. x 250 mm x 5 µm) HPLC columns. Methanol (HPLC grade), 
acetonitrile (HPLC grade) and deionized water were used as mobile phase solvents with 
formic acid (HPLC grade) as buffer. All solvents and samples were filtered with 0.45 
μm nylon membrane filter prior to HPLC analysis. The data were collected and 
analysed by using MassLynx software. 
 
8.3.5 Centrifugal Partition Chromatography (CPC) 
Armen Instruments CPC was used for CPC separations; SCPC-250 system coupled with 
Armen Glider Spot Prep II CPC software and provided by Armen Technologies 
(France). The SCPC-250 system was equipped with a 250 mL column with injection 
capacity ranging from 10 mg to 3-6 g. The rotation speed was adjustable from 0 to 
3000 rpm. Binary gradient pump with a flow-rate that ranges from 5 to 15 mL/min, 
built-in automatic injection valve, UV-vis dual wavelength spectrophotometer with high 
pressure flow cell were also used. The rotor was first filled with the upper phase of the 
solvent system as the stationary phase. The apparatus was rotated at 1600 rpm and the 
lower mobile phase of the solvent mixture was then pumped into the inlet of the column 
(rotor) at a flow rate of 10 mL/min in the descending mode. Samples were loaded in the 
5 mL injection-loop, and injected in the column in a “sandwich” mode, i.e. at the same 
time with the mobile phase. First elution occurred in the descending mode (reversed-
phase mode): the rotor was filled with the upper apolar phase of the solvent mixture, 
and the pumped mobile phase is the polar lower phase. The first batch was collected in 
descending mode for 50, 150, 300 and 500 mg of samples. After collecting fractions in 
the descending mode by peak, another batch was injected to collect as multidual mode, 
where by the switching valve is turned to the ascending mode and the mobile phase 
pumped is the upper one this time. The descending-ascending switching went on until 
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all the peaks observed in the descending mode were eluted. Extrusion was performed 
after the last tube; the lower phase was pumped in the ascending mode to eject the sum 
of the upper phase out of the rotor108,109. n-Heptane (Hept), ethyl acetate (EtOAc), 
methanol (MeOH), acetonitrile (CH3CN) were purchased from Carlo Erba Reactifs (Val 
de Reuil, France) as analytical grade solvents used for CPC analyses. Trifluoroacetic 
acid (TFA) was purchased from Sigma-Aldrich (Lyon, France). Water was of ultrapure 
quality. Samples were filtered with 0.45 μm nylon membrane filter prior to injection. 
 
8.4 Detection Reagents 
8.4.1 Vanillin-Sulphuric Acid 
Vanillin (1.0 g) in concentrated H2SO4 (10 mL) was added upon cooling to 90 mL of 
ethanol before spraying onto the TLC plate. The TLC plate was then heated at ~50 ºC 
until full development of the colours had occurred. The occurrence of blue, purple, dark 
green, grey or brown spots indicated the presence of coumarins and phenylpropenes. 
 
8.4.2 Anisaldehyde-Sulphuric Acid 
Anisaldehyde (0.5 mL) was added in glacial acetic acid (50 mL) and 1 mL concentrated 
H2SO4. After the reagent was sprayed onto the TLC plate, the TLC plate was then 
heated to ~105°C until maximum visualization of spots had occurred. The occurrence of 
purple, blue, red, grey or green spots indicated the presence of phenols, sugars, steroids, 
and terpenes. 
  
8.5  Extraction and Isolation 
8.5.1 Extraction and Isolation of Mesua elegans 
The extraction, fractionation and isolation of the bark of Mesua elegans (King) 
Kosterm. were performed using the bioassay-guided study method, in which after each 
Chapter 8                                                                                                                                    Experimental 
298 
stage, the sample was tested for the activity; in this case for the acetyl cholinesterase 
(AChE) inhibitory activity. 
  
The extraction was carried out by the cold percolation method. Dried ground bark (1.5 
kg) was macerated with hexane (3 x 4L, each 48 hours) at room temperature. The 
hexane extract was then evaporated using rotary-evaporator and a yellow gummy 
extract (120.3 g) was obtained. The plant material was then subjected to ethyl acetate 
and methanol extraction successively (3 x 4L, each 48 hours, respectively) at room 
temperature. The extracts were then evaporated using a rotary-evaporator. The ethyl 
acetate crude (81.1 g) was obtained as a brown gummy residue while the methanol 
extract (93.2 g) was obtained as a brown amorphous powder. All the crude extracts were 
tested for AChE inhibitory activity, and the hexane extract gave the highest inhibitory 
activity (90% inhibition at 10 μg/mL concentration). Thus, the hexane extract was 
subjected to further chromatographic analysis. Both the crude ethyl acetate and 
methanol extracts were kept for future use and study.  
 
The crude hexane extract of the bark (13.0 g) was subjected to column chromatography 
fractionation over silica gel (230-400 mesh). The amount of eluent solvent used was 
based on the ratio of 1 g of crude extract to 1 L of solvent for each fraction. Thus, in this 
case, 13 L of eluent solvent was used for each fraction. All the fractions were then 
tested for AChE inhibitory activity. Fraction 1 (F1) was the most potent fraction with 
100% inhibition at 10 μg/mL concentration. Thus F1 was subjected for further isolation 
and purification steps. 
 
F1 (8.0 g) was subjected to column chromatography over silica gel. The further 
fractionation steps were based on the gradient elution method. Sub-fractions were 
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collected for every 500 mL of eluent. The sub-fractions were then treated individually 
and subjected to either further column chromatography (CC), Preparative Thin Layer 
Chromatography (PTLC), High Performance Liquid Chromatography (HPLC) or 
Centrifugal Partition Chromatography (CPC) analysis. The bioassay-guided isolation 
procedure of AChE inhibitors from the bark of Mesua elegans are outlined in Scheme 
8.1. Listed in Table 8.1 are the PTLC conditions for the purification of F1-1. HPLC 
conditions for F1-2, F1-3-sub-fraction B and F1-4 are shown in the next few pages, 
along with their respective HPLC profiles in Figures 8.3 - 8.5. Scheme 8.2 shows the 
isolation procedure of fraction F2, where as Scheme 8.3 and Scheme 8.4 show the 
isolation procedure for fraction F3 and F4, respectively. 
 
Structural identification of the isolated compounds was carried out using spectroscopic 
methods; 1H NMR, 13C NMR, COSY, HSQC, HMBC, DEPT, IR, UV and mass 
spectrometry. Compounds isolated from the bark of M. elegans and their yield, are 
listed in Table 8.2. 
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Scheme 8.1: Bioassay-Guided Isolation Procedure of AChE Inhibitors from the Bark of 
Mesua elegans (King) Kosterm. 
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Table 8.1: PTLC Condition for the Purification of F1-1 
Condition Compound D 189 Compound E 190 Compound B 187 
Solvent System Hexane : Ethyl Acetate  98 : 2; developed 4 times 
Rf  (Hex:EA _ 98:2) 0.26 0.26 0.21 
 
HPLC 1 (F1-2) 
LC mode : Analytical 
LC column : ZORBAX Eclipse Plus C18 (4.6 x 150 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-20 min, 
50-100% B 
Flow Rate : 1 mL/min 
Weight of sample injected  : 20 mg 
Sample injection volume   : 10 μL 
Sample injection concentration : 1 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound I 47 - 18.81 min 
       Compound J 48 - 19.05 min 
 
HPLC 2 (F1-3-Sub-fraction B) 
LC mode : Semi-preparative 
LC column : Genesis C18 (10.0 x 150 mm, 4.0 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: ACN + Formic Acid 0.1%; 0-30 min, 
60-100% B 
Flow Rate : 4.7 mL/min 
Weight of sample injected  : 120 mg 
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Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound O 196 - 18.60 min 
       Compound J 48 - 24.22 min 
 
HPLC 3 (F1-4) 
LC mode : Semi-preparative 
LC column : Chromolith RP18 Endcapped (10.0 x 100 mm) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-20 min, 
50-100% B; 20-25 min, 100-100% B 
Flow Rate : 4.7 mL/min 
Weight of sample injected   : 150 mg 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound M 194 - 12.00 min 
       Compound G 28 - 17.45 min 
  Compound O 196 - 18.81 min 
  Compound H 191 - 20.87 min 
  Compound J 48 - 22.22 min 
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Figure 8.3: HPLC Profile of Fraction F1-2 (HPLC 1) 
 
 
 
 
 
 
Figure 8.4: HPLC Profile of F1-3-Sub-fraction B (HPLC 2) 
 
 
 
 
 
 
Figure 8.5: HPLC Profile of Fraction F1-4 (HPLC 3) 
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Scheme 8.2: Isolation Procedure of F2 from the Bark of Mesua elegans 
 
HPLC 4 (F2) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-60 min, 
85-85% B; 60-61 min, 85-100% B; 61-67 min, 100-100% B; 67-68 min, 100-85% B; 
68-75 min, 85-85% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound N 195 – 41.47 min 
       Compound O 196 – 47.29 min 
 
 
 
 
 
 
HPLC 4 
F2               
Hex:EA 90:10  
(120 mg)     
Compound N 195  Compound O 196  
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Scheme 8.3: Isolation Procedure of F3 from the Bark of Mesua elegans 
 
HPLC 5 (F3-1) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-80 min, 
85-85% B; 80-81 min, 85-100% B; 81-90 min, 100-100% B; 90-91 min, 100-85% B; 
91-100 min, 85-85% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound K 192 - 43.75 min 
       Compound L 193 - 56.72 min 
  Compound M 194 - 73.25 min 
 
Hex:EA                     
83:17 
Flash Column Chromatography 
F3               
Hex:EA 80:20  
(600 mg)     
Compound K 192 
Compound L 193 
Compound M 194 
Hex:EA                     
85:15 
F3-1                 
(200 mg)           
F3-2                 
(105 mg)           
F3-4                 
(100 mg)           
F3-3                 
(120 mg)           
Hex:EA                     
80:20 
Hex:EA                     
77:23 
HPLC 5 
Compound P 197 
Compound U 202   
HPLC 6 
Compound Q 198 
Compound R 199 
Compound S 200 
HPLC 7 
Compound V 203 
Compound W 204  
HPLC 8 
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HPLC 6 (F3-2) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-110 
min, 82-82% B; 110-120 min, 82-100% B; 120-130 min, 100-100% B; 130-131 min, 
100-82% B; 131-140 min, 82-82% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound P 197 - 29.41 min 
       Compound U 202 - 98.12 min 
 
HPLC 7 (F3-3) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-100 
min, 85-85% B; 100-101 min, 85-100% B; 101-110 min, 100-100% B; 110-111 min, 
100-85% B; 111-120 min, 85-85% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound Q 198 - 67.59 min 
       Compound R 199 - 79.63 min 
       Compound S 200 - 85.90 min 
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HPLC 8 (F3-4) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-55 min, 
80-80% B; 55-56 min, 80-100% B; 56-63 min, 100-100% B; 63-64 min, 100-80% B; 
64-70 min, 80-80% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound V 203 - 49.57 min 
       Compound W 204 - 52.30 min 
        
 
 
 
 
 
 
 
 
Scheme 8.4: Isolation Procedure of F4 from the Bark of Mesua elegans 
 
 
Flash Column Chromatography 
F4               
Hex:EA 70:30  
(350 mg)     
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HPLC 9 (F4-1) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-40 min, 
75-75% B; 40-60 min, 75-100% B; 60-70 min, 100-100% B; 70-71 min, 100-75% B; 
71-80 min, 75-75% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound T 201 - 31.95 min 
 
HPLC 10 (F4-2) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-45 min, 
80-80% B; 45-46 min, 80-100% B; 46-52 min, 100-100% B; 52-53 min, 100-80% B; 
53-60 min, 80-80% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound X 205 - 27.66 min 
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Table 8.2: Chemical Constituents from M. elegans and Their Yield 
Isolates Yield (mg) 
Compound B 40.3 
Compound D 55.1 
Compound E 15.1 
Compound F 5.2 
Compound G 7.3 
Compound H 20.0 
Compound I 3.2 / 30.2 (CPC) 
Compound J 5.6 / 56.3 (CPC) 
Compound K 5.0 
Compound L 7.3 
Compound M 15.1 
Compound N 35.2 
Compound O 60.3 
Compound P 3.1 
Compound Q 5.0 
Compound R 6.5 
Compound S 7.5 
Compound T 11.3 
Compound U 4.0 
Compound V 3.0 
Compound W 2.5 
Compound X 12.4 
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8.5.1.1 CPC Separation of Mesua elegans 
A CPC study was carried on with the fraction F1 (hexane: ethyl acetae 95:5) of Mesua 
elegans. Comparison study between isocratic mode and multiple dual-mode of CPC 
injections have been carried out for 50, 150, 300 and 500 mg injections of fraction F1. 
Apart from CPC modes comparison, both the CPC modes (isocratic and multiple dual-
mode) have been compared with semi-preparative HPLC separations as well. Five 4-
phenylcoumarins have been identified in these investigations; compound F 55, 
compound G 28, compound H 191, compound I 47 and compound J 48. From the CPC 
separations, in both isocratic mode and multiple dual-mode, fraction II contained a 
mixture of compounds F 55 and G 28, fraction III contained compound G 28, fraction 
IV contained compound H 191 and fraction V contained a mixture of compounds I 47 
and J 48. 
 
Two 4-phenylcoumarins were isolated as pure compounds by using CPC in both 
isocratic and multiple-dual mode injections; compound G 28 and compound H 191. The 
purity of the CPC isolated compounds G 28 and H 191 were shown in Table 8.3. In the 
isocratic mode, only 50 and 150 mg injections gave compounds G 28 with a HPLC (293 
nm) purity of above 90%; 50 mg (98.5%) and 150 mg (96.2%). Increment of the 
injected mass to 300 and 500 mg in the isocratic mode did not manage to give 
compounds G 28 with a purity above 90% (Figure 8.6). Meanwhile in the multiple dual-
mode, all the injection gave compounds G 28 with a purity of above 90%; 50 mg 
(99.6%), 150 mg (97.6%), 300 mg (93.2%) and 500 mg (93.0%). For compound H 191, 
the CPC separation in the isocratic mode for the 50, 150 and 300 mg injections gave a 
HPLC (293 nm) purity of above 90%; 50 mg (98.1%), 150 mg (94.6%) and 300 mg 
(91.1%) (Figure 8.7). As for the multiple dual-mode separation, all the injections gave a 
purity of above 90% for compound H 191; 50 mg (100%), 150 mg (96.6%), 300 mg 
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(95.5%) and 500 mg (94.3%). Until 150 mg injection, differences of HPLC purity for 
both compounds between isocratic and multiple-dual modes were insignificant. The 
chromatogram for the comparison between 150 and 300 mg multiple-dual modes were 
depicted in Figure 8.8. However, when injected masses were higher, the purity 
decreased below 90% in isocratic mode, where as in multiple-dual mode, compound G 
28 and compound H 191 were up to 93% pure even when 500 mg of sample were 
injected. From the purity results of compound G 28 and compound H 191, it may be 
deduced that CPC multiple-dual mode separation was better than isocratic mode 
separation for these compounds. 
 
Another comparative study of the percentage yield between semi-preparative HPLC and 
CPC separations (both isocratic and multiple dual-modes) has also been conducted. 
Table 8.4 displayed the yield and percentage recovery of fraction H1 using both semi-
preparative HPLC and CPC separations techniques. Recovery of total mass injected 
from semi-preparative HPLC separation was merely 85.0%, whereas for the CPC 
separations (both modes), gave a recovery with more than 90%. Yields obtained in 150, 
300 and 500 mg injections from CPC isocratic and multiple dual-modes were also 
compared, in which 300 mg gave the highest yield; 94.8% in batch mode, and 93.7% in 
multiple-dual mode.  
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Figure 8.6:  CPC chromatogram of 300 mg injection, isocratic mode. Column capacity: 
250 mL, solvent system: heptane-ethyl acetate-acetonitrile-water (9:1:9:1, v/v/v/v), 
containing trifluoroacetic acid 0.1%, mobile phase: lower phase, flow rate: 10 mL/min, 
rotation speed of column: 1600 rpm, retention of stationary phase: 72.8%. 
 
 
 
 
 
 
Figure 8.7: CPC chromatogram of 300 mg injection, multiple dual-mode. Column 
capacity: 250 mL, solvent system: heptane-ethyl acetate-acetonitrile-water (9:1:9:1, 
v/v/v/v), containing trifluoroacetic acid 0.1%, mobile phase: lower phase in descending 
mode and upper phase in ascending mode, flow rate: 10 mL/min, rotation speed of 
column: 1600 rpm, retention of stationary phase in descending mode: 72.8%. 
F
1 
F
2 
F
3 
F
4 
F
5 
F
1 
F
2 
F3 
F
4 
F
5 
Chapter 8                                                                                                                                    Experimental 
313 
 
 
 
 
 
 
Figure 8.8: Comparison between CPC chromatograms of multiple dual-mode 150 mg 
and 300 mg injections. Column capacity: 250 mL, solvent system: heptane-ethyl 
acetate-acetonitrile-water (9:1:9:1, v/v/v/v), containing trifluoroacetic acid 0.1%, mobile 
phase: lower phase in descending mode and upper phase in ascending mode, flow rate: 
10 mL/min, rotation speed of column: 1600 rpm, retention of stationary phase in 
descending mode: 72.8%. 
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Table 8.3: HPLC Purity Comparison of Compound G 28 and Compound H 191 at 293 
nm Isolated by Isocratic and Multiple-Dual Mode CPC Injections 
 
 
Table 8.4: Yield and Percentage Recovery Comparison Between HPLC and CPC 
(Isocratic and Multiple-Dual Mode) Injections of Fraction F1 
 
 
 
 
Mode Isocratic Multiple dual 
Mass Injected 
(mg) 
Compound G 
28                 
(% purity) 
Compound H 
191                
(% purity) 
Compound G 
28                  
(% purity) 
Compound H 
191                
(% purity) 
50 98.5 98.1 99.6 100.0 
150 96.2 94.6 97.6 95.5 
300 84.2 91.1 93.0 96.6 
500 82.3 79.4 93.2 94.3 
Mode Semi-
Preparative 
HPLC 
Isocratic CPC Multiple dual CPC 
Fractions 
(mg) 
10 50 150 300 500 50 150 300 500 
Total 
Mass of 
Recovery 
(mg) 
8.5 45.5 139.8 284.3 451.0 46.1 139.5 281.0 463.1 
% 
Recovery 
85.0 91.0 93.2 94.8 90.2 92.2 93.0 93.7 92.6 
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8.5.2 Extraction and Isolation of Mesua kunstleri 
Dried ground bark of M. kunstleri (1.5 kg) was macerated with hexane (3 x 4L, each 48 
hours) at room temperature. The hexane extract was dried off using rotary-evaporator 
and some yellow gummy residue (110.4 g) were obtained. The plant material was then 
subjected for ethyl acetate and methanol extraction successively (3 x 4L, each 48 hours, 
respectively) at room temperature. Both of the extracts were then evaporated off to 
dryness using rotary-evaporator. The ethyl acetate crude (70.1 g) was obtained as brown 
gummy residue while the methanol extract (80.3 g) was obtained as brown amorphous 
powder. Hexane crude exhibited the most potent neuroprotection activity (136.94 + 
2.03%). Thus, the hexane crude was subjected for further chromatographic analysis. 
Both ethyl acetate and methanol crude were kept for future use and study. 
 
A portion of the hexane crude (10.0 g) was subjected to column chromatography 
fractionation over silica gel (230-400 mesh) and eluted with hexane-EtOAc (from 9.5 to 
0) and EtOAc-MeOH (5:5) to give fractions BH1-BH6. Fraction BH1 showed the most 
potent neuroprotective activity (131.29 + 3.03%), thus fraction BH1 was then subjected 
to silica gel chromatography and eluted with hexane-EtOAc (from 9.7 to 9.4) to produce 
subfractions BH1-a and BH1-b. Both of these subfractions were subjected for 
neuroprotective assay study and BH1-b was found to be the most active subfraction 
(101.07 + 4.81%). The isolation procedure of the neuroprotective compounds from the 
bark of M. kunstleri are outlined in Scheme 8.5. Compounds isolated from the bark of 
M. kunstleri and their yield, are listed in Table 8.5. 
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Scheme 8.5: Isolation Procedure of Chemical Constituents from the Bark of Mesua 
kunstleri (King) Kosterm. 
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HPLC 11 (BH1-a) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-180 
min, 85-85% B; 180-181 min, 85-100% B; 181-190 min, 100-100% B; 190-191 min, 
100-85% B; 191-200 min, 85-85% B 
Flow Rate : 3 mL/min 
Weight of sample injected  : 150 mg 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound A 186 - 48.14 min 
       Compound B 187 - 52.60 min 
       Compound C 188 - 105.99 min 
       Compound D 189 - 157.20 min 
       Compound E 190 - 174.74 min 
 
HPLC 12 (BH1-b) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-50 min, 
90-90% B; 50-51 min, 90-100% B; 51-60 min, 100-100% B; 60-61 min, 100-90% B; 
61-70 min, 90-90% B 
Flow Rate : 3 mL/min 
Weight of sample injected  : 200 mg 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
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UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound F 55 - 17.15 min 
       Compound G 28 - 17.89 min 
       Compound H 191 - 31.26 min 
       Compound I 47 - 42.09 min 
       Compound J 48 - 44.05 min 
 
Table 8.5: Chemical Constituents from M. kunstleri and Their Yield 
Isolates Yield (mg) 
Compound A 3.2 
Compound B 5.2 
Compound C 8.0 
Compound D 20.2 
Compound E 30.3 
Compound F 8.1 
Compound G 15.3 
Compound H 10.6 
Compound I 30.5 
Compound J 50.8 
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8.6  Semi-synthesis 
8.6.1 Acetylation 
Fraction F1 (hexane:ethyl acetate 95:5) from the hexane extract of the bark of Mesua 
elegans was subjected to the acetylation process. This fraction mainly contained five 
chemical constituents; compound F, compound G, compound H, compound I and 
compound J. Below is the method used for the acetylation. The semi-synthesized 
compounds were isolated from the acetylation product (Scheme 8.6) and the following 
Table 8.6 shows the PTLC condition for the fractionation of acetylation products. Table 
8.7 shows the names of the isolates and yield obtained. 
 
The method 
Acetic anhydride (4.3 mL, 45.47 mmol) was added to a solution of 305 mg of fraction 
F1 in pyridine (5.0 mL). After stirring for 14 hours, the solution was concentrated with 
vacuum evaporator and chromatographed using PTLC and HPLC110. 
 
 
 
 
 
 
 
Scheme 8.6: Isolation Procedure of the Acetylation Product 
 
 
FA1         
(88.3 mg) 
PTLC 1 
Acetylation Product 
(293 mg) 
FA2         
(40.4 mg) 
FA3         
(75.2 mg) 
FA4         
(50.3 mg) 
HPLC 13 HPLC 14 HPLC 15 HPLC 16 
Compound A3 208 
Compound A4 209 
Compound A1 206 
Compound A2 207 
Compound A8 213 
Compound A9 214 
Compound A5 210 
Compound A6 211 
Compound A7 212 
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Table 8.6: PTLC Condition for the Fractionation of Acetylation Product 
Condition FA1 FA2 FA3   FA4 
Solvent System Hexane : Ethyl Acetate  90 : 10; developed 3 times 
Rf      Hex:EA 
         90:10 
0.90 0.84 0.75 0.60 
 
 
HPLC 13 (FA1) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-150 
min, 95-95% B; 150-151 min, 95-100% B; 151-160 min, 100-100% B; 160-161 min, 
100-95% B; 161-170 min, 95-95% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound A4 209 - 132.98 min 
       Compound A3 208 - 150.39 min 
 
HPLC 14 (FA2) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-40 min, 
85-85% B; 40-41 min, 85-100% B; 41-50 min, 100-100% B; 50-51 min, 100-85% B; 
51-60 min, 85-85% B 
Flow Rate : 3 mL/min 
Chapter 8                                                                                                                                    Experimental 
321 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound A9 214 - 30.15 min 
       Compound A8 213 - 34.89 min 
 
HPLC 15 (FA3) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-30 min, 
80-80% B; 30-31 min, 80-100% B; 31-40 min, 100-100% B; 40-41 min, 100-80% B; 
41-50 min, 85-80% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound A6 211 – 11.60 min 
       Compound A5 210 – 12.79 min 
       Compound A7 212 – 23.20 min 
 
HPLC 16 (FA4) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-50 min, 
85-85% B; 50-51 min, 85-100% B; 51-60 min, 100-100% B; 60-61 min, 100-85% B; 
61-70 min, 85-85% B 
Flow Rate : 3 mL/min 
Sample injection volume   : 500 μL 
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Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound A2 207 – 39.87 min 
       Compound A1 206 – 44.13 min 
 
Table 8.7: Acetylation Isolates and Their Yield 
Acetylation Isolates Yield (mg) 
Compound A1 206 12.5 
Compound A2 207 19.8 
Compound A3 208 21.6 
Compound A4 209 35.6 
Compound A5 210 12.3 
Compound A6 211 17.3 
Compound A7 212 11.3 
Compound A8 213 19.5 
Compound A9 214 30.2 
 
 
8.6.2 Methylation 
Methylation was carried out using fraction F1 (hexane:ethyl acetate 95:5) from the 
hexane extract of the bark of Mesua elegans. The parent compounds F - J in this 
fraction were methylated to afford compounds M1 - M4. Table 4.2 depicts the isolates 
of the methylation process. 
 
The method 
A mixture of fraction F1 (499.3 mg), potassium carbonate (583.1 mg, 4.21 mmol) and 
iodomethane (449.0, 3.16 mmol) in dry acetone was heated to reflux over 8 hrs. The 
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mixture was then be filtered to remove potassium carbonate and was concentrated. The 
residue were dissolved in ethyl acetate and washed with water. The organic layer were 
dried over sodium sulphate, evaporated at reduced pressure and chromatographed by 
HPLC (HPLC 17). The methylation product gained was 450.3 mg. Table 8.8 shows the 
names of the isolates and yield obtained. 
 
HPLC 17 (Methylation Product) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-100 
min, 85-85% B; 100-101 min, 85-100% B; 101-110 min, 100-100% B; 110-111 min, 
100-85% B; 111-120 min, 85-85% B 
Flow Rate : 3 mL/min 
Weight of sample injected  : 160 mg 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
Retention time of compound  : Compound M1 215 - 26.43 min 
       Compound M2 216 - 58.56 min 
       Compound M4 218 - 80.57 min 
       Compound M3 217 - 85.39 min 
Table 8.8: Methylation Isolates and Their Yield 
Methylation Isolates Yield (mg) 
Compound M1 215 15.6 
Compound M2 216 24.3 
Compound M3 217 33.6 
Compound M4 218 56.9 
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8.6.3 Bromobenzoylation 
Fraction F1-2 from the hexane extract of the bark of Mesua elegans was been subjected 
to the bromobenzoylation process. This fraction contained two major chemical 
constituents; compound I 47 and compound J 48. Table 8.9 designates the isolates from 
the bromobenzoylation reaction.  
 
The method 
To a solution fraction F1-2 (500.0 mg) and dry acetone (20 mL), potassium carbonate 
(437.0 mg, 3.16 mmol) and benzylbromide (541.1 mg, 3.16 mmol) were added. The 
mixture was heated for reflux for 12 hrs. The solution was then diluted with ethyl 
acetate, and was washed with brine and water, respectively. The organic phase were 
dried over sodium sulphate, evaporated at reduced pressure and chromatographed by 
HPLC (HPLC 18). The bromobenzoylation product gained was 443.3 mg. Table 8.9 
shows the names of the isolates and yield obtained. 
 
HPLC 18 (Bromobenzoylation Product) 
LC mode : Semi-preparative 
LC column : ZORBAX Eclipse Plus C18 (9.4 x 250 mm, 3.5 m) 
Mobile system: A: H2O + Formic Acid 0.1%; B: MeOH + Formic Acid 0.1%; 0-105 
min, 90-90% B; 105-106 min, 90-100% B; 106-115 min, 100-100% B; 115-116 min, 
100-90% B; 116-125 min, 90-90% B 
Flow Rate : 3 mL/min 
Weight of sample injected  : 150 mg 
Sample injection volume   : 500 μL 
Sample injection concentration : 10 mg/mL 
UV detection (nm)   : 200-400, PDA detector 
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Retention time of compound  : Compound B1 219 - 46.27 min 
       Compound B2 220 - 52.89 min 
       Compound B3 221 - 88.20 min 
       Compound B4 222 - 98.11 min 
 
 
Table 8.9: Bromobenzoylation Isolates and Their Yield 
Bromobenzoylation Isolates Yield (mg) 
Compound B1 10.2 
Compound B2 15.3 
Compound B3 30.2 
Compound B4 53.6 
 
 
8.7  Acetyl Cholinesterase Inhibitory Activity Evaluation 
Acetylcholinesterase (AChE) from Electrophorus electricus (C2888) was purchased 
from Sigma. Inhibition of AChE activity was determined by the spectroscopic method 
of Ellman, using acetylthiocholine iodide as substrate, in 96-well microtiter plates. All 
solutions were brought to room temperature prior to use. Aliquots of 200 μL of a 
solution containing 640 μL of 10 mM of 5,5’-dithio-bis-2-nitrobenzoic acid (DTNB) in 
0.1M sodium phosphate, pH 8.0, 19.2 mL of the same buffer, and 13 μL of a solution of 
AChE (100 U/mL) in water, were added to each well, followed by 2 μL of a DMSO 
solution of the inhibitor (0.9% final volume). The reaction was initiated by adding 20 
μL of acetylthiocholine iodide (7.5 mM) to each well, and was followed by monitoring 
the appearance of the thiolate dianion produced by the reduction of DTNB at 412 nm 
every 13 s for 120 s at 25 °C in a Molecular Devices spectra Max 384 Plus plate reader. 
Each inhibitor was evaluated at ten concentrations (ranging from 1 mg/mL to 0.05 
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μg/mL by diluting by a factor of 3). Percentage inhibition was calculated relative to a 
control sample of DMSO (% inhibition = [1-(slope cpd/slope DMSO)] x 100) with 
SoftMax® Pro software. IC50 values displayed represent the mean ± standard deviation 
for six assays (SD = [∑(x – x)2/n]1/2). Tacrine hydrochloride (Sigma, purity > 99%) was 
used as reference compound111.  
 
8.8 Neuroprotective Activity Evaluation 
NG108-15 hybridoma cell line was obtained from American Type Culture Collection 
(ATCC). Dulbecco’s Modified Eagle’s Medium (DMEM), epigallocatechin gallate 
(EGCG), Hypoxanthine-Aminopterin-Thymidine (HAT), phosphate buffered saline 
(PBS), sodium bicarbonate, HEPES salt and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) were provided by Sigma-Aldrich. Fetal bovine 
serum (FBS), 100 unit/mL penicillin/100 g/mL streptomycin and amphotericin B (50 
µg/mL) were supplied by PAA Laboratories. Accutase was bought from Innovative Cell 
Technologies, Inc. Hydrogen peroxide (H2O2) was purchased from Systerm
®. Murine 
Nerve Growth Factor 2.5s was purchased from Promega. All chemicals used were of 
analytical and molecular grade. NG108-15 cells were cultured in DMEM supplemented 
with 10% heat-inactivated FBS, 2% penicillin/streptomycin, 1% amphotericin B, and 
HAT as a complete medium. Cells were cultured at 37 °C in 5% CO2 atmosphere with 
95% humidity and checked routinely under inverted microscope (Motic) for any 
contamination. NG108-15 cell viability was assessed by MTT assay107. Metabolically 
active cells containing mitochondrial dehydrogenase convert the tetrazolium salt, MTT, 
into insoluble purple formazan crystals at a rate that is proportional to the cell viability. 
NG108-15 cells were rinsed with PBS, harvested with accutase and plated at a total 
density of 5 x 103 cells/well in a 96-well plate and left to adhere for 48 hours. Cells 
were preincubated for 2 hours with compounds prior to H2O2 (2 mM) exposure for 
Chapter 8                                                                                                                                    Experimental 
327 
subsequent 10 hours. 20 µL MTT solution (5 mg/mL) (Sigma Aldrich) was added and 
incubated at 37°C for another 4 hours. The medium was removed subsequently and 
DMSO was added to dissolve the formazan crystals. The eluted samples were measured 
directly in a microplate reader (ASYS UVM340) at 570 nm (with a reference 
wavelength of 650 nm). Cell viability was calculated based on the formula below: 
% of cell viability = [absorbance of treated cells (As)/ absorbance of control cells (AC)] 
x 100%               
    
The neurite outgrowth analysis was conducted based on protocol discussed by Lozano 
et al.112 and Mitchell et al.113. The cells were primed by changing the medium to 5% 
FBS for 4 - 6 days prior to the neurite outgrowth assay. Cells were plated into at cell 
density of 2 × 104 cells and were left to adhere overnight. Cells were then treated with 
different range of concentration of compounds at 48 hour in order to determine the best 
concentration of the compound that would induce neurite outgrowth without toxicity 
effect. For comparison purpose, cells were also treated with different concentration of 
NGF-2.5S from murine submaxillary gland (Promega) which served as positive control. 
Cells with 5% serum medium were used as negative control. Cell bearing neurite was 
scored positive if it possesses polygonal morphology with a thin neurite extension with 
length greater than twofold the cell body diameter and possessing a terminal growth 
cone. Cells were photographed with inverted microscope (Leica Inverted Fluorescence 
Microscope, DM16000B) using phase-contrast objectives and images of ten fields per 
well were taken with an average of 100 cells per field and examined. The percentage of 
neurite-bearing cells were quantified by scoring total number of neurite-bearing cells 
and total number of viable cells in 10 microscopic fields. 
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